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Abstract 
 
This thesis describes studies, which have been realised towards the total syntheses of two 
natural products (±)-FR901483 (1) and (+)-TAN1251B (3), which are thought to be 
biosynthetically related.  
 
The introduction summarises the isolation and biological activities of both natural products. It 
then focuses on previous methods used to overcome the key challenges in their syntheses: 
formation of their related tricyclic cores and the quaternary stereocentre next to nitrogen. Our 
initial retrosynthetic analysis is presented, which proposes the formation of both targets from 
a common intermediate. 1,5-CH insertion of an alkylidene carbene would allow formation of 
this common intermediate, containing the challenging quaternary stereocentre adjacent to 
nitrogen, in a stereoselective fashion. A brief review of work employing this methodology, 
which has been described within the Hayes group towards these natural products follows. 
 
The results and discussion begins with the synthesis of the common intermediate. From here, 
work towards the formation of the tricyclic core of (±)-FR901483 (1) is presented. The 
initially proposed route of closing the final ring of the tricyclic core via a regioselective 
intramolecular aldol cyclisation was found to be unsuccessful. A revised route involving an 
intramolecular peptide coupling as the key ring closing step gives our first tricyclic derivative 
of (±)-FR901483 (1). Formation of a related tricycle is subsequently achieved via a 
palladium-catalysed alkenylation reaction. The unsuccessful attempts at elaboration of this 
structure are then discussed. Finally, the progress made in a revised route towards the 
IRUPDWLRQ RI D NH\ LQWHUPHGLDWH LQ )XNX\DPD¶V V\QWKHVLV RI (±)-FR901483 (1) is depicted. 
The progress made towards the target, and possible work for the future is then reviewed.   
ii 
 
 
In the final part of the results and discussion, efforts made towards the synthesis of (+)-
TAN1251B (3) are presented. The successful installation of the key hydroxyl group alpha to 
the ketone in a stereoselective manner via treatment of a silyl enol ether derived from the 
common intermediate with DMDO is reported. From here, formation of the tricyclic core is 
achieved using an intramolecular peptide coupling. Further elaboration allows installation of 
the side-chain and results in the carbon skeleton required for the total synthesis of (+)-
TAN1251B (3). A summary of this work and the future steps required to complete the 
synthesis are then presented.  
 
The thesis concludes with an experimental section, which gives detailed procedures and full 
characterisation data for the novel compounds discussed in the results and discussion part. 
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Chapter 1: Introduction 
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1.0 Introduction 
 
This thesis describes studies towards the total syntheses of two biosynthetically related 
alkaloid natural products: (±)-FR901483 and (+)-TAN1251B. We developed a common 
approach for the construction of both molecules. 
 
 
1.1 Isolation and biological activity 
 
(±)-FR901483 (1) (figure 1) was isolated from the fermentation broth of the fungal strain 
Cladobotryum sp. No. 11231, in 1996 by scientists at the Fujisawa Pharmaceutical Company 
from litter collected at Iwaki, Japan.1  
 
 
 
Figure 1. Structure of (±)-FR901483 (1) 
 
At its core, the molecule contains an azatricyclic ring system, consisting of a 2-
azabicyclo[3.3.1]nonane and a spiro-fused pyrrolidine ring, which was previously  
unprecedented in Nature. The structure and relative stereochemistry of 1 was elucidated from 
a combination of chemical and spectroscopic evidence, and confirmed by X-ray 
crystallography.1 The absolute stereochemistry was later established by Snider and Lin when 
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they reported the first total synthesis of 1.2 
 
(±)-FR901483 (1) exhibits potent immunosuppressive activity in vitro and was found to 
significantly prolong graft survival time in the rat skin allograft model.1 Experimental results 
indicated that (±)-FR901483 (1) has a non-specific immunosuppressive profile and led to the 
conclusion that it might be an anti-metabolite. Its activity is thought to be a result of 
interference with de novo purine nucleotide biosynthesis via inhibition of key enzymes 
involved in the pathway. In particular, it is likely that the enzyme which catalyses the 
formation of adenylosuccinate (adenylosuccinate synthetase) and/or the enzyme which 
catalyses the formation of AMP (adenylosuccinase) are inhibited. The mode of action of (±)-
FR901483 (1) differs from that of known immunosuppressants including Cyclosporine A and 
Tacrolimus (FK-506) and this could be therapeutically significant given the toxic drug-
associated side-effects of both drugs.1  
 
 
The TAN1251 alkaloids were isolated in 1994 from a culture of Penicillium thomii RA-89 by 
scientists at Takeda Chemical Industries Ltd. in Japan.3 These compounds possess a novel 
tricyclic ring system, consisting of a 1,4-diazabicyclo[3.2.1]octane ring and a spiro-fused 
cyclohexanone ring. The relative stereochemistry of (+)-TAN1251B (3, Figure 2) was 
determined by X-ray crystallography, and CD analysis of a derivative of 3 allowed 
determination of its absolute stereochemistry.4 Since (씀)-TAN1251A (2) is converted into 3 
by Penicillium thomii RA-89, the absolute stereochemistry of both compounds was assumed 
to be the same.4 The absolute and relative stereochemistry of (+)-TAN1251D (5) and the 
relative stereochemistry of (+)-TAN1251C (4) were established later by Snider and Lin after 
completion of their total syntheses.4  
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Figure 2. Structures of TAN1251 alkaloids 
 
To date, only 2 and 3 have shown interesting biological activity and are of value as mydriatic 
or antispasmodic/antiulcer agents. They are both muscarinic antagonists, which exhibit 
cholinergic activity and cause acetylcholine-induced contraction of Guinea pig ileum with 
ED50 values of 8.0 nM and 10 nM respectively. The affinity of TAN1251B (3) for the 
muscarinic acetylcholine receptor is stronger than that of atropine.5 
 
 
1.2 Proposed biosynthesis 
 
It is known that the natural product (±)-FR901483 (1) and the TAN1251 family (2-5) are 
biosynthetically related and are derived from the same dipeptide 6 consisting of two 
molecules of L-tyrosine (scheme 1).1 Under oxidative conditions 6 would form the 
spirolactam 8, which can subsequently be converted into the key keto-aldehyde intermediate 
9 by simple chemical transformations. From here, an intramolecular aldol reaction of 9 would 
afford the tricyclic skeleton of (±)-FR901483 (1), or alternatively intramolecular enamine 
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formation from 9 would provide an advanced intermediate in the synthesis of the TAN1251 
alkaloids. 
 
 
 
Scheme 1. Proposed biosynthesis of (±)-FR901483 (1) and TAN1251 (2-5) family 
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1.3  Previous syntheses 
 
This part of the introduction will focus first on previous total syntheses of (±)-FR901483 (1) 
and studies conducted towards the formation of the tricyclic core. The focus will then turn 
towards the different syntheses of the members of the TAN1251 alkaloids family. The 
introduction concludes with what has been achieved previously in this area within the Hayes 
group. 
 
 
1.3.1 Previous syntheses of (±)-FR901483 (1) 
 
There have been six enantioselective total syntheses of (±)-FR901483 (1) reported so far, as 
well as two racemic syntheses, and a number of model studies towards the tricyclic core of 1. 
Each of these will be briefly described in the order stated, highlighting only the key steps in 
the synthesis or study: the selective formation of the quaternary stereocentre and the 
formation of the tricyclic core of the molecule.  
 
 
1.3.1.1 6QLGHU¶VV\QWKHVLV6,2 
 
Snider and Lin reported the most comprehensive work towards the total syntheses of (±)-
FR901483 (1) and all the TAN1251 alkaloids (2-5). Initially, in 1998, they reported the 
synthesis of racemic desmethylamino FR901483 (11, Figure 3).6 
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Figure 3. Desmethylamino FR901483 
 
One year later they published the first total synthesis of enantiopure (±)-FR901483 (1),2 using 
the method developed in their first publication.6 To create the quaternary centre adjacent to 
nitrogen, they utilised a 1,3-dipolar cycloaddition of nitrone 14 with ethyl acrylate (scheme 
2). The nitrone was obtained by reaction between optically active hydroxylamine 12 and 
cyclohexanone 13. 
 
 
Scheme 2. 6QLGHU¶V-dipolar cycloadition 
 
The 1,3-dipolar cycloaddition afforded the desired product 15 (major) and its diastereoisomer 
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(minor), which was epimeric at the C(3) position. The diastereoisomers proved inseparable at 
this stage and therefore subsequent steps were conducted on the 6:1 mixture. Hydrogenolysis 
of 15 in acidic media afforded the desired spiro-fused pyrrolidine ring 16 in good yield 
(scheme 2). Inversion of the stereochemistry at C(3) was achieved via tosylation of alcohol 
16 and subsequent displacement with sodium azide to give 17, at which point the two 
diastereoisomers could be separated. Further simple chemical transformations allowed access 
to the key aldehyde 18 (scheme 3).  Although this approach allowed rapid access to the aldol 
precursor 18, there were problems when attempting to close the last ring of the tricycle. As 
there is little to discriminate the diastereotopic methylenes (a and b) adjacent to the ketone, 
poor regio- and stereocontrol were observed during the intramolecular aldol reaction. As a 
result, a mixture of three products was obtained. The major product, formed in modest yield 
was the required tricycle 19, which proved inseparable from its diastereoisomer 21. Again, 
the material was taken through the synthesis as a mixture until separation was possible. 
 
 
 
Scheme 3. 6QLGHU¶VWULF\FOHIRUPDWLRQvia aldol reaction 
 
The amide and ketone functionalities were reduced with LiAlH4, and the resultant amine 
protected with a Cbz group to afford diol 22 (scheme 4), which, at this point could be 
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separated from its diastereoisomer. Inversion of the stereochemistry at C(8) was completed in 
three steps: nosylation of the equatorial alcohol, protection of the axial alcohol as the 
triethylsilyl ether and displacement of the nosylate with cesium acetate to afford 24. The 
acetate group was then hydrolysed to allow introduction of a dibenzyl phosphite ester, which 
was subsequently oxidised to the dibenzyl phosphate ester 25. A three step sequence allowed 
removal of all the protecting groups to afford the monohydrochloride salt of (±)-FR901483 
(1) in 22 overall steps and a yield of 2%. 
 
 
 
Scheme 4. &RPSOHWLRQRI6QLGHU¶VV\QWKHVLVRI(±)-FR901483 (1) 
 
 
1.3.1.2 6RUHQVHQ¶V7 and &LXIROLQL¶VV\QWKHVHV8-10 
 
In 2001, two groups published very similar approaches to the total synthesis of (±)-FR901483 
(1), which were inspired by the biosynthetic pathway depicted previously (scheme 1).  Indeed, 
the formation of the key 5,6-spirocycle was realised using an oxidative spiroannulation. 
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6RUHQVHQ¶V PHWKRG ZDV WR H[SRVH WKH DPLQRSKHQRO 26 to iodobenzene diacetate in 
1,1,1,3,3,3-hexafluoro-2-propanol to afford the dienone 27 in a reasonable 51% yield (based 
on 70% of starting material consumed).7 &LXIROLQL¶VPHWKRGXVHGDYDULDQWRIWKLVFKHPLVWU\
which involved the use of oxazoline as a nucleophile instead of the free secondary amine.9-10 
The oxazoline 28 was thus treated with the same oxidant, which was then followed by an 
acetylation step leading to the isolation of 41% of the dienone 29. 
 
 
 
Scheme 5. 6RUHQVHQ¶VDQG&LXIROLQL¶VFRQVWUXFWLRQVRIWKHTXDWHUQDU\VWHUHRFHQWUH 
 
6RUHQVHQ¶V LQWHUPHGLDWH 27 was elaborated further to the aldol precursor 30 (analogous to 
6QLGHU¶V LQWHUPHGLDWH 18) by protecting group manipulations, complete reduction of the 
dienone and methyl ester, and subsequent re-oxidation to the keto aldehyde 30. From this 
point, the tricyclic core was established using an aldol cyclisation, in an analogous manner to 
that previously described by Snider.2 Thus, treatment of 30 with sodium methoxide in 
methanol yielded the desired tricycle 31 in 34% yield (scheme 6). However, again this 
reaction suffered from a lack of regiocontrol (also observed by Snider2) and 40% of other 
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isomeric aldol products were isolated LQ DGGLWLRQ WR WKH GHVLUHG FRPSRXQG 6RUHQVHQ¶V
synthesis of (±)-FR901483 (1) was continued by reduction of the ketone to give the alcohol 
32, which was then involved in a Mitsunobu reaction with dibenzyl hydrogen phosphate. This 
SURFHGXUHVKRUWHQHGWKHV\QWKHVLVFRPSDUHGWR6QLGHU¶VURXWHDV LWDOORZHG LQYHUVLRQRI WKH
stereochemistry at C(8) and installation of the phosphate ester in a single step, though in poor 
yield. Protecting group removal completed the synthesis. 
 
 
 
Scheme 6. 6RUHQVHQ¶VHQG-game 
 
From intermediate 29, Ciufolini completed the synthesis of (±)-FR901483 (1)9-10 using a very 
similar approach to that employed by Sorensen.7 Again, although the oxidative 
spiroannulation step proved to be an efficient way of constructing two of the three rings of 
the tricyclic core, the key aldol cyclisation lacked regioselectivity and afforded the desired 
tricycle 35 in only 44% yield (scheme 7). In addition, from the same intermediate 29, 
Ciufolini also reported the synthesis of (+)-TAN1251C (4, section 1.3.3.3).10 
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Scheme 7. &LXIROLQL¶VHQGJDPH 
 
 
1.3.1.3 %UXPPRQG¶VV\QWKHVLV11-12 
 
Brummond described a racemic approach to the core structure of FR901483 in 2001,11 and 
then four years later a formal synthesis of enantiopure (±)-FR901483 using the same 
methodology.12 The strategy was to perform a tandem cationic aza-Cope/Mannich cyclisation 
as the key step for construction of both the tricycle and the quaternary stereocentre next to 
nitrogen. Amino-ketone 36 was treated with PTSA in refluxing benzene to afford the desired 
unstable aldehyde 39, which was then reduced to the alcohol and isolated (scheme 8). 
Unfortunately, they obtained the desired product (minor) along with its diastereoisomer 
epimeric at the C(3) position (major) in a 1:2 ratio. However, treatment of the crude aldehyde 
39 from the cyclisation with L-phenylalanine enabled epimerisation at the C(3) position and 
resulted in isolation of the diastereoisomers in a 2:1 ratio, this time in favour of the desired 
product. After reduction to the alcohol 40, the diastereoisomers were separated and the 
relevant isomer was converted, in a few simple transformations, into compound 33 (an 
DGYDQFHGLQWHUPHGLDWHLQ6RUHQVHQ¶VV\QWKHVLVRI(±)-FR901483 (1)7). 
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Scheme 8. %UXPPRQG¶V tricycle construction 
 
 
1.3.1.4 .HUU¶VV\QWKHVLV13 
 
More recently in 2009, Kerr reported a total synthesis of (±)-FR901483 (1) where an 
intramolecular imine/cyclopropane annulation was employed to provide the key pyrrolidine 
ring and put in place the stereocentre next to the nitrogen.13 Addition of amine 41 to a dilute 
solution of paraformaldehyde in the presence of ytterbium (III) triflate afforded 67% of the 
desired tricycle 44 (scheme 9). 
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Scheme 9. .HUU¶VWULF\FOHIRUPDWLRQ 
 
This was followed by a Krapcho dealkoxycarbonylation,14 which unfortunately afforded a 1:1 
mixture of the desired product 45 and its epimer at the C(3) position. However, these isomers 
were separable and it was possible, to some extent, to recycle the undesired diastereoisomer 
by exposure to KHMDS, which resulted in epimerisation to a 1:1 mixture of 
diastereoisomers. Hydrolysis of the remaining ester of 45, followed by a Curtius 
rearrangement15 furnished the N-Boc protected amine, which was methylated to afford the 
compound 46 DNQRZQ LQWHUPHGLDWH LQ%UXPPRQG¶V V\QWKHVLV12). From here, the synthesis 
was completed using methodology previously reported by Sorensen.7 
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1.3.1.5 )XQN¶VV\QWKHVLV16 
 
Funk used another method to construct the quaternary stereocentre in his racemic synthesis of 
FR901483 in 2001.16 The 1,3-dioxin 47 was heated in benzonitrile to generate the 
amidoacrolein 48, which was trapped in situ with the silyloxydiene 49 to afford aldehyde 50. 
Two consecutive aldol reactions generated the tricycle 51, core of FR901483 (1), in good 
yield (scheme 10).  
 
 
 
Scheme 10. )XQN¶VWULF\FOHFRQVWUXFWLRQ 
 
One interesting feature of this synthesis is the installation of the p-methoxybenzyl group 
(PMB) at the C(11) position, which had to be done at a late stage (scheme 11). 
Stereoselective p-methoxybenzylation of the enolate of 52 led to formation of 53. The 
introduction of the amine functionality at C(3) was accomplished by azidification of the 
enolate derivative of lactam 54, which led to the desired product 55 in 59% yield. In addition, 
a significant amount of the undesired diastereoisomer 56 was also isolated. The synthesis was 
completed in a few simple transformations including reduction of the azide and lactam 
functionalities, manipulation of protecting groups and introduction of the phosphate ester.  
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Scheme 11. )XQN¶VHQGJDPH 
 
 
1.3.1.6 )XNX\DPD¶VV\QWKHVHs17-19 
 
In 2004, Fukuyama described the synthesis of racemic FR901483 (1)17-18 where he rapidly 
constructed the spirolactam. Michael addition of nitromethane to methyl acrylate provided 
the triester 57, which upon reduction of the nitro group and ester-amide exchange furnished 
lactam 58 (scheme 12). Dieckman condensation of 58 afforded spirolactam 59, which after 
basic hydrolysis of the methyl ester and subsequent neutralisation with acid decarboxylated to 
provide spirolactam 60. A four-step sequence involving protection of the ketone, allylation of 
the amide, cleavage of the protecting group and oxidative cleavage of the double bond 
afforded keto-aldehyde 61. This was then used in an intramolecular aldol reaction 
FRPSDUDEOHWRWKHRQHXVHGRULJLQDOO\LQ6QLGHU¶VV\QWKHVLV2 to prepare 62, the tricyclic core 
of FR901483.  
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Scheme 12. )XNX\DPD¶VUDFHPLFV\QWKHVLVRI)5 
 
From 62, the method used by Fukuyama to install the PMB group was similar to that 
previously employed by Funk,16 and in a few steps the intermediate 63 was reached. Selective 
reduction of the ketone and protection of the resultant alcohol gave 64 (scheme 13). Addition 
of solid CO2 to the enolate of 64 afforded carboxylic acid 65. Nitrosation followed by 
decarboxylation was achieved via treatment with sodium nitrite under acidic conditions. 
Amine 66 was isolated as a single isomer after reduction of the oxime with zinc in acetic 
acid. The racemic synthesis was completed in a few steps including methylation of the 
nitrogen, reduction of the lactam and introduction of the phosphate ester. 
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Scheme 13. )XNX\DPD¶VHQGJDPH 
 
Recently in 2010, Fukuyama published a stereocontrolled synthesis19 of an optically active 
compound 63, a key intermediate in his racemic synthesis.17-18 This time, he utilised an Ugi 
reaction,20 similar to one previously employed by Sorensen for his second-generation 
synthesis of the tricyclic core of FR901483 (section 1.3.2.7).21 Reaction between chiral amine 
67 (prepared in seven steps from commercially available N-Boc tyrosine methyl ester), 
protected cyclohexanone 13, p-methoxyphenyl isocyanide 68 and acetic acid afforded in one 
step and in good yield compound 69, in which all of the carbon atoms needed for the 
synthesis of the tricycle were assembled (scheme 14). 
 
 
 
Scheme 14. )XNX\DPD¶V8JLUHDFWLRQ 
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Conversion of 69 into the key aldol precursor 70 was achieved in a few steps including an 
intramolecular Dieckmann condensation in which the spiro-lactam ring was constructed. An 
intramolecular aldol reaction of 70, analogous to the approach previously reported by Snider 
(section 1.3.1.1),2 was used to close the tricyclic core of (±)-FR901483. Thus, treatment of 70 
with acetic acid, and a catalytic amount of pyrrolidine afforded the tricycle 71 as a single 
diastereoisomer (scheme 15). The rest of the synthesis consisted of simple chemical 
transformations to obtain 62, an intermediate in the racemic synthesis. 
 
 
 
Scheme 15. )XNX\DPD¶Vnd generation tricyclic closure 
 
 
1.3.2 Model studies towards (±)-FR901483 (1) 
 
In addition to the total syntheses described previously, (±)-FR901483 (1) has been the subject 
of numerous model studies. It has attracted substantial synthetic interest, in particular because 
the formation of the quaternary stereocentre next to the nitrogen, and the formation of the 
tricyclic core represent two significant challenges. As discussed previously, this part of the 
introduction will focus on how these challenges were met. 
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1.3.2.1 .LED\DVKL¶VDSSURDFK22-23 
 
An interesting method for the formation of the quaternary centre adjacent to nitrogen in the 
synthesis of the tricyclic structure of (±)-FR901483 was used by Kibayashi.22-23 This 
approach was based on vinylation at the bridgehead position of 2-azabicyclo[3.3.1]nonane 
via an anti-Bredt iminium ion. Thus, the racemic tricyclic oxazilidine 72 was treated with 
Et2AlCH=CH2 to form the bridgehead iminum ion 73, which susbsequently underwent 
nucleophilic attack by the vinyl group to give the desired bicycle 74 in excellent yield. The 
last ring of the tricycle was closed a few steps later by metathesis to give the tricycle core 76 
(scheme 16). 
 
 
 
Scheme 16. .LED\DVKL¶VDSSURDFK 
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1.3.2.2 Wardrop¶VDSSURDFK24 
 
In 2001 Wardrop reported a formal synthesis of racemic desmethylamino FR901483 11,24 
which employed the cyclisation of an N-alkoxy-N-acylnitrenium ion to form the key 5,6-
spirocycle intermediate. Thus, oxidative spiroannulation of phenol derivative 77 was 
achieved using bis(trifluoroacetoxy)iodobenzene to afford the 5,6-spirocycle 78 in good 
yield. A series of simple chemical transformations converted the spirocycle into the 
trimethylsilyl enol ether 79, precursor for a radical cyclisation. Treatment of 79 with Bu3SnH 
and AIBN, followed by protodestannylation with methanolic HCl gave the desired cyclisation 
product 80 in 40% yield (scheme 17). Unfortunately, the major compound isolated from the 
reaction was the undesired tricycle 81. This presumably forms as a result of a 1,5-transfer of 
the allylic hydrogen atom at C(10) to form an allylic radical, which subsequently undergoes 
diastereoselective cyclisation with the pendant vinyl stannane. 
 
 
 
Scheme 17. :DUGURS¶VDSSURDFK 
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1.3.2.3 Bonjoch¶VDSSURDFK24-28 
 
Bonjoch used a different method to complete a synthesis of the tricyclic core of FR901483,28 
in which formation of the quaternary centre adjacent to the nitrogen was achieved using an 
intermediate imine species. Cyclohexanone 13 was easily converted into the corresponding 
imine, which was then treated with allylmagnesium bromide to give homoallylic amine 80 in 
excellent yield (scheme 18). Treatment of 80 with iodine under basic conditions resulted in 
formation of the iodoaminocyclisation product 81. Closing the ring to yield the tricyclic 
structure was achieved via an intramolecular Pd-catalysed coupling of vinyl bromide with the 
enolate made in situ from ketone 82. Unfortunately, this step proceeded without regiocontrol, 
and they obtained the desired tricycle 83 in poor yield along with its regioisomer 84 in a 1:1 
ratio. 
 
 
 
Scheme 18. %RQMRFK¶VDSSURDFK 
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1.3.2.4 Weinreb¶VDSSURDFK29 
 
Weinreb employed the imine chemistry previously used by Bonjoch25 to form the quaternary 
centre next to nitrogen (and the same intermediate 80).29 However, from this key intermediate 
a different approach for the synthesis of the tricyclic core was employed. Homoallylic amine 
80 was converted into iodo-ketone 85, which cyclised under basic conditions to afford the 
desired bicyclo[3.3.1]nonanone 86 in good yield (scheme 19). The tricyclic structure 88 of 
FR901483 (1) was obtained in reasonable yield by a 5-endo-trig cyclisation of homoallylic 
amine 87, which occurred upon treatment with phenylsulfenyl chloride in the presence of a 
mild acid, pyridinium p-toluenesulfonate (PPTS). 
 
 
 
Scheme 19. :HLQUHE¶VDSSURDFK 
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1.3.2.5 Martin¶VDSSURDFK30 
 
In this approach to the tricyclic core of (±)-FR901483 (1), Martin used the nucleophilic 
addition of a silane to an iminium ion for the formation of the quaternary centre next to 
nitrogen.30 The iminium ion was generated in situ from the addition of CbzCl to the imine 89 
and after addition of the allyl silane 90 in the presence of trimethylsilyl triflate, the desired 
product 91 was isolated in moderate yield (scheme 20). Subsequent ring closing metathesis of 
diene 91 XVLQJ *UXEEV¶ VHFRQG JHQHUDWLRQ FDWDO\Vt,31 afforded the 5,6-spirocycle 92 in 
excellent yield. This was quickly converted into the lactone 93, which underwent lactone-
lactam rearrangement under microwave irradiation in a methanolic NaOMe solution to give 
tricycle 94.    
 
 
 
Scheme 20. 0DUWLQ¶VDSSURDFK 
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1.3.2.6 Reissig¶VDSSURDFK32 
 
Reissig employed an approach to the tricyclic core of (±)-FR901483 (1),32 which used the 
reaction of lithiated methoxyallene with a protected enantiopure ketimine as the key step. 
Firstly condensation of the L-tyrosine derivative 95 with the cyclohexanone derivative 96 
afforded imine 97, which upon addition of lithiated methoxyallene was converted to the 
allenylamine 98 (scheme 21). Subsequent treatment with AgNO3 and K2CO3 afforded the key 
5,6-spirocycle 99 in good yield over the three steps. The third ring of the tricycle was closed 
via an intramolecular aldol cyclisation, in an analogous manner to that previously described 
by Snider.2 However, even after extensive optimisation, they were only able to isolate the 
desired tricycle 101 in 17% yield using L-proline in methanol. Under these conditions they 
also isolated three other tricyclic structures (diastereo- and regioisomers of the desired 
product) in a combined yield of 42%. 
 
 
 
Scheme 21. 5HLVVLJ¶VDSSURDFK 
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1.3.2.7 Sorensen¶Vsecond-generation approach21 
 
After his total synthesis (section 1.3.1.2),7 Sorensen recently published a synthesis of the 
tricyclic core structure of (±)-FR901483 using an Ugi four-component coupling reaction.20-21 
Thus, mixing chiral amine 102, protected cyclohexanone 13, cyclohexenyl isocyanide 103 
and acetic acid afforded, in one step and in good yield, compound 104. This reaction allowed 
the formation of the key carbon-nitrogen bond in addition to putting in place all of the carbon 
atoms needed for formation of the tricyclic core (scheme 22).  
 
 
 
Scheme 22. 6RUHQVHQ¶V8JLIRXUFRPSRQHQWFRXSOLQJUHDFWLRQ 
 
The pyrrolidine ring was closed using an intramolecular Dieckmann cyclisation, and after 
simple transformations the key intermediate 105 was reached. From here, an internal base-
mediated elimination of the mesylate provided the desired alkene 107 in excellent yield and 
with excellent regioselectivity (scheme 23). The regioselectivity was rationalised by the 
hypothesis that the bulky nitrogen side-chain would restrict rotation of the C-N bond and 
favour a conformation in which the hydroxide (the internal base) would be close to only one 
of the axial C-H bonds with an antiperiplanar relationship to the mesylate. 
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Scheme 23. Regioselective elimination of mesylate 
 
A high-yielding two step sequence, which involved an intramolecular nitrone/alkene dipolar 
cycloaddition of 108 to isoxazolidine 109 followed by reduction of the N-O bond with zinc, 
completed the synthesis of the tricyclic core of (±)-FR901483 (1) (scheme 24). 
 
 
 
Scheme 24. 6RUHQVHQ¶VIRUPDWLRQRIWKHWULF\FOLFFRUH 
 
 
1.3.3 Synthetic approaches to the TAN1251 family of alkaloids 
 
In this next part of the introduction, the focus will turn to the previous methods employed for 
the synthesis of different members of the TAN1251 family. To date, there has been only one 
reported synthesis of (+)-TAN1251B (3), which was achieved from transformatiRQVRI (씀)-
TAN1251A (2 ,Q FRQWUDVW (씀)-TAN1251A (2) has been synthesised the most (five times 
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including one racemic synthesis) and (+)-TAN1251C (4) and (+)-TAN1251D (5) have each 
been made twice. The syntheses will be described briefly, highlighting only the key steps, 
and in particular formation of the quaternary centre next to nitrogen and the formation of the 
tricyclic core of the molecule.  
 
 
1.3.3.1 Kawahara¶VDSSURDFK4,33-34 
 
In 1998, Kawahara reported the first racemic synthesis of TAN1251A (2).4,33 The strategy 
involved formation of the key spirocycle 115, which was further elaborated to enable the 
final ring of the tricyclic core to be closed via an intramolecular peptide coupling. The key 
spirocycle 115 was synthesised in a few steps from carboxylic acid 111 (scheme 25). 
Alkylation of 111, followed by Curtius rearrangement using DPPA and benzyl alcohol gave 
the protected amine 113. Simple chemical transformations provided the free amine 114, 
which was subsequently cyclised by treatment with DBU in refluxing benzene to afford 
spirocycle 115.  
 
 
 
Scheme 25. .DZDKDUD¶VUDFHPLFV\QWKHVLV 
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Conversion to amino-ester 116 was realised in a couple of steps involving N-alkylation, 
reaction under Mitsunobu conditions and hydrogenation of the resulting azide (scheme 26). 
Hydrolysis of the ester functionality in 116 afforded the free amino-acid, which was 
subsequently cyclised using DPPA and triethylamine to give tricycle 117. Methylation of the 
amine, followed by aldol reaction with aldehyde 118 afforded a mixture of diastereoisomers 
119. From here the synthesis was completed by dehydration of the hydroxyl functionality, 
reduction of the amide and cleavage of the ketal protecting group. 
 
 
 
Scheme 26. .DZDKDUD¶VHQG-game 
 
A few years later, in 2002 Kawahara published the synthesis of the optically active 
compound 116,34 a key intermediate in his racemic synthesis.4,33 This time, Kawahara used 
alkylation of a trans-4-hydroxy-L-proline derivative 121 with 4-iodo-1-butene to construct 
the quaternary centre (scheme 27). This reaction led to the formation of a mixture of 
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diastereoisomers 122 and 123 in a ratio of 4.5:1. These were both separately converted into 
the same intermediate 124, which was transformed in a couple of steps into amino-ester 116, 
key intermediate in their racemic synthesis. 
 
 
 
Scheme 27. .DZDKDUD¶VHQDQWLRSXUHV\QWKHVLV 
 
 
1.3.3.2 :DUGURS¶VDSSURDFK35 
 
In a formal synthesis of (±)-TAN1251A (2),35 :DUGURS¶VJURXSXVHGDYHU\VLPLODUDSSURDFK
to the one they employed for (±)-FR901483 (1) (section 1.3.2.2).24 In the early stages of this 
synthesis, a compound derived from L-tyrosine 125 was treated with 
bis(trifluoroacetoxy)iodobenzene to form the desired oxidative spiroannulation product 126 
in reasonable yield (scheme 28). Simple chemical transformations, including a DPPA-
mediated cyclisation, led to 127, an advanced interPHGLDWH LQ .DZDKDUD¶V UDFHPLF
synthesis,4-33 in good overall yield. The group did actually finish the first synthesis of 
enantiopure (±)-TAN1251A (2), from 127 E\HPSOR\LQJ.DZDKDUD¶VURXWH4-33 
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Scheme 28. :DUGURS¶VDSSURDFK 
 
 
1.3.3.3 &LXIROLQL¶VDSSURDFK10 
 
As mentioned previously (section 1.3.1.2), Ciufolini completed the total synthesis of (+)-
TAN1251C (4) in addition to the total synthesis of (±)-FR901483 (1) from the same common 
intermediate 27.10 The key step used to form this 5,6-spirocyclic intermediate 29 was an 
oxidative spiroannulation. Subsequently, a series of simple manipulations allowed access to 
the aldehyde 128 (scheme 29). This was treated with a cadmium/lead couple, which resulted 
in Troc deprotection and subsequent cyclisation to afford enantiopure (+)-TAN1251C (4) in 
good yield. 
 
 
 
Scheme 29. &LXIROLQL¶VHQGJDPH 
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1.3.3.4 +RQGD¶VDSSURDFK36-37 
 
Honda used a similar oxidative spiroannulation to that used by Ciufolini9 (and Sorensen) at a 
late stage of the synthesis in order to form the last ring of the tricyclic core of (±)-TAN1251A 
(2).36 Treatment of amino-phenol 129 with iodobenzene diacetate afforded the desired 
tricycle 130 in good yield (scheme 30). Reduction of the dienone 130 to the ketone 131 was 
achieved using a mixture of triethylsilane in the presence of a catalytic amount of CuCl and 
dppf, as other reduction methods proved to be inefficient for the required transformation. 
Ketone 131 was protected as its ketal form to give the advanced intermediate 127 in 
:DUGURS¶VV\QWKHVLVRI(±)-TAN1251A (2).35 
 
 
 
Scheme 30. +RQGD¶VDSSURDFKWR(±)-TAN1251A (2) 
 
Honda used a similar approach for the synthesis of (+)-TAN1251D (5),37 where the more 
advanced amino-phenol substrate 132 was treated with iodobenzene diacetate to afford the 
tricyclic structure 133 with most of the side chain already in place (scheme 31). Reduction of 
the dienone using CuH, protection of the ketone and removal of the benzyl group by 
hydrogenation afforded phenol 134. Prenylation afforded 135, which was subsequently 
reduced to the amine and finally converted to (+)-TAN1251D (5) after hydrolysis of the ketal 
group. 
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Scheme 31. +RQGD¶VV\QWKHVLVRI-TAN1251D (5) 
 
In addition, in two steps from the advanced intermediate 135 in the synthesis of (+)-
TAN1251D (5), Honda was also able to synthesise (+)-TAN1251C (4).37 DIBAL-H reduction 
of the amide functionality in 135 gave the desired enamine 136 in good yield (scheme 32). 
Unmasking of the ketone in 136 gave (+)-TAN1251C (4). 
 
 
 
Scheme 32. +RQGD¶VV\QWKHVLVRI-TAN1251C (4) 
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1.3.3.5 Snider¶VDSSURDFK5 
 
The most important work towards the synthesis of the TAN1251 alkaloids has been 
conducted by Snider.5 To date, he is the only one to have synthesised all the members of the 
family. For the synthesis of (+)-TAN1251C (4), from which (±)-TAN1251A (2) and (+)-
TAN1251D (5) were synthesised, a 1,3-dipolar cycloaddition of nitrone 139 with ethyl 
acrylate was used to construct the quaternary centre (scheme 33). This is a similar method to 
the one used in his work towards (±)-FR901483 (1) (section 1.3.1.1),2 except that the nitrone 
is protected slightly differently in order to avoid incompatibility with some of the reaction 
conditions employed.  
 
 
 
Scheme 33. 6QLGHU¶VV\QWKHVLVRI-TAN1251C 
 
The cycloaddition yielded a mixture of the desired product 140 in addition to its 
diastereoisomer, epimeric at the C(3) position in a 6:1 ratio. Cleavage of the N-O bond in 140 
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and concurrent removal of the benzyl group was followed by the acid-catalysed formation of 
spiro-lactam 141. A few steps enabled conversion of 141 into amino alcohol 142, which was 
treated with trifluoroacetic anhydride and triethylamine in DMSO to form an aldehyde 
intermediate. Hydrolysis of the trifluoroacetamide group and subsequent cyclisation formed 
the ketal of (+)-TAN1251C (4), which after acidic hydrolysis afforded 4. 
 
(+)-TAN1251D (5) was obtained by reduction of 143 (the ketal of (+)-TAN1251C (4)) 
followed by acidic hydrolysis of the ketal (scheme 34). Depending on the solvent employed 
for the reduction with sodium cyanoborohydride, varying amounts of the undesired 
diastereomer (epimer at the C(11) position) were isolated. However, using the polar 
1,1,1,3,3,3-hexafluoro-2-propanol as a solvent allowed isolation of a separable mixture of the 
desired product along with its diastereoisomer in a 25:1 ratio.  
 
(씀)-TAN1251A (2) was also obtained from 143 after DDQ oxidation to afford the eniminium 
salt 144ZKLFKZDVVXEVHTXHQWO\UHGXFHGWRDIIRUGWKHNHWDORI(씀)-TAN1251A (2) (scheme 
$FLGLFK\GURO\VLVVXEVHTXHQWO\JDYH(씀)-TAN1251A (2) in good yield. 
 
(+)-TAN1251B (3) is possibly the most challenging of the four members of the family to 
synthesise, since the presence of the hydroxyl group alpha to the ketone turns the quaternary 
FHQWUH QH[W WR WKH QLWURJHQ LQWR D VWHUHRFHQWUH7UHDWPHQWRI (씀)-TAN1251A (2) with LDA 
formed a mixture of enolates, which were quenched by trimethylsilyl chloride to give a 
mixture of silyl enol ethers 145 (scheme 34). After oxidation of the crude mixture of 145 with 
osmium tetroxide, Snider was able to obtain a complicated mixture of products containing 
(+)-TAN1251B (3) in a small amount, which after much effort he was able to isolate using 
HPLC Chiralpack AD column. The other products isolated resulted from a lack of 
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regiocontrol in the formation of the silyl enol ether, and a lack of stereocontrol in the 
subsequent oxidation step. 
 
 
 
Scheme 34. 6QLGHU¶VV\QWKHVLVRIDOOPHPEHUVRI7$1IDPLO\ 
 
 
1.3.4 Summary of the syntheses of (±)-FR901483 (1) and (+)-TAN1251B (3) 
 
In most of the previous syntheses reviewed above there has not been a satisfactory solution to 
the stereoselective formation of (±)-FR901483 (1) or (+)-TAN1251B (3). In particular, the 
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issue of installing the quaternary stereocentre adjacent to the nitrogen has not always been 
addressed. When considering the previous syntheses of (±)-FR901483 (1), although a 
substantial amount of work has been performed, in many cases the quaternary centre next to 
the nitrogen was converted into a stereocentre at a late stage in the synthesis by closing the 
third ring of the tricycle via an intramolecular aldol condensation. This aldol condensation 
was often not selective, giving the desired product in low yield in addition to other regio- and 
stereoisomers. Other syntheses, which employed different methodologies for their cyclisation 
steps also suffered from a lack of diastereoselectivity. 
 
To date, the only total synthesis of enantiopure (+)-TAN1251B (3) is the one reported by 
Snider.5 However, this does not represent a satisfactory solution for its formation since it was 
V\QWKHVLVHGLQYHU\ORZ\LHOGIURP(씀)-TAN1251A (2). In addition, the current synthesis does 
not address the issue of installing the quaternary stereocentre adjacent to the nitrogen in a 
selective fashion.  
 
 
1.4 Retrosynthetic analysis 
 
As discussed in the description of the previous syntheses oI(씀)-FR901483 (1) and its tricyclic 
core, the main challenges for the synthesis of 1 are the stereoselective construction of the 
quaternary centre next to the nitrogen and the formation of the tricyclic structure in both a 
regio- and stereoselective manner. For the synthesis of (+)-TAN1251B (3), the main 
challenge is again the formation of the quaternary stereocentre next to the nitrogen in addition 
to the regio- and stereoselective formation of the hydroxyl group alpha to the ketone. The 
biosynthetic relaWLRQVKLSEHWZHHQ(씀)-FR901483 (1) and the TAN1251 family (2-5) led us to 
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make the hypothesis that both compounds could be achieved from the same synthetic 
LQWHUPHGLDWH 2XU UHWURV\QWKHWLF DQDO\VLV IRU (씀)-FR901483 (1) brought us to the tricyclic 
intermediate 146 with the idea that the phosphate ester moiety and the p-methoxybenzyl 
group could be added at a late stage of the synthesis (scheme 35). Tricycle 146 could be 
accessed from a regioselective aldol reaction of keto-aldehyde 147. To avoid the 
regioselectivity problems encountered in the previous syntheses, we decided to block one 
side of the 6-membered ring with a double bond in order to ensure the aldol reaction occurred 
in the desired position. Keto-aldehyde 147 would be easily accessible from the 5,6-
spirocyclic enone 148. 
 
 
 
Scheme 35. 5HWURV\QWKHWLFDQDO\VLVRI(씀)-FR901483 (1) and (+)-TAN1251B (3) 
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This key intermediate 148 can also be used to install in a regioselective fashion the hydroxyl 
group alpha to the ketone, which is needed for the synthesis of (+)-TAN1251B (3). The side-
chain could be added at a late stage from tricycle 152, which would be the product of the 
intramolecular peptide coupling of amino-acid 151. For the synthesis of our common and key 
intermediate 148, we now face a new and exciting challenge, which is the construction of a 
quaternary stereocentre next to nitrogen. We envisaged that the 5,6-spirocyclic enone 148 
could be accessed from the 5,5-spirocyclic alkene 149, which would be the result of a 1,5-CH 
alkylidene carbene insertion. This methodology has been applied already within the Hayes 
group38-43 and should provide an elegant way of installing the stereocentre next to nitrogen 
since it proceeds with complete retention of stereochemistry.  
 
 
1.5 Alkylidene Carbenes44-46 
 
Alkylidene carbenes are versatile reagents in organic synthesis, which undergo a variety of 
distinct C-C bond forming reactions. Their regioselectivity in intramolecular cyclisation 
reactions is excellent and they react predominantly by 1,5 C-H insertion, irrespective of the 
substitution pattern of the molecule. In addition, they reliably react with retention of 
stereochemistry at the insertion site. 
There are quite a few methods, which have been developed for alkylidene carbene generation 
but two of the most commonly used will be briefly discussed. The first method involves the 
base mediated Į-elimination of vinyl halides47,48 or enol triflates49,50 153 (scheme 36). A 
strong amide base (e.g. KHMDS) is the preferred choice for this transformation since it 
enables the reaction temperature to be kept low, and thus minimises unwanted side-reactions 
of the carbene.51,52 The second method employs the thermal decomposition of diazoalkenes 
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156 and since it does not involve the use of a strong base, a wider range of functionality can 
be tolerated. One approach to forming the desired diazoalkenes 156 involves treating the 
corresponding ketone with lithiated trimethylsilyldiazomethane at low temperature.53,54 
Warming up of the reaction results in evolution of nitrogen and formation of the alkylidene 
carbene 155. 
 
 
 
Scheme 36. Methods for generation of alkylidene carbenes55 
 
 
1.3.5 Previous work within the Hayes group 
 
1.3.5.1 Synthesis of (±)-TAN1251A (2)56,57 and work towards (+)-TAN1251B (3)57-59 
 
In 2004, an enantioselective synthesis of (±)-TAN1251A (2) was completed by James Auty, 
working within the Hayes group.56,57 The trans-4-hydroxy-L-proline derivative 157 was 
converted into ketone 158 in good yield by a three step sequence consisting of a DIBAL-H 
reduction, Wittig reaction and hydrogenation (scheme 37). A second Wittig reaction allowed 
formation of a vinylchloride as a mixture of Z and E isomers, which were treated with 
KHMDS to afford the insertion product 162. The 5,5-spirocycle 162 was converted into the 
5,6-spirocycle 163 in a few steps involving oxidative cleavage of the double bond, an 
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intramolecular aldol reaction and then dehydration of the aldol product. Exchange of 
protecting groups on the hydroxyl group and hydrogenation of the double bond furnished 
saturated ketone 164. Installation of the azide group with inversion of stereochemistry at 
C(3), followed by protection of the ketone as a ketal led to the formation of azide 165, 
LQWHUPHGLDWH LQ .DZDKDUD¶V VHFRQG-generation synthesis.34 From here the synthesis of (±)-
TAN1251A (2) was completed using the method of Wardrop35 and Kawahara.34 
 
 
 
Scheme 37. +D\HV¶VV\QWKHVLVRI(±)-TAN1251A 
 
Auty then attempted to use his key intermediate 163 for a total synthesis of (+)-TAN1251B 
(3) as the quaternary stereocentre required for its synthesis was already in place.57 It was 
envisaged that the double bond of the enone could be used as a tool for insertion of the 
hydroxyl group. This could be envisaged via conjugate reduction of enone 167 followed by 
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trapping of the resultant enolate as a silyl enol ether to give 168 (scheme 38). Oxidation of 
silyl enol ether 168 would then give the desired Į-hydroxy ketone 169. Unfortunately, despite 
literature precedent for this kind of transformation,60-63 it was never possible to form the silyl 
enol ether 168 or isolate the desired Į-hydroxy ketone 169. 
 
 
 
Scheme 38. Possible formation of Į-hydroxy ketone 
 
A final, alternative approach was attempted by Auty using the ketone 170.57 This time, it was 
thought that use of the double bond as a blocking group would allow Į-hydroxylation to 
occur selectively on the opposite side of the carbonyl to the double bond. Indeed, oxidation 
using iodosobenzene with NaOH in methanol afforded a separable mixture of isomers 171 
and 172 in a 1.3:1 ratio (scheme 39). Although the product had the wrong regiochemistry for 
completing the total synthesis of (+)-TAN1251B (3), this problem could be solved if the 
oxidation conditions were applied to the epimer of 170 (at the quaternary centre). 
 
 
 
Scheme 39. Successful attempt of Į-hydroxylation 
 
43 
 
Following the progress made by Auty, Asnuzilawati Asari continued the work towards (+)-
TAN1251B (3).58,59 Using the chemistry developed previously, but starting from cis-4-
hydroxy-D-proline 173, the 5,6-spirocycle 148, diastereoisomer of 163 (scheme 37), was 
obtained (scheme 40). This was subsequently converted into its azido version 178 in just 
three steps before being treated with the oxidation conditions previously employed by Auty.57 
The desired product with the hydroxyl group in the equatorial position 179 was obtained 
along with its epimer 180. Unfortunately the major compound was the undesired axial 
hydroxy ketone 180, and attempted epimerisation of this compound to the desired 
stereoisomer was unsuccessful. 
 
 
 
Scheme 40. Synthesis of 179, precursor to (+)-TAN1251B (3) 
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1.3.5.2 Work towards (±)-FR901483 (1)57,58,64 
 
Auty also initiated work towards a total synthesis of (±)-FR901483 (1).57 The original plan 
involved as a key step, the selective formation of the same silyl enol ether 182 as that 
required for the synthesis of (+)-TAN1251B (3, scheme 41). As all previous attempts to form 
this enol ether had been unsuccessful, it was no longer possible to use the double bond as a 
means for controlling the regioselectivity of the cyclisation step in the manner originally 
proposed. 
  
 
 
Scheme 41. Original plan for the synthesis of the tricycle of (±)-FR901483 (1) 
 
However, considering the way this problem was solved during work towards the synthesis of 
(+)-TAN1251B (3), it was hypothesised that the double bond could act as a blocking group to 
enable a regioselective cyclisation to occur on the opposite side of the ring to the double 
bond. Indeed, Auty was able to obtain the tricycle structure 186 using methodology 
developed by Bonjoch,28 which involved a palladium-catalysed cyclisation of vinylbromide 
185.57 The cyclisation precursor 185 was made in two steps from enone 184 (scheme 42). 
Although the yield was fairly low over these steps, some starting material was also recovered 
and it was encouraging to see that the cyclisation could work. Again, although the product 
had the wrong regiochemistry for completing the total synthesis of (±)-FR901483 (1), use of 
the epimer of 181 (at the quaternary centre) should overcome this problem. 
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Scheme 42. Tricycle formation 
 
$VDUL FRQWLQXHG $XW\¶V ZRUN DQG V\QWKHVLVHG WKH FRUUHFW GLDVWHUHRLVRPHU RI WKH key 5,6-
spirocycle 148 for (+)-TAN1251B (3).58,64 Conversion to the vinyl bromide 187 proceeded in 
reasonable yield using the conditions previously employed by Auty (scheme 43).57 After 
extensive optimisation of the palladium-catalysed alkenylation reaction, the desired tricycle 
188 was formed in moderate yield as a single regio- and stereoisomer. 
 
 
Scheme 43. Tricycle formation 
 
 
1.6  Aims of the research 
 
As mentioned previously, the aim of this research is to develop a common strategy for a 
QRYHODQGHIILFLHQWDSSURDFKWRZDUGVWKHELRV\QWKHWLFDOO\UHODWHGDONDORLGV(씀)-FR901483 (1) 
and (+)-TAN1251B (3). As shown in our retrosynthetic analysis (scheme 35, p. 38) we 
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envisaged that the 5,6-spirocycle 148 could be an intermediate in the syntheses of both of 
these targets. Firstly therefore, we aimed to focus on a scalable and efficient synthesis of this 
key compound 148:HWKHQSURSRVHGWRZRUNWRZDUGVWKHV\QWKHVHVRIERWK(씀)-FR901483 
(1) and (+)-TAN1251B (3) from this common intermediate. 
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Chapter 2: Results and discussion 
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2.0 Results and discussion 
 
Firstly, the synthesis of our key intermediate 148 via a 1,5-CH insertion will be described and 
discussed. Then the focus will turn to the progress made towards the WRWDOV\QWKHVLVRI(씀)-
FR901483 (1), before moving to discuss the progress made towards the total synthesis of (+)-
TAN1251B (3). We will conclude this section by describing work to be considered in the 
future in order to complete both syntheses. 
 
 
2.1  Formation of the key intermediate 
 
,QRUGHUWRGHYHORSDQHIILFLHQWDSSURDFKWRWKHWRWDOV\QWKHVLVRI(씀)-FR901483 (1) and (+)-
TAN1251B (3), we first required an efficient synthesis of the 5,6-spirocyclic enone 148, our 
key intermediate. Our retrosynthetic analysis has shown that 148 could be accessed from the 
5,5-spirocycle alkene 149 (scheme 44), via a 1,5-CH insertion of a suitable carbene 
cyclisation precursor 189, followed by a ring expansion. Ketone 189 can be accessed from a 
suitably protected cis-4-hydroxy-D-proline derivative 174, via simple chemical 
transformations. 
 
 
 
Scheme 44. Retrosynthesis of our key intermediate 148 
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Since cis-4-hydroxy-D-proline 173 is quite expensive (£300 for 10 g)65 and a large amount of 
it was required for our synthesis, we looked for a way to convert the inexpensive trans-4-
hydroxy-L-proline 19065 into our desired chiral pool starting material. Lowe reported a 
method to achieve this,66 which initially involved the treatment of trans-4-hydroxy-L-proline 
190 with acetic anhydride to give the N-acylated compound 191 (scheme 45). The presence 
of this N-acyl group allowed formation of the corresponding bicyclic mesoionic intermediate 
192. Selective protonation is controlled by the existing stereocentre and occurs from the less 
hindered side (opposite to the hydroxyl group) to form 193. From here, intramolecular attack 
of the hydroxyl goup onto the carbonyl leads to lactone 194. This lactone 194 is therefore 
obtained with inversion of configuration at C(5). Subsequent acidic hydrolysis affords the 
hydrochloride salt of cis-4-hydroxy-D-proline, and basification or use of an ion-exchange 
resin allows isolation of 173.67 
 
 
 
Scheme 45.  Proposed mechanism for the epimerisation of 19067 
 
This method allowed isolation of the desired cis-4-hydroxy-D-proline 173 in good yield 
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(scheme 46) and the method also proved to be easily scalable (it has been performed on a 70 
g scale using normal laboratory glassware). 173 was then suitably protected using a sequence 
of straight forward chemical transformations: the carboxylic acid was protected as the methyl 
ester; the amine as a carbamate (Boc group), and the free hydroxyl group as a TBS ether. The 
use of the orthogonal protecting TBS and Boc groups was deliberate at this stage to enable 
selective manipulations at a later stage in the synthesis. In addition, many subsequent steps in 
the synthesis required the protecting groups to be resistant to basic conditions. The protected 
derivative of cis-4-hydroxy-D-proline 174 was obtained in 70 % yield over the 3 steps, and 
no purification by column chromatography was necessary. 
 
 
 
Scheme 46. Reagents and conditions: (a) i. Ac2O:AcOH (1:4), reflux, 5.5 h; ii. 2 M HCl, reflux, 3 h; iii. 
precipitation in Et3N:H2O:EtOH (4:5:30) then recrystallisation, overall yield : 39%; (b) i. AcCl, MeOH, reflux 7 
h; ii. Boc2O, Et3N, CH2Cl2 Û& - UWKRYHUVWHSV LLL7%6&O LPLGD]ROH'0)PLQ Û&
quant. 
 
 
The ester 174 was then reduced using DIBAL-H to the unstable aldehyde 195, which was 
used without purification in a subsequent Wittig reaction with 1-triphenylphosphoranylidene-
2-propanone 160 to afford the Į,ȕ-unsaturated ketone 175 in good yield (scheme 47). The 
enone functionality was then reduced to give the ketone 189 using catalytic hydrogenation. 
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Scheme 47. Reagents and conditions: (a) DIBAL-H, CH2Cl2, -Û&KWKHQ0H2+KE160, CH2Cl2, 
5 d, 80% over 2 steps; (c) H2, Pd/C, EtOAc, 2 d, quant. 
 
 
From this point we considered two possible routes in order to achieve the alkylidene carbene 
insertion. The first route involved the formation of the vinyl chloride 177, which could be 
made via a Wittig-like reaction using KOtBu (solid or made in situ) and ylide 176 (scheme 
48). Treatment of the resultant mixture of E and Z isomers (ratio 2:1) with KHMDS afforded 
the desired insertion product 149 in excellent yield and as a single diastereoisomer. The 
second route employed another well-known method for the formation of an alkylidene 
carbene and treatment of the ketone 189 with lithiated trimethylsilyldiazomethane afforded 
the desired insertion product 149, again in excellent yield. 
 
 
 
 
Scheme 48. Reagents and conditions: (a) KOtBu, 176, THF, 1 h, 88%, E:Z (2:1); (b) KHMDS, Et2O, 3 h, 
91%; (c) TMSCHN2, nBuLi then 189, THF, 85%. 
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Although the alkylidene carbene insertion proceeded with complete retention of 
configuration, it is important to note that epimerisation of 149 readily occurs at the newly 
formed quaternary stereocentre when the product is exposed to acid. Indeed, the trace acid 
contained in deuterated chloroform is enough to result in the observation of both 
diastereoisomers by 1H NMR. This problem can be avoided if the 1H NMR is recorded using 
d6-DMSO or when the CDCl3 is neutralised with K2CO3 prior to use. Racemisation studies on 
a similar substrate have been conducted by previous members of the Hayes group.55,58,68  
 
The ring expansion to convert the 5,5-spirocycle 149 into the 5,6-spirocyclic enone 148 was 
achieved in a straightforward sequence involving oxidative cleavage, intramolecular aldol 
reaction and dehydration of the resultant alcohol (scheme 49). Firstly, dihydroxylation of 
alkene 149 afforded the 1,2-diol 196, and subsequent periodate cleavage furnished keto-
aldehyde 197.  A base-catalysed aldol reaction of 197 resulted in formation of alcohol 198, 
which was dehydrated via elimination of the corresponding mesylate under basic conditions. 
 
 
 
Scheme 49. Reagents and conditions: (a) K2OsO4.2H2O (1 mol%), NMO.H2O, acetone:H2O (10:1), 4 d, 86%; 
(b) NaIO4, THF:H22KF.2+(W2+Û&KRYHUVWHSVG0V&O(W3N, CH2Cl2Û&WR
r.t., 2 d, 92%. 
 
 
The synthesis of our key intermediate 148 was thus completed in an overall yield of 12.3% in 
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12 steps from trans-4-hydroxy-L-proline 190 (or in 32% over 11 steps starting from 
commercially available cis-4-hydroxy-D-proline 173). The whole synthetic sequence has 
been regularly performed on a multigram scale without difficulty. 
 
 
2.2  Progress towards the total syntheVLVRI(씀)-FR901483 (1) 
 
With a successful route to our 5,6-spirocyclic enone intermediate 148, the first challenge in 
WKHV\QWKHVLVRI(씀)-FR901483 (1) was to investigate the key aldol cyclisation step for closing 
the last ring of the tricyclic core. It was important to verify whether the use of a double bond 
as a blocking group would enable the cyclisation on keto-aldehyde 200 to occur in a 
regioselective manner (scheme 50). 
 
 
 
Scheme 50. Reminder of retrosynthetic analysis 
 
 
2.2.1 Aldol approach 
 
We envisaged that we could obtain the desired precursor for the aldol reaction 200 by 
oxidation of the corresponding alcohol 201. It was thought that we could obtain the alcohol 
201 directly from the key 5,6-spirocyclic intermediate 148. However, removal of the Boc 
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group of 148 with TFA and treatment of the resultant free amine with oxirane (condensed 
gas), led to formation of an unexpected tricyclic structure 202 in excellent yield (scheme 51). 
This product is probably the result of an intramolecular Michael addition of the alcohol to the 
enone functionality in 201. This suggests that we did indeed manage to form our desired 
keto-alcohol 201, but that it is inherently too reactive to be isolated. It was therefore not 
possible to oxidise it for subsequent use in the aldol reaction and a new approach was needed. 
 
 
 
Scheme 51. Reagents and conditions: (a) i. TFA, CH2Cl2, 1 h; ii. oxirane, CH2Cl2:MeOH (1:1), -Û&K
then r.t., 1 d, 87%. 
 
 
Alkylation of the free amine in 148 with ethylbromoacetate afforded the keto-ester 203 in 
good yield (scheme 52). Lithium aluminium hydride reduction of the ester and ketone 
functionalities in the molecule afforded the corresponding diol 204. We then attempted to 
convert this into the desired keto-aldehyde 200 via double Swern oxidation. The 1H NMR 
spectrum of the crude reaction mixture did indicate that the desired keto-aldehyde 200 was 
indeed the sole product of the reaction. Unfortunately, all attempts to purify it were 
unsuccessful, presumably due to it being highly unstable. Use of the crude reaction mixture 
directly for the next cyclisation step was therefore considered. The two sets of conditions, 
ZKLFKKDGEHHQXVHGSUHYLRXVO\ LQWKHWRWDO V\QWKHVLVRI(씀)-FR901483 (1) by Snider2 were 
both applied to our substrate, but the desired tricycle 205 was never isolated (scheme 52). 
Instead a complex mixture was obtained, within which the main product was the tricyclic 
hemiacetal structure 206. Isolation of this undesired product may result from the fact that 
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under the reaction conditions the hydrate of aldehyde 200 is formed. This could then undergo 
intramolecular Michael addition to the enone functionality to give the hemiacetal 206.  
 
 
 
Scheme 52. Reagents and conditions: (a) i. TFA, CH2Cl2 1h; ii. BrCH2CO2Et, NaI, K2CO3, MeCN, r.t., 18 h, 
87% over 2 steps; (c) i. LiAlH47+)Û&PLQWKHQUWKLL&2&O2, DMSO, CH2Cl2, -Û&
h then Et3N, -Û&- UWG1D20H0H2+Û&KRU.2tBu, toluene. 
 
 
At this point it seemed that use of the double bond as a blocking group for the aldol 
cyclisation was not viable due to its innate reactivity. This was disappointing, but we decided 
to investigate the use of different methodology for closing the third ring of the tricyclic core 
RI(씀)-FR901483 (1). 
 
 
2.2.2 Enolate chemistry: first-generation approach 
 
$IWHU UHYLHZLQJ WKH OLWHUDWXUHRQSUHYLRXVZRUNV WRZDUGV (씀)-FR901483 (1), it was thought 
WKDW:HLQUHE¶VPRGHOVWXG\29 might be applicable to our synthesis (see 85 to 86, scheme 19, 
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p. 23). The study showed good precedent for the formation of the 2-azabicyclo-[3.3.1]-
nonane ring 86 by intramolecular coupling of an Į-iodo-amide and a ketone (via its enolate) 
in the presence of base.  
 
Based on this methodology reported by Weinreb,29 the new retrosynthetic analysis is shown 
(scheme 53). The key tricyclic core 207 of our target would therefore be obtained from an 
intramolecular cyclisation involving the alkylation of enolate 208 derived from ketone 209. 
With the double bond still blocking one side of the ring, the enolate should be formed on the 
opposite side, thus allowing us to control the regioselectivity of the reaction. 
 
 
 
Scheme 53. Revised retrosynthetic analysis 
 
Starting with key intermediate 148, Boc deprotection followed by alkylation of the free amine 
with chloroacetylchloride afforded the corresponding Į-chloro-amide 210 in good yield 
(scheme 54). Halide exchange was achieved via a Finkelstein reaction and proceeded 
quantitatively to provide iodo-ketone 211.  
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Scheme 54. Reagents and conditions: (a) TFA, CH2Cl2 then ClCH2COCl, Et3N, CH2Cl2Û&KWKHQUW, 3 
h, 77% over 2 steps; (b) NaI, acetone, 4 h, 97%; (c) K2CO3, acetone:H2O (3:1), 10 d, 68% (91% based on SM 
recovered). 
 
 
Treatment with K2CO3, according to the procedure used by Weinreb29 however, failed to give 
the desired tricycle 207, affording instead the unexpected tricycle 212. Formation of this 
product could be explained by displacement of the iodide with water, followed by an 
intramolecular Michael addition to the enone in a similar fashion to that observed whilst 
trying to close the ring via an aldol cyclisation of alcohol 201 (scheme 51, p. 54). The tricycle 
212 was crystalline, enabling us to obtain an X-ray crystal structure, which confirmed our 
interpretation of the spectroscopic data (figure 4). 
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Figure 4. X-ray crystal structure of tricycle 212 
 
Attempts to perform the cyclisation step were continued and a variety of bases were screened 
(avoiding water to prevent halide displacement) for the reaction. The conditions were applied 
to both the keto-iodide 210 and the chloride 211, but most of them led to recovery of the 
starting material (N,N-diisopropylethylamine, LDA, KHMDS) or halide displacement with 
the base (triethylamine). Even at higher temperatures, no conversion to the desired product 
was observed. 
 
These results appeared to confirm that the double bond, which was hoped would block one 
side of the 6-membered ring to enable a regioselective cyclisation, was unfortunately too 
reactive under the conditions used and was actually blocking formation of the correct tricycle. 
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2.2.3 Enolate chemistry: second-generation approach 
 
7KHSURSRVDORIFORVLQJWKHODVWULQJRIWKHWULF\FOLFFRUHRI(씀)-FR901483 (1) using enolate 
chemistry in this manner was reconsidered. It was now thought that a new disconnection was 
needed, in which this time the enolate chemistry could be used to install a carboxylic acid 
side-chain on key intermediate 148 (scheme 55). This, after installation of the amino group, 
would lead to the amino acid 214, which could undergo an intramolecular peptide coupling to 
close the final ring and form tricycle 213. The new retrosynthetic analysis is shown (scheme 
55).  
 
 
 
Scheme 55. Revised retrosynthetic analysis 
 
We decided to work on a more advanced intermediate, with the amino group of the natural 
product installed (protected as an azide) in order to reduce the number of transformations 
required later in the synthesis. A short 3-step sequence allowed us to invert the stereocentre at 
C(3) and install the azido group. Deprotection of the TBS group of 148 using TBAF solution 
afforded alcohol 215 (scheme 56). Mesylation of the alcohol followed by reaction with 
sodium azide afforded the azido compound 178 with inversion of configuration at this centre 
in good yield from our key intermediate 148. 
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Scheme 56. Reagents and conditions: D7%$)7+)Û&KWKHQUWGE0V&O(W3N, CH2Cl2, 
r.t., 16 h, 98%; (c) NaN3'0)Û&G 
 
 
With successful formation of the more advanced enone 178, installation of the side-chain was 
investigated. Thus enone 178 was treated with LDA to form the corresponding enolate, which 
upon reaction with ethylbromoacetate resulted in the isolation of a mixture of 
diastereoisomers in 21% yield in addition to the recovery of a substantial amount of starting 
material (41%) (scheme 57). We were pleased to observe that the desired axial ester 217 was 
the major product, formed in a 2.5:1 ratio to the equatorial isomer 218. Although we were 
able to recover starting material (that could be recycled) from this reaction after purification, 
the yield of desired product was still low, and needed improvement. It is known that using an 
additive such as HMPA or DMPU in alkylation reactions of this type can improve yields,69 
and due to its reduced toxicity70 the use of DMPU was investigated for our system. 
Pleasingly, the yield increased from 21% to 60% (in addition to the isolation of 20% of 
starting material that could again be recycled). Unfortunately the stereoselectivity of the 
reaction was reduced with isolation of the axial isomer 217 and the equatorial isomer 218 in a 
ratio of only 1:1.3 respectively. This was disappointing as we required the axial isomer in 
order for the key cyclisation step to proceed. In addition the mixture of diastereoisomers 
proved to be difficult to separate, and therefore the next step was performed on the mixture, 
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in anticipation of being able to separate them at a later stage. 
 
 
 
Scheme 57. Reagents and conditions: (a) LDA, THF, 1 h then BrCH2CO2Et, 4 h, 217 15%, 218 6%, 178 
41%; (b) LDA, THF, 1 h then BrCH2CO2Et and DMPU, 4 h, 217 26%, 218 34%, 178 20%. 
 
 
Hydrolysis of the mixture of esters 217:218 was performed as a biphasic reaction using 
aqueous NaOH solution (2 M) and THF, and surprisingly we observed formation of the acid 
219 as a single diastereomer (Scheme 58). We suspected that it would be the desired axial 
product as there appeared to be a plausible mechanism to explain this result (scheme 59). 
Using NaOH as a base could lead to the presence of the enolate 220 in the reaction mixture. 
Upon work-up, re-protonation of the enolate from the bottom face could be preferred, due to 
the bulky Boc group sterically shielding the top face. If this bias towards reprotonation from 
the bottom face was substantial then this would explain the exclusive presence of the axial 
isomer 219. 
 
 
 
Scheme 58. Reagents and conditions: (a) NaOH (2M):THF (1:1), 2 d, 90%. 
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Scheme 59. Proposed mechanism of epimerisation 
 
The key cyclisation step (which would only be possible with the axial isomer) was attempted. 
Boc deprotection of 219 followed by an intramolecular peptide coupling of the resultant free 
amine with the carboxylic acid, using DPPA and triethylamine in DMF afforded the desired 
tricyclic structure 221 in excellent yield (scheme 60). This provided further evidence that the 
carboxyl group was in the axial position. 
 
 
 
Scheme 60. Reagents and conditions: (a) i. TFA, CH2Cl2, 1 h.; ii. DPPA, Et3N, DMF, 2 h, 99% over 2 steps. 
 
 
We were pleased to subsequently be able to confirm the structure of the tricycle 221 by X-ray 
crystallography (figure 5).  
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Figure 5. X-ray crystal structure of tricycle 221 
 
 
This study was really important as it showed that it was indeed possible to form the novel 
tricyclic structure 221 RI (씀)-FR901483 (1) using this methodology. However, it was not 
immediately obvious that it would be possible to install the p-methoxybenzyl (PMB) in a 
stereoselective manner at C(11). In addition, there were concerns about introducing the 
hydroxyl group at the C(12) position. We therefore decided to contLQXHWKHZRUNWRZDUGV(씀)-
FR901483 (1) using an approach that had been developed previously within the Hayes 
group58,64 and which perhaps had more chance of enabling us to complete the total synthesis. 
Some promising studies using this methodology had already been conducted when this 
decision was made. 
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2.2.4 Palladium-catalysed cyclisation approach 
 
The strategy previously employed within the Hayes group involved the use of a palladium-
catalysed cyclisation to close the final ring of the tricycle.58,64 Thus our new retrosynthesis 
LQYROYHV GLVFRQQHFWLRQ RI (씀)-FR901483 (1) to the advanced tricycle 188, product of the 
cyclisation of vinyl bromide 187 (Scheme 61).  This cyclisation offers a significant advantage 
over the previous methodology (section 2.2.3), as it should be relatively straightforward to 
form the ketone at the C(12) postion. This would subsequently enable installation of the PMB 
group at the C(11) position using enolate chemistry previously described by Funk16 and in 
addition it should be trivial to convert the ketone into the required hydroxyl group. 
 
 
 
Scheme 61. Revised retrosynthetic analysis 
 
Boc cleavage and N-alkylation of the resultant amine with 2,3-dibromopropene converted the 
key-intermediate 148 into the vinyl bromide 187, precursor to the cyclisation step in good 
yield (scheme 62). Treatment with Pd2(dba)3 in the presence of Xanpthos (222) and KOPh 
(made in situ from phenol and KOtBu) afforded the desired tricycle 188 in reasonable yield, 
along with a significant amount of an unusual tricycle 224. The formation of the latter can be 
explained by the palladium-catalysed cyclisation of an allene such as 223, which had been 
previously observed by Asari during optimisation of this process.64 
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Scheme 62. Reagents and conditions: (a) TFA, CH2Cl2 then 2,3-dibromopropene, K2CO3, NaI, MeCN, 74%; 
(b) 10 mol% Pd2(dba)3, 20 mol% 222, KOtBu/PhOH, THF, 4 h (188, 30-52% and 224, 19-30% depending on 
the scale). 
 
 
Having succeeded in forming a reasonable amount of the tricyclic core 188, the next 
FKDOOHQJHZDVWRPRYHWRZDUGVFRPSOHWLQJDWRWDOV\QWKHVLVRI(씀)-FR901483 (1). The double 
bond of the enone had served its purpose as a blocking group (preventing cyclisation onto the 
undesired side of the ring) and was not needed anymore. It was successfully removed via a 
dissolving metal (Birch) reduction to give the desired keto-alkene 225 in good yield (scheme 
63).71 
 
 
 
Scheme 63. Reagents and conditions: (a) Li, NH3, THF, 1h, 60% 
 
The next key challenge in the synthesis was installation of the PMB group at the C(11) 
position. As discussed previously, the exocyclic double bond of 225 needs to be converted 
into the corresponding ketone in order for this to be plausible. Firstly, it was necessary to 
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protect the ketone at C(8) and to achieve this we decided to reduce it to the corresponding 
alcohol and then install a protecting group. This strategy would both remove the possibility of 
any selectivity issues during the introduction of the PMB group and form a more advanced 
LQWHUPHGLDWH LQ WKH V\QWKHVLV RI (씀)-FR901483 (1). Reduction of the ketone of 225 with 
sodium borohydride afforded the alcohol 226 as a single diastereoisomer in good yield 
(scheme 64). This product was the result of axial attack by the reductant, although 
interestingly the use of L-selectride gave the same single diastereoisomer in comparable 
yield. Although the diastereoisomer 226 formed was opposite in configuration to that 
UHTXLUHG SUHYLRXV ZRUN RQ (씀)-FR901483 (1) has shown that it is possible to invert this 
centre and install the phosphate ester in one step (section 1.3.1.2).7 
 
 
 
Scheme 64. Reagents and conditions: (a) NaBH40H2+Û&WKHQUWK86%; (b) Ac2O:pyridine (1:1), 12 
h, 78%. 
 
 
The alcohol 226 was found to be quite unstable at room temperature and during the 
purification process an unexpected compound, tentatively assigned as the epoxy compound 
227 was isolated on a number of occasions. In addition, protection of the alcohol 226 was not 
as straightforward as expected. Attempted benzyl or benzoyl protection led to complete 
recovery of starting material, whilst attempted TBS protection allowed isolation of only a 
67 
 
small amount of the desired product. Fortunately acetate protection proved to be reasonably 
efficient and afforded 228 in 56% over two steps from ketone 225. 
 
The formation of this epoxy compound 227 remains unexplained. Epoxidation of a double 
bond in air is known, but requires the presence of a metal (e.g. Co,  Mo, Ag)72-74 so it is 
difficult to understand how this could occur under the reaction conditions applied. We did, 
however try to render this material useful for our synthesis by investigating its conversion 
into the desired ketone 230 directly75 or to the intermediate diol 229 (scheme 65).76 
Unfortunately, attempted opening of the epoxide 227 proved to be impossible, even under 
forcing conditions, which prevented it being useful to the synthesis. Its formation was for us 
only proof of the high reactivity of the double bond. 
 
 
 
Scheme 65. Reagents and conditions: (a) 5% HClO4 (aq.), THF76 or NaOH (1M), acetone or H2SO4 (2M), 
MeCN; (b) NaIO4, H5IO6, THF/H2O (10/1), r.t.75 
 
 
With the suitably protected alkene 228 in hand, the next step was to convert it into the 
corresponding ketone. This type of transformation could be achieved via ozonolysis, but 
might not be compatible with the presence of a tertiary amine, which could oxidise under the 
reaction conditions to form a N-oxide. A procedure reported by Mariano in a formal synthesis 
of Cephalotaxine employed a similar transformation to the one we required, where the 
tertiary amine was protected as an ammonium salt (scheme 66).77 
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Scheme 66. Reagents and conditions: (a) HClO4, O3, CH2Cl2:MeOH then DMS, 63%.77 
 
 
This method was applied to our substrate 228 and pleasingly we did indeed obtain our desired 
ketone 233 (scheme 67). The yield had to be estimated by analysis of the 1H NMR spectrum 
of the crude reaction mixture as the ketone appeared to be highly unstable and purification by 
silica gel chromatography was not possible. In addition the ketone 233 could not be stored 
and was used immediately in the next step of the synthesis. 
  
 
 
Scheme 67. Reagents and conditions: (a) HClO4, O3, CH2Cl2:MeOH (1:2) then DMS, 90% (based on analysis 
of 1H NMR spectrum of crude reaction mixture). 
 
 
The key alkylation of ketone 233 to install the PMB group could now be investigated. 
$OWKRXJKLQSUHYLRXVZRUNWRZDUGV(씀)-FR901483 (1), most research groups had installed the 
PMB group early on in the synthesis, there are a few examples where it was installed at a late 
VWDJH ,Q )XQN¶V URXWH WR (씀)-FR901483 (1),16 ketone 52 was treated with KOtBu and the 
resultant enolate reacted with p-methoxybenzylbromide to afford the PMB alkylated 
compound 53 (a, scheme 68). Fukuyama applied a very similar approach to his advanced 
substrate 234, which only differed by the use of KHMDS as a base for the initial 
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deprotonation (b, scheme 68).17,18 Wardrop employed a stepwise procedure to achieve the 
same transformation, where the enolate of 235 was trapped as silyl enol ether 236, which was 
then alkylated with p-methoxybenzylbromide in the presence of ZnCl2 (c and d, scheme 
68).24 Based on this amount of literature precedent we were confident that the installation of 
the PMB group in our substrate would be possible. 
 
 
 
Scheme 68. Reagents and conditions: (a) KOtBu, THF then p-MeOBnBr, DMF, 97%;16 (b) KHMDS, 
TMEDA then p-MeOBnBr, THF, - Û& WR U.t., 64%;17,18 (c) KHMDS, TESCl, THF, - Û& PLQ G p-
MeOBnBr, ZnCl2·Et2O, Et2O, -Û&WR-Û& h, 68% over 2 steps.24 
 
 
Therefore the crude ketone 233 was firstly treated with KOtBu (in an attempt to form enolate 
238) and then p-methoxybenzylbromide was added (Scheme 69). Unfortunately a mixture of 
degradation products was isolated from this reaction and formation of the desired product 240 
was not observed. The process was repeated using KHMDS as the base, but again only 
degradation of the starting material was observed. Attempts to form enolate 238 and 
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subsequently trap it as a silyl enol ether were also unsuccessful. A final effort to install the 
PMB group involved attempting an aldol condensation of 233 with p-methoxybenzaldehyde, 
but unfortunately once again only degradation of the ketone 233 was observed. 
 
 
 
Scheme 69. Reagents and conditions: (a) KHMDS or KOtBu, TMEDA, THF then p-MeOBnBr or KHMDS, 
then TESCl, then p-MeOBnBr, ZnCl2; (b) p-methoxybenzaldehyde, KOH, MeOH. 
 
 
Given the similarity of our substrate with previous precedence in the literature, it was 
disappointing not to be able to obtain the desired product 240. It may simply be that the 
innate instability of the starting ketone 233 caused it to decompose under the reaction 
conditions. The major difference between this compound and the substrates reported to 
undergo this transformation is that it contains a tertiary amine instead of an amide moiety.16-
18,24
 This difference could contribute to explaining the problem with stability that we 
encountered with ketone 233 and led us to reconsider our retrosynthesis. 
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2.2.5 Amide series approach 
 
$WWKLVSRLQWLQWKHSURMHFWZHUHYLHZHGSUHYLRXVZRUNRQ(씀)-FR901483 (1) and reflected on 
what we had learnt whilst working on our different routes. This led us to realise that it might 
EH SRVVLEOH WR UDSLGO\ UHDFK RQH RI WKH LQWHUPHGLDWHV LQ )XNX\DPD¶V V\QWKHVLV17-18 RI (씀)-
FR901483 (1) using chemistry that was developed within the Hayes group. The new 
retrosynthetic analysis is shown below (scheme 70). 
 
 
 
Scheme 70. Revised retrosynthetic analysis 
 
)XNX\DPD¶V LQWHUPHGLDWH 241 could be accessed from the terminal alkene 242 via similar 
transformations to those previously utilised in the tertiary amine series (section 2.1). This 
alkene 242 could result from a dissolving metal reduction of enone 243. The key step in this 
route would involve a regioselective palladium-catalysed alkenylation of the 5,6-spirocyclic 
enone 244 to afford 243, the tricyclic core of our target molecule. The Hayes group has 
previously developed a method to synthesise 5,6-spirocycles (comparable to 245), which 
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contain a quaternary stereocentre next to nitrogen, via an alkylidene carbene 1,5-CH 
insertion. Thus D-pyroglutamic acid 246 would be an ideal chiral pool starting material; 
however the much cheaper L-pyroglutamic acid 247 was used for preliminary model studies.  
 
The preliminary protection steps were carried out smoothly following a literature procedure 
reported by Aggarwal78 to afford ester 249 (scheme 71). The sequence involved esterification 
of 247 and protection of the amide as a methyl aminal (after Boc protection of the amide and 
reduction of the carbonyl group). Protection of the amide was necessary in order to avoid any 
potential problems with this functionality in some of the steps of the synthesis, which would 
UHTXLUHVWURQJEDVH2QHPLQRUFKDQJHWR$JJDUZDO¶VSURFHGXUHZDVPDGH78 which involved 
the use of L-selectride in place of lithium triethylborohydride (super hydride) for the 
reduction. The reaction proceeded in comparable yield to that reported.78 
 
 
 
Scheme 71. Reagents and conditions: (a) i. SOCl2, MeOH, 2 h; ii. Boc2O, DMAP, MeCN, 3 h, 50% over 2 
steps; (b) i. L-selectride, THF, -78 °C, 2 h; ii. PTSA, MeOH, 20 h, 66% over 2 steps; (c) DIBAL-H, CH2Cl2, -78 Û&KWKHQ0H2+h; (d) 160, CH2Cl2, 4 d, 76% over 2 steps. 
 
 
Reduction of ester 249 to the corresponding aldehyde 250 was achieved smoothly using 
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DIBAL-H, and was followed by a subsequent Wittig reaction with 1-
triphenylphosphoranylidene-2-propanone 160, which gave the enone 251 in good yield. The 
yield of the Wittig reaction was greatly improved (and the reaction time shortened) when it 
was performed at high concentration. The 1,4-reduction of the enone 251 appeared to be 
more complicated than was first envisaged. Under normal hydrogenation conditions using 
palladium over carbon as a catalyst, the 1H NMR spectrum of the crude reaction mixture 
indicated that both reduction of the double bond and hydrolysis of the aminal had occurred to 
give 252 (scheme 72). We thought that the slight acidity of this catalyst could offer an 
explanation for this result and therefore we tried employing palladium hydroxide instead. 
Unfortunately in this case, the aminal moiety was reduced completely to afford the 
corresponding amine 253, as confirmed by interpretation of the 1H NMR spectrum of the 
crude reaction mixture. 
 
 
 
Scheme 72. Reagents and conditions: (a) H2, Pd/C, EtOAc, 12 h; (a) H2, Pd(OH)2, EtOAc, 12 h; (b) Li, NH3, 
THF, -78 °C, 68%. 
 
 
A dissolving metal (Birch) reduction was also attempted, but this resulted in the isolation of 
an acyclic product 254, derived from opening of the pyrrolidine ring. There is a plausible 
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mechanism, which could explain the formation of this novel compound 254 (scheme 73). 
Electron addition to enone 251 would form the radical anion 255, from which the pyrrolidine 
ring can be opened to afford the diene 257 after protonation of the amine. Addition of another 
electron would form the enolate species 258 and subsequent quenching of the anion via 
protonation would lead to the formation of the ȕ,Ȗ-unsaturated ketone 254. 
 
 
 
Scheme 73. Proposed mechanism for opening of the pyrrolidine ring via Birch reduction 
 
After further attempts (use of DIBAL-H, L-selectride, Raney Nickel) where mostly starting 
material was recovered, we employed the use of sodium dithionite (sodium hydrosulfite: 
Na2S2O4) in water and dioxane.79 Pleasingly we were actually able to isolate the desired 
product 260 although the yield was poor (scheme 74). This provided some optimism that the 
transformation was possible on our substrate and eventually conditions were found, which 
provided the reduced product 260 in quantitative yield. This involved hydrogenation of enone 
251 using a palladium over carbon catalyst again, but critically a few drops of pyridine were 
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added to the reaction mixture. Presumably the use of slightly basic conditions for the 
hydrogenation was important for the stability of the aminal protecting group.  
 
 
 
Scheme 74. Reagents and conditions: (a) H2, Pd/C, pyridine, EtOAc, quantitative or Na2S2O4, H2O, dioxane, 
26%; (b) TMSCHN2, nBuLi, THF, -60 °C to r.t., 79%. 
 
 
The next step was the alkylidene carbene insertion to form 5,5 spirocycle 261, which was 
achieved using lithiated trimethylsilyldiazomethane in good  yield (scheme 74). The use of 
KHMDS for the 1,5-CH insertion was not investigated as it required an additional step. 
 
The ring expansion of spirocycle 261 was conducted using a similar oxidative cleavage/aldol 
reaction/dehydration sequence to that described previously for the amine series (section 2.1). 
The dihydroxylation proceeded without complication using potassium osmate and N-
methylmorpholine-N-oxide. Cleavage of the resulting diol was less straightforward and use of 
sodium periodate gave a mixture of products (scheme 75). The major product was indeed a 
keto aldehyde (262), but demethylation of the aminal protecting group had occurred and the 
desired keto-aldehyde 263 was isolated only in low yield. In order to avoid this unwanted 
side reaction, we attempted the diol cleavage using lead tetraacetate in dry CH2Cl2 and 
pleasingly this afforded the desired product 263 in good yield from the 5,5-spirocycle 261. 
Aldol reaction of the keto-aldehyde 263 using potassium hydroxide, followed by mesylation 
of the resultant alcohol and subsequent elimination gave the desired 5,6-spirocyclic enone 
264. Pleasingly, and perhaps not that surprisingly after the observations of its high acid 
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lability, the aminal was hydrolysed during simple purification on silica gel.  
 
 
 
Scheme 75. Reagents and conditions: (a) i. K2OsO4.2H2O, NMO.H2O, acetone:H2O (10:1), 4 d, 93%; ii. 
NaIO4, THF:H2O (2:1), 1 h, 262, 69% and 263, 16%; (b) i. K2OsO4.2H2O, NMO.H2O, acetone:H2O (10:1), 4 d, 
93%; ii. Pb(OAc)4, CH2Cl2, 10 min, 90% (based on analysis of 1H NMR spectrum of crude reaction mixture); 
(c) i. .2+(W2+ÛC, 1.5 h; ii. MsCl, Et3N, CH2Cl2, 0 Û&- r.t., 3 d, 18% over 3 steps. 
 
 
The challenge now was to re-oxidise the aminal 264 into the corresponding amide. For this 
purpose, a model study was undertaken on a less advanced intermediate 251, which was 
similar in term of key functionalities (i.e. presence of the enone moiety). Firstly the aminal 
251 was hydrolysed with a simple acidic wash (HCl 2M) to give 265 (scheme 76). From here 
use of the Collins oxidation80 (preparation of the CrO3· (pyridine)2 complex in situ) according 
to the procedure of Katsuo81 afforded only a small amount of the desired amide 266. 
However pleasingly the use of pyridinium chlorochromate (PCC)82 in dry CH2Cl2 as reported 
by Burke83 was more efficient and the desired amido-enone 266 was obtained in 60% yield. 
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Scheme 76. Reagents and conditions: (a) HCl wash, 84%; (b) CrO3, pyridine, Ac2O, CH2Cl2, 4 Å molecular 
sieves, 26% (50% based on recovered SM) or PCC, CH2Cl2, 4 Å molecular sieves, 20 h, 59%. 
 
 
We therefore applied these conditions (PCC in dry CH2Cl2) to the advanced substrate 264, 
and pleasingly obtained the key 5,6-spirocyclic intermediate 267 in good yield (scheme 77). 
This intermediate was a colourless solid and it was possible to confirm the structure by X-ray 
crystallography (figure 6). 
 
 
 
Scheme 77. Reagents and conditions: (a) PCC, CH2Cl2, 4 Å molecular sieves, 20 h, 62%. 
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 Figure 6. X-ray crystal structure of key intermediate 267 
 
We had now reached the key intermediate 267 in our synthesis in an overall yield of 2% over 
11 steps. The next challenge was to investigate a palladium-catalysed alkenylation reaction 
for closing the last ring of the tricyclic structure and to subsequently complete a formal 
V\QWKHVLVRI(씀)-FR901483 (1E\UHDFKLQJ)XNX\DPD¶VLQWHUPHGLDWH241.17-18 
 
The first step towards achieving this goal was to alkylate the Boc-deprotected 5,6-spirocycle 
267 in order to form the vinylbromide 268, precursor to the cyclisation step. Therefore after 
removal of the Boc group in acidic conditions, the resulting TFA salt was treated with sodium 
hydride and 2,3-dibromopropene.84 Unfortunately, only a complex mixture of products was 
observed, with no indication of formation of the desired compound 268 (scheme 78). A 
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variety of different bases were employed, for the alkylation step (including KOtBu and 
NaOH) but unfortunately no more than a trace of the desired product 268 was ever obtained. 
 
 
 
Scheme 78. Reagents and conditions: (a) i. TFA, CH2Cl2; ii. 2,3-dibromopropene, NaH, DMF or 2,3-
dibromopropene, TBAB, NaOH (2M), EtOAc or 2,3-dibromopropene, KOtBu, THF. 
 
 
It was really disappointing to have reached this key-intermediate 267 and not be able to 
alkylate to afford the desired vinyl bromide. This was particularly frustrating as we could not 
attempt the key palladium-catalysed alkenylation. 
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2.2.6 Summary of progress made tRZDUGV(씀)-FR901483 (1) 
 
From cis-4-hydroxy-L-proline, the key 5,6-spirocyclic intermediate 148 was synthesised, 
using a 1,5-CH insertion of an alkylidene carbene as the key step, in good yield and on a 
multigram scale. Our initial hypothesis was that the presence of the enone functionality in 
148 would enable a regioselective aldol reaction to be employed to close the final ring of the 
tricyclic core 205 RI (씀)-FR901483 (1).Unfortunately the apparent innate reactivity of the 
double bond, which we had hoped would act as a blocking group, prevented this from being 
possible (route a, scheme 79).  
 
 
 
Scheme 79. Summary of progress towards (?-FR901483 (1) 
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Revision of our retrosynthesis led to the proposal that the final ring could be formed via an 
intramolecular peptide coupling of amino acid 219 derived from the key intermediate 148 
(route b, scheme 79). Pleasingly, this route did indeed lead to formation of the tricyclic core 
221 of (씀)-FR901483 (1) in excellent yield and with excellent stereoselectivity. Having 
shown that it was possible to form the tricyclic core, in order to move forward towards a total 
synthesis, a new route was envisaged. This involved a key palladium-catalysed cyclisation of 
vinyl bromide 187, derived from alkylation of the key intermediate 148 (route c, scheme 79). 
Indeed this methodology was successful and the tricyclic core 188 of (씀)-FR901483 (1) was 
again constructed. Unfortunately, problems with the stability of compounds later in this 
synthesis, and failure to install the key PMB side-chain led us to regretfully abandon this 
route. In the final approach, it was thought that use of a palladium-catalysed alkenylation 
reaction of N-alkylated 268 ZRXOGDOORZUDSLG DFFHVV WRDNH\ LQWHUPHGLDWH LQ )XNX\DPD¶V
synthesis of  (씀)-FR901483 (1) (scheme 80).17,18 Unfortunately, the formation of the 
precursor 268 to this key step was not possible and therefore disappointingly we were not 
able to investigate this route any further. 
  
 
 
Scheme 80. Summary of amide series approach towards (씀)-FR901483 (1) 
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2.2.7 )XWXUHZRUNWRZDUGVFRPSOHWLQJWKHV\QWKHVLVRI(씀)-FR901483 (1) 
 
From the work presented thus far we can envisage moving forwards towards completing a 
WRWDO V\QWKHVLV RI (씀)-FR901483 (1) in several different ways. From the tricycle 221, 
formation of the hydroxy intermediate 269 could be realised via Į-hydroxylation (scheme 
81). From this point, installation of the side-chain should be possible, and (씀)-FR901483 (1) 
should subsequently be attained after a few straight forward transformations. Alternatively, if 
the problems with stability of the ketone derived from 188 could be overcome, perhaps by 
modifying its structure slightly, it should be simpler to introduce the PMB group. Subsequent 
introduction of the amine functionality and inversion of stereochemistry at the hydroxyl 
group in order to finish the synthesis, are well described in the literature.2,7 
 
 
 
Scheme 81. Possible future work 
 
83 
 
For a formal synthesis of (씀)-FR901483 (1) )XNX\DPD¶V NH\ LQWHUPHGLDWH 241 could be 
reached.17-18 Although attempts at achieving this within this thesis were unsuccessful, we can 
envisage another route to this intermediate 241. Starting with the amide intermediate 267, 
transformation of the enone to the silyl enol ether 271 could be followed by an aldol 
cyclisation. This would form the tricyclic core of (씀)-FR901483 (1), and only a few 
VXEVHTXHQWVWHSVZRXOGEHUHTXLUHGWRUHDFK)XNX\DPD¶VLQWHUPHGLDWH241.17-18 
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2.3  Progress towards the total synthesis of (+)-TAN1251B (3) 
 
The next part of this thesis will present the progress made from our key 5,6-spirocyclic enone 
intermediate 148 towards the total synthesis of (+)-TAN1251B (3). Installation of the 
hydroxyl group adjacent to the ketone is the main challenge of this synthesis. 
 
 
2.3.1  Enantioselective Į-hydroxylation to the ketone 
 
As described previously, (+)-TAN1251B (3) could be accessed from the advanced tricycle 
152 (scheme 82), where the side chain would be installed using a similar method to that used 
E\$XW\LQKLVV\QWKHVLVRI(씀)-TAN1251A.56 This tricycle would result from simple chemical 
transformations of tricycle 272, which could be accessed by cyclisation of amino acid 151. 
This amino acid 151 can be formed from the N-Boc protected azido compound 179. This then 
makes our main synthetic challenge the Į-hydroxylation of the key intermediate ketone 148. 
 
 
 
Scheme 82.  Retrosynthetic analysis of (+)-TAN1251B (3) 
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From the common intermediate 148, inversion of stereochemistry at C(3) with installation of 
the azido group to afford enone 178 was realised as described previously in the work towards 
(씀)-FR901483 (1) (scheme 56, p. 60). Although numerous methods exist for the preparation 
of simple Į±hydroxy ketones,85 methods for the preparation of Į±hydroxy enones, 
particularly in a stereoselective manner are less common. However, the presence of the 
double bond in our intermediate should offer an advantage in this transformation by blocking 
one site where the hydroxylation could take place. Previous work in this area by Asari58,59 
during her studies towards (+)-TAN1251B (3) XVHGDPHWKRGLQVSLUHGE\0RULDUW\¶VZRUN86-
88
 Treatment of the substrate 178 with iodosobenzene disappointingly afforded a mixture of 
diastereoisomers 179 and 180 in a 79% combined yield and a 1:1.2 ratio respectively (scheme 
83). In addition Asari found that the two diastereoisomers were difficult to separate by 
column chromatography and hence it was almost impossible to isolate a sufficient amount of 
the correct stereoisomer in order to proceed with the synthesis.  
 
 
 
Scheme 83. Reagents and conditions: (a) PhIO, NaOH, MeOH 0 °C, 3 h, 179, 36% and 180, 43%. 
 
 
This method was not satisfactory and as a key step in the synthesis, we were keen to improve 
RQ$VDUL¶VLQLWLDOUHVXOW2¶%ULHQ89 reported that treatment of the enolate derived from a cyclic 
enone 273 ZLWK'DYLV¶R[D]LULGLQH27590 led to the formation of a single diastereoisomer of 
the hydroxy ketone 274 in excellent yield (scheme 84). It was postulated that the high degree 
of stereoselectivity arose from attack of the enolate onto the oxaziridine occurring trans to the 
bulky TBS groups. 
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Scheme 84. Reagents and conditions: (a) NaHMDS, THF, -78 °C, 30 min then 275, 91%.89 
 
 
We thought that we could apply this methodology to our system and made the hypothesis that 
the bulky Boc group could influence the stereochemical outcome of the reaction in an 
DQDORJRXVPDQQHUWRWKH7%6JURXSVLQ2¶%ULHQ¶VV\VWHP89 Initially we used a model cyclic 
enone 276 and were disappointed to find that in our hands this method did not result in the 
isolation of any of the desired Į-hydroxy enone 277 (scheme 85). We used a variety of bases 
to form the enolate (KHMDS, LiHMDS, LDA) but only ever recovered the starting material 
276. We did attempt the reaction on our real substrate 178, but unsurprisingly it failed to 
provide any of the desired product 179. 
 
 
 
Scheme 85. Reagents and conditions: (a) base, THF, -78 °C, 30 min then 275. 
 
 
An alternative method for the formation of Į-hydroxy enones involves the trapping of the 
enolate as a silyl enol ether, followed by treatment with an oxidant such as m-CPBA, OsO4 or 
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DMDO.91-93 One possible limitation of this transformation is that it can often occur with little 
stereoselectivity. However, we decided to employ these conditions93 to our key substrate 178. 
Thus, the enone 178 was treated with LDA to form the corresponding enolate, which was 
then trapped using trimethylsilylchloride to give the desired silyl enol ether 278 in good yield 
after purification on silica gel (scheme 86). Treatment of this intermediate 278 with DMDO 
led to the formation of a single compound in excellent yield. 
 
 
 
Scheme 86. Reagents and conditions: (a) TMSCl, LDA, THF, -78 °C, 4 h, 278, 72%, 178, 24%; (b) DMDO, 
acetone, -78 °C, 20 min, 97%. 
 
 
The product 179 was crystalline and we were able to confirm that it was the desired pseudo-
equatorial alcohol by X-ray crystallography (figure 7). We postulated that the high degree of 
diastereoselectivity could be explained by the bulky Boc group sterically blocking the top 
face of the molecule. This would force the attack of DMDO to occur from the bottom face, 
resulting in formation of the pseudo equatorial product. This was a really pleasing result and 
represented a significant improvement to the method used previously by Asari.58,59 
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Figure 7. X-ray crystal structure of key intermediate 179 
 
 
2.3.2  Formation of the tricyclic core of (+)-TAN1251B (3) 
 
With the desired hydroxy ketone 179 in hand, the next challenge was to close the final ring to 
obtain the tricyclic core structure of (+)-TAN1251B (3). Initially the alcohol was protected 
with a TBS group, chosen to be compatible with the conditions proposed for the rest of the 
synthesis. Treatment of the hydroxy ketone 179 with TBSCl and imidazole afforded the 
desired product 279 in a moderate 60% yield (scheme 87). However the use of TBS triflate 
and 2,6-lutidine afforded the TBS protected alcohol in 87% yield. Unfortunately when the 
reaction was scaled up to 500 mg (initially a 50 mg scale was employed), we observed 
formation of the undesired doubly TBS-protected compound 280. This compound is 
presumably a result of attack of the TBS triflate by the lone pair of the carbonyl and 
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subsequent removal of the acidic proton alpha to it. This side-product 280 was formed in a 
25% yield, and the isolated yield of our desired product 279 was reduced to 53%. 
 
 
 
Scheme 87. Reagents and conditions: (a) TBSCl, imidazole, DMF, 60% or TBSOTf, 2,6-lutidine, CH2Cl2, 2 
h, -78 °C, 279, 87%-53%, 280, 0-25% depending on scale. 
 
 
However, we still managed to isolate enough material to pursue our synthesis of the 
cyclisation precursor. It was therefore decided to move on with the synthesis and re-optimise 
this step at a later point. The next transformation required reduction of the double bond, 
which had served its purpose in the regioselective hydroxylation, whilst keeping the azido 
(masked amine) group intact. Unfortunately, it proved almost impossible to reduce the double 
bond without reducing the azido group. One example reported in the literature,94 where this 
FKHPRVHOHFWLYLW\ KDG EHHQ SRVVLEOH HPSOR\HG :LONLQVRQ¶V FDWDO\VW LQ D KRPRJHQHRXV
catalysed hydrogenation. We therefore applied this method to our substrate 279, but this 
unfortunately resulted in complete recovery of starting material (scheme 88). Even at higher 
pressures of hydrogen no conversion was observed. 
 
 
 
Scheme 88. Reagents and conditions: (a) RhCl(Ph3P)3, benzene, H2 (10 bars), 1 d. 
 
 
Based on the difficulties in achieving this chemoselective reduction, it was decided to 
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investigate reducing the double bond in addition to the azide later in the synthesis, when it 
was necessary to unmask the amine. Therefore, the next step was now to protect the enone 
functionality of 279 in preparation for the key cyclisation step. Attempts to convert the enone 
279 into its acetal were unsuccessful, so instead it was envisaged that ketone 279 could be 
reduced to the corresponding alcohol and protected. Treatment of ketone 279 with L-
selectride afforded the desired product 282 as a mixture of diastereoisomers in a 1:5 ratio 
(scheme 89). The major diastereoisomer was thought to be the pseudo-equatorial isomer, but 
since the alcohols would be re-oxidised to the ketone at a later point in the synthesis, the 
stereochemistry at this centre was not critical. Treatment of the crude alcohols 282 with 
acetic anhydride in pyridine gave the protected diols 283 in excellent yield and in the same 
diastereoisomeric ratio. 
  
 
 
Scheme 89. Reagents and conditions: (a) L-selectride, THF, -78 °C, 2 h; (b) Ac2O, pyridine, 14 h (86% over 
2 steps). 
 
 
Only a few steps remained before the key cyclisation step could be attempted. Boc 
deprotection of amine 283 was readily achieved using TFA, and the free amine was 
subsequently alkylated with ethylbromoacetate in the presence of K2CO3 and NaI (scheme 
90). At this point separation of the major pseudo-equatorial diastereoisomer 284 and the 
minor pseudo-axial diastereoisomer 285 was possible. 
 
91 
 
 
 
Scheme 90. Reagents and conditions: (a) i. TFA/CH2Cl2, 1 h; ii. BrCH2CO2Et, NaI, K2CO3, MeCN, 3 days, 
284, 74%, 285, 15%. 
 
 
To simplify spectroscopic analysis of the subsequent key steps, initially the synthesis was 
continued with only the major pseudo-equatorial isomer 284. At a later point, with a robust 
route in hand, both diastereoisomers could be utilised. The last steps before the key 
cyclisation required conversion of the azido group to the free amine (and the ethyl ester to the 
carboxylic acid). It was thought that hydrogenation of the double bond could be achieved at 
the same time as reduction of the azide. Unfortunately we were not able to isolate any of the 
desired product 286 after hydrogenation of 284 using either palladium over carbon or 
palladium hydroxide. Although it was disappointing not to be able to combine the two steps, 
we decided to look specifically at reducing the azide. Pleasingly, the Staudinger reaction 
proceeded cleanly for our substrate 284 and the free amine 287 was clearly the only 
compound in the 1H NMR spectrum of the crude product (scheme 91). Subsequent treatment 
of the amine 287 with LiOH.H2O resulted in the formation of a highly polar product, which 
could not be purified. However, the mass of the product was consistent with hydrolysis of the 
ester functionality, and perhaps not surprisingly cleavage of the acetate protecting group to 
give the free amino acid 288. This crude product was treated directly with DPPA and 
triethylamine to try and affect the cyclisation, but unfortunately the desired product 289 was 
not isolated. It was thought that this result could be due to the free hydroxyl group interfering 
with the reaction and therefore we reflected on our initial choice of protecting the alcohol 
moiety with an acetate group. 
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Scheme 91. Reagents and conditions: (a) H2, Pd/C or Pd(OH)2, EtOAc; (b) Ph3P, H2O, THF, reflux, 4 h; (c) 
LiOH.H2O, THF, 2 h; (d) DPPA, Et3N, DMF. 
 
 
It was decided to try to protect both alcohol functionalities as a silyl ether, which would also 
serve to reduce the number of steps in the synthesis. Literature precedence suggests it is 
possible to selectively deprotect an allylic TBS-protected alcohol in the presence of another 
TBS-protected alcohol.95-97 This strategy would enable us to make use of the double bond 
again in our synthesis. Starting from the keto-alcohol 179, reduction of the ketone using L-
selectride pleasingly afforded the desired diol 290 in good yield and as a single 
diastereoisomer (scheme 92). Prior to protection of the diol as the TBS ethers, installation of 
the N-ethyl acetate group in place of the N-Boc group was achieved. Use of the conditions 
employed previously gave our desired N-alkylated product 291 in 85% yield. The diol 291 
was then protected as planned with the two TBS groups, using TBS triflate and 2,6-lutidine to 
give the desired product 292 in 91% yield. 
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Scheme 92. Reagents and conditions: (a) L-selectride, THF, -78 °C, 2 h, 80% (b) i. TFA/CH2Cl2, 1 h; ii. 
BrCH2CO2Et, NaI, K2CO3, MeCN, 3 d, 85%; (c) TBSOTf, 2,6-lutidine, CH2Cl2, 2 h, -78 °C, 91%. 
 
 
At this point it was just necessary to convert the azide into the free amine and hydrolyse the 
ester before the cyclisation could be attempted. Treatment of the azide 291 with PPh3 in 
H2O/THF afforded the free amine 293 in excellent yield (scheme 93). Hydrolysis of the ester 
of 293 was achieved using K2CO3 in methanol and subsequent amide coupling with DPPA 
and triethylamine afforded the desired tricycle 294 in 40% yield over two steps from amine 
293. This was a pleasing result as we had successfully synthesised an advanced intermediate 
in the synthesis of (+)-TAN1251B (3) containing the key tricyclic core. 
 
 
 
 
Scheme 93. Reagents and conditions: (a) Ph3P, H2O, THF, 85 °C, 4 h, 93%; (b) i. K2CO3, MeOH; ii. DPPA, 
Et3N, DMF, r.t., 2 h, 40% over 2 steps. 
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2.3.3  Installation of the side-chain of (+)-TAN1251B (3) 
 
Our next step involved alkylating at the amide nitrogen, which was readily achieved using 
NaH and MeI to afford the advanced tricycle 295 in 90% yield (scheme 94). Pleasingly the 
tricycle was crystalline and its structure and stereochemistry were unambiguously confirmed 
by X-ray crystallography (figure 8). 
 
 
 
Scheme 94. Reagents and conditions: (a) NaH, MeI, THF, 0 °C, 2 h, 90%. 
 
 
 
Figure 8. X-ray crystal structure of key intermediate 295  
(The TBS groups on oxygen atoms (O1 and O2) have been omitted for clarity) 
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The installation of the key side-chain could now be attempted. The necessary aldehyde 118 
was easily synthesised from prenyl bromide 296 and 4-hydroxybenzaldehyde 297 in good 
yield (scheme 95). Treatment of the tricycle 295 with LDA resulted in formation of the 
corresponding enolate, which was then reacted with the aldehyde 118 to afford the desired 
product 298 as a mixture of diasteroisomers in good yield. Separation of the two 
diastereoisomers was possible, although the stereochemical outcome of this reaction was not 
important. Both of the stereocentres, introduced in this step, would be removed via 
dehydration later in the synthesis. Installation of this side-chain means that all the carbon 
atoms needed to complete the synthesis of (+)-TAN1251B (3) are now in place.  
 
 
 
Scheme 95. Reagents and conditions: (a) K2CO3, acetone, reflux, 2 h, 80%; (b) LDA, THF, -78 °C, 30 min 
then 118, 2 h, 73% (combined yield). 
 
 
 
2.3.4 Summary of progress made towards (+)-TAN1251B (3) 
 
From the common intermediate 178, the key step in the synthesis of (+)-TAN1251B (3) was 
installation of the hydroxyl group alpha to the ketone (scheme 96). Pleasingly, this 
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transformation occurred in a completely regio- and stereoselective manner and with excellent 
yield.  
 
 
Scheme 96. Progress towards (+)-TAN1251B (3) 
 
The tricyclic core was subsequently formed via an intramolecular peptide coupling of the 
amino acid 299, which was derived in a few simple transformations from the Į-hydroxy 
ketone 179. Subsequent methylation of the nitrogen of the amide, and introduction of the 
side-chain were achieved in good yield to afford the advanced intermediate 298. At this point, 
the carbon skeleton required for completion of the total synthesis of (+)-TAN1251B (3) is in 
place. 
 
 
2.2.7 Future work towards completing the synthesis of (+)-TAN1251B (3) 
 
As shown in the summary of work achieved so far, the intermediate 298 is only steps away 
from a total enantioselective synthesis of (+)-TAN1251B. From this point, we can envisage 
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selective deprotection of the allylic TBS-protected alcohol and subsequent oxidation to the 
give the enone 300 (scheme 97).95-97 1,4-Reduction of the enone followed by dehydration 
would afford the ketone 301. From here, the synthesis of (+)-TAN1251B (3) could be 
completed by reduction of the amide moiety and removal of the TBS protecting group. 
 
 
 
Scheme 97. Completing the synthesis of (+)-TAN1251B (3) 
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Chapter 3: Experimental 
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3.1 General Experimental 
 
Starting materials were obtained from commercial suppliers and used without further 
purification unless otherwise stated. THF was distilled from potassium/benzophenone. 
CH2Cl2 was distilled from CaH2. MeOH was distilled from Mg/I2. Et3N was distilled from 
CaH2. Thin-layer chromatography (TLC) was carried out on Merck silica gel 60 F254 
aluminium plates. They were visualised by exposure to UV light (254 nm) followed by 
staining with basic potassium permanganate and/or vanillin as appropriate. Flash column 
chromatography was carried out using Merck silica gel 60, 35-70 ȝm as the stationary phase 
with solvents of analytical purity. All petrol used was petroleum ether (boiling point: 40-60 
°C) and all water was previously de-ionised. 
 
NMR spectra were obtained as dilute solutions in the appropriate solvent at 25 °C unless 
otherwise stated. 1H NMR and 13C spectra were recorded using a Bruker DPX 360 MHz, AV 
400 MHz, AVIII 400 MHz or Jeol EX 270 MHz spectrometer. All chemical shifts were 
recorded on WKH į-scale using residual solvent as an internal standard (CDCl3 įH  įC 
77.16; d6-'062 įH  įC 39.52, D2O: įH 4.79). All coupling constants are reported in 
Hertz (Hz) and are rationalised. Multiplicities are labelled s (singlet), d (doublet), t (triplet), q 
(quartet), p (pentet) or some combination thereof. Where necessary the prefixes br (broad) or 
app (apparent) were used. Assignments were made based on chemical shift and where 
appropriate, with the benefit of DEPT sequences and correlation techniques (COSY, HMQC, 
HMBC). Infrared spectra were recorded using a Perkin-Elmer 1600 FT spectrophotometer, as 
dilute solutions in CHCl3 unless otherwise stated. Mass spectra were recorded using a Bruker 
MicrOTOF 61 spectrometer using electrospray ionisation (ESI+) technique. Optical rotations 
were measured on a JASCO DIP-370 or a ADP440 polarimeters at a wavelength of 589 nm 
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with a path length of 50 or 100 mm. Concentrations were given as g/100 ml. Microanalytical 
data were obtained using an Exeter Analytical CE-440 elemental analyser. Melting points 
(mp) were measured using a Stuart SMP3. 
 
 
3.1 General Procedures 
 
Preparation of DMDO 
 
Following a modified procedure of Esmieu,55 a single neck, 3L round bottom flask was 
equipped with an air condenser and connected to a two neck 250 mL receiving flask cooled to 
-78 °C. The air condenser was wrapped in a polyethylene bag containing solid CO2 and 
maintained in place with cable ties. The 3L flask was charged with NaHCO3 (29.0 g, 345 
mmol), H2O (127 mL) and acetone (reagent grade, 96 mL) and cooled to 0 °C with vigorous 
stirring. A suba-seal was placed on top of the air condenser. Oxone (60.0 g) was added in one 
portion and all joints were sealed with sealing tape. Suction (20 mmHg) was applied through 
a water aspirator connected to the receiving flask. The ice bath was removed and the yellow 
DMDO solution was distilled under reduced pressure into the receiving flask over 30 
minutes. The vacuum was carefully controlled by venting the apparatus through a needle 
placed in the suba-seal to prevent over-spilling. The solution was poured onto anhydrous 
K2CO3 pre-cooled at 0 °C, then filtered in a pre-cooled (-78 °C) 100 mL flask. The flask was 
flushed with argon, stoppered with a glass stopper and stored in a freezer at -25 °C until 
required. Before utilisation, the concentration of the solution was determined by iodometric 
titration: A 0.02 M aqueous solution of sodium thiosulfate (496 mg Na2S2O3.5H2O in 100 mL 
of water) was prepared and placed in a graduated burette. A 100 mL conical flask was 
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charged with NaI (2.00 g), water (70 mL), glacial acetic acid (1 mL), and the solution of 
DMDO (2 mL) was added to give a yellow solution. The solution was then titrated with the 
aqueous solution of Na2S2O3 until complete disappearance of the yellow colour. The 
concentration was then calculated using the following equation: Concentration = [(molarity 
of titrant) × (mL of titrant)]/[(mL of DMDO solution) × 2] and was found to be in the range 
0.05 to 0.07 M. 
 
 
Preparation of LDA 
 
To a solution of diisopropylamine (5.32 mL, 37.8 mmol, freshly distilled over NaH) and dry 
THF (35 mL), cooled (0 °C) under argon, was added dropwise nBuLi (23.5 mL, 35.2 mmol, 
1.50 M in hexanes). The resultant light yellow solution was stirred for 30 min at 0 °C before 
being used. 
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Cis-4-hydroxy-D-proline (173)66 
 
A solution of glacial acetic acid (872 mL) and acetic anhydride (256 mL, 2.67 mol) was 
heated to 50 °C. Trans-4-hydroxy-L-proline 190 (70.0 g, 534 mmol) was added in one 
portion, and the mixture was heated under reflux for 5.5 h. The solvent was removed under 
reduced pressure to give a thick oil, which was dissolved in HCl (2 M, 1020 mL) and stirred 
under reflux for 3 h. The solution was treated with charcoal while hot, then filtered through 
celite®. The filtrate was concentrated under reduced pressure to afford a yellow oil. 
Trituration with Et2O gave a white precipitate which was collected by suction filtration. The 
white solid was recrystallised from ethanol to afford the hydrochloride salt of cis-4-hydroxy-
D-proline (62.0 g, 69%). 20.0 g of this salt was dissolved in the minimum volume of water 
(50 mL), and triethylamine (40 mL) and ethanol (300 mL) were added sequentially. A white 
solid precipitated formed, which was collected by suction filtration, followed by 
recrystallisation from water/ethanol to afford the pure cis-4-hydroxy-D-proline 173 (27.0 g, 
39% total yield for the epimerisation) as a white solid; mp: 252-Û&GHFRPS>OLW.,66 mp: 
250-Û& GHFRPS.)]; [Į]D27 59.6 (c 2.0, H2O) [lit.,66 [Į]D25 60.3 (c 2.0, H2O)]; įH (400 
MHz, D2O) 4.50-4.47 (1H, m, C3H), 4.12 (1H, dd, J 10.4 and 2.4, C5H), 3.37 (1H, app dt, J 
12.6 and 2.4, C2HAHB), 3.28 (1H, ddd, J 12.6, 4.0 and 2.4, C2HAHB), 2.40 (1H, ddd, J 14.6, 
10.4 and 4.8, C4HAHB), 2.15 (1H, app dp, J 14.6 and 2.4, C4HAHB); įC (100 MHz, D2O) 
174.5 (C=O), 69.1 (CH), 59.7 (CH), 52.9 (CH2), 37.1 (CH2); m/z EI+ found 132.0661 (M+H, 
C5H10NO3 requires 132.0662). 
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N-Boc-cis-4-hydroxy-D-proline methyl ester (302)58 
 
Acetyl chloride (21.3 mL, 288 mmol) was slowly added to dry methanol (197 mL) under 
argon at 0 °C. Cis-4-hydroxy-D-proline 173 (27.0 g, 206 mmol) was added and the mixture 
was heated under reflux for 7 h. The mixture was cooled to rt, and trituration with Et2O gave 
a precipitate, which was collected by suction filtration and dried under high vacuum to give 
white needles (31.9 g, 85%). This hydrochloride salt (31.9 g, 176 mmol) was then suspended 
in dry CH2Cl2 (300 mL) under argon at 0 °C. Di-tert-butyl dicarbonate (42.2 g, 193 mmol) 
dissolved in dry CH2Cl2 (100 mL) and then triethylamine (61.2 mL, 439 mmol) were slowly 
added. The mixture was stirred for 3 days during which time the ice bath expired. The 
reaction mixture was hydrolysed with HCl (1M, 400 mL). The aqueous layer was extracted 
with CH2Cl2 (2 × 50 mL), and the combined organic layers were washed with saturated 
NaHCO3 solution (200 mL), dried over MgSO4, and concentrated in vacuo. The resulting oil 
was kept in the fridge for 3 days until crystallisation was complete. The solid was triturated 
with hexane, and the Boc-protected amine 302 (35.1 g, 70%) was collected by suction 
filtration as a white solid. >Į@D27 11.0 (c 0.8, CHCl3) [lit.,58 >Į@D23 2.2 (c 0.2, CHCl3)]; įH (270 
MHz, d6-DMSO, 70 °C) 4.79 (1H, d, J 3.6, OH); 4.23-4.18 (2H, m, C5H and C3H), 3.64 (3H, 
s, C7H3), 3.52 (1H, dd, J 10.8 and 5.7, C2HAHB), 3.16-3.10 (1H, m, C2HAHB), 2.41-2.30 (1H, 
m, C4HAHB), 1.84 (1H, app dt, J  12.8 and 4.9, C4HAHB), 1.37 (9H, s, CO2C(CH3)3). 
Spectroscopic data matched that previously reported.58 
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N-Boc-cis-4-(tert-butyl-dimethyl-silyloxy)-D-proline methyl ester (174)58 
 
Imidazole (9.73 g, 143 mmol) and tert-butyl-dimethylsilyl chloride (23.7 g, 157 mmol) were 
added to a stirred solution of the alcohol 302 (35.1 g, 143 mmol) in dry DMF (65 mL) under 
argon at 0 °C. The mixture was then stirred at 60 °C for 1 h before being cooled to rt and 
water (300 mL) added. The mixture was then diluted with Et2O (200 mL), the layers were 
separated, and the aqueous layer was extracted with Et2O (3 × 50 mL). The combined organic 
layers were sequentially washed with HCl (1 M, 300 mL) and saturated NaHCO3 solution 
(200 mL) before being dried over MgSO4, and concentrated in vacuo.to afford 174 (51.0 g, 
100%) as a colourless oil pure by 1H NMR. [Į]D27 37.1 (c 1.0, CHCl3) [lit.,58 [Į]D23 36.8 (c 
1.0, CHCl3@įH (270 MHz, d6-DMSO, 70 °C) 4.43-4.37 (1H, m, C3H), 4.27 (1H, dd, J 8.9 
and 3.8, C5H), 3.63 (3H, s, C7H3), 3.56 (1H, dd, J 10.6 and 5.3, C2HAHB), 3.12 (1H, dd, J 
10.6 and 3.3, C2HAHB), 2.45-2.34 (1H, m, C4HAHB), 1.91 (1H, app dt, J 12.9 and 3.8, 
C4HAHB), 1.38 (9H, s, CO2C(CH3)3), 0.85 (9H, s, Si-C(CH3)3), 0.05 (6H, s, 2 × Si-CH3).  
Spectroscopic data matched that previously reported.58 
 
 
N-Boc-(2R,4R)-2-((E)-3-oxo-but-1-enyl)-4-(tert-butyl-dimethyl-silyloxy)-
pyrrolidine (175)58 
 
DIBAL-H (96.4 mL, 1.50 M in toluene, 145 mmol) was added dropwise via syringe pump 
over 3 h to a cold (-78 °C) stirred solution of ester 174 (26.0 g, 72.3 mmol) in dry CH2Cl2 
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(350 mL) under argon. The mixture was stirred for another 2 h before the dropwise addition 
of dry methanol (90 mL). The solution was allowed to warm to rt and then potassium sodium 
tartrate solution (2 M, 350 mL) was added and the mixture stirred vigorously for 30 min. The 
organic layer was separated and the aqueous layer further extracted with CH2Cl2 (3 × 100 
mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo to give 
the crude aldehyde 195 (23.8 g) as a clear, colourless oil. The procedure was then repeated on 
the same scale to give a second batch of the crude aldehyde (combined mass 47.6 g). 1-
Triphenylphosphoroanylidene-2-propanone 160 (60.4 g, 189 mmol) was added to a stirred 
solution of the crude aldehyde (47.6 g, 145 mmol) in CH2Cl2 (75 mL). The reaction mixture 
was stirred for 5 days before concentration of the solution in vacuo. Trituration with petrol 
gave a white precipitate of triphenylphosphine oxide, which was removed by filtration. The 
filtrate was concentrated in vacuo and the crude product was purified by column 
chromatography (8:2 petrol/Et2O then 1:1 petrol/Et2O) to give the aldehyde (3.40 g, 7%) 
which could be recycled, followed by the enone product 175 (41.6 g, 77%) as a yellow oil. 
[Į]D22 -12.4 (c 0.8, CHCl3) [lit.,58 [Į]D27 -10.4 (c 0.50, CHCl3@įH (270 MHz, d6-DMSO, 70 
°C) 6.81 (1H, dd, J 16.1 and 6.9, C6H), 5.96 (1H, dd, J 16.1 and 1.0, C7H), 4.45-4.35 (2H, m, 
C3H and C5H), 3.55 (1H, dd, J 11.5 and 4.8, C2HAHB), 3.20 (1H, app dt, J 11.5 and 1.5, C2 
HAHB), 2.33 (1H, ddd, J 13.3, 8.9, 4.8, C4HAHB), 2.16 (3H, s, C9H3), 1.74 (1H, app dq, J 13.3 
and 1.5, C4HAHB), 1.39 (9H, s, CO2C(CH3)3), 0.86 (9H, s, Si-C(CH3)3), 0.06 (6H, s, 2 × Si-
CH3).  Spectroscopic data matched that previously reported.58 
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N-Boc-(2R,4R)-2-(3-oxo-butyl)-4-(tert-butyl-dimethyl-silyloxy)-pyrrolidine 
(189)58 
 
Palladium (1.50 g, 10% on carbon) was added in one portion to a stirred solution of the enone 
175 (20.3 g, 55.0 mmol) in EtOAc (110 mL). The reaction vessel was purged with hydrogen 
by three evacuate/fill cycles and the mixture was stirred under a hydrogen atmosphere 
(balloon) for 24 h. The catalyst was removed by removed by filtration through Celite®, and 
the filtrate was concentrated in vacuo to afford the crude ketone 189 (20.4 g, 99%) as a 
yellow oil. For analytical purposes, some of the crude product was purified by column 
chromatography (4:1 petrol/Et2O) to afford the pure ketone 189 as a yellow oil. [Į]D27 20.6 (c 
0.5, CHCl3) [lit.,58 [Į]D26 8.9 (c 0.5, CHCl3)]įH (270 MHz, d6-DMSO, 70 °C) 4.38-4.29 (1H, 
m, C3H), 3.75-3.65 (1H, m, C5H), 3.57 (1H, dd, J 11.5 and 5.6, C2HAHB), 3.03 (1H dd, J 11.5 
and 3.3, C2HAHB), 2.45-2.35 (2H, m, C7H), 2.18-2.10 (1H, m, C4HAHB), 2.07 (3H, s, C9H3), 
2.05-1.97 (1H, m, C6HAHB), 1.83-1.71 (1H, m, C6HAHB), 1.57 (1H, app dt, J 13.1 and 3.5, 
C4HAHB), 1.41 (9H, s, CO2C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.07 (6H, s, 2 × Si-CH3). 
Spectroscopic data matched that previously reported.58 
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N-Boc-(2S,4R)-2-(4-chloro-3-methyl-but-3-enyl)-4-(tert-butyl-dimethyl-
silyloxy)-pyrrolidine (177)58 
 
EITHER: KH (suspension in mineral oil) was added to a flame-dried flask under argon. The 
solid was washed with dry pentane (3 × 10 mL) by addition, and removal of the liquid via 
syringe. The resultant white solid (3.10 g, 77.3 mmol) was dried under high vacuum for 1 
min. The flask was slowly filled with argon before dry THF (90 mL) was added. The flask 
was cooled to 0 °C and tBuOH (5.73 g, 77.3 mmol) was added, followed by the portionwise 
addition of (chloromethyl)triphenylphosphonium chloride 176 (27.7 g, 79.9 mmol). 
Subsequently, more THF (40 mL) was added prior to the slow addition of ketone 189 (9.09 g, 
24.5 mmol) in THF (20 mL). The mixture was then stirred for 2 h at 0 °C, and 1 h at rt before 
being diluted with Et2O (50 mL) and saturated NH4Cl solution (50 mL). The aqueous layer 
was extracted with Et2O (3 × 50 mL) and then the combined organic extracts washed with 
brine, dried over MgSO4, and concentrated in vacuo. The crude product was purified by 
column chromatography (7:1 petrol/Et2O) to afford vinyl chloride 177 (9.21 g, 93%) as a 
light yellow oil (mixture of (E)-and (Z)-isomers in 2:1 ratio). 
OR: KOtBu (80.2 mg, 714 ȝmol) was suspended in dry THF (2 mL) under argon and the 
mixture was cooled down at 0 °C. Then (chloromethyl)triphenylphosphonium chloride 176 
(256 mg, 738 ȝPROZDVDGGHGDQGWKHresultant yellow solution stirred for 10 min, before the 
slow addition of ketone 189 (88.5 mg, 23.8 ȝmol) in THF (2 mL). The mixture was stirred 
for 1 h at 0 °C, and two days at rt before being diluted with Et2O (10 mL) and saturated 
NH4Cl solution (10 mL). The aqueous layer was extracted with Et2O (3 × 10 mL) and the 
combined organic fractions washed with brine (20 mL), dried over MgSO4, and concentrated 
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in vacuo. The crude product was purified by column chromatography (11:1 petrol/Et2O) to 
afford the vinyl chloride 177 (85.5 mg, 88%) as a light yellow oil. [Į]D23 14.1 (c 0.6, CHCl3) 
[lit.,58 [Į]D27 13.5 (c 0.8, CHCl3)]; Data was collected for a mixture of (E)-and (Z)-isomers in 
a 2:1 ratio: įH (400 MHz, d6-DMSO): Data for the (E)-isomer : 6.03 (1H, s, C10H), 4.36 (1H, 
s, C3H), 3.62 (1H, s, C5H), 3.5 (1H, dd, J 11.2 and 5.2, C2HAHB), 3.02 (1H, m, C2HAHB), 
2.22-2.01 (3H, m, C7H2 and C4HAHB), 1.98-1.86 (1H, m, C4HAHB), 1.73 (3H, s, C9H3), 1.72-
1.59 (2H, m, C6H2), 1.39 (9H, s, CO2C(CH3)3), 0.86 (9H, s, Si-C(CH3)3), 0.05 (6H, s, 2 × Si-
CH3); Data for the (Z)-isomer, where different from the (E)-isomer : 5.99 (1H, s, C10H); m/z 
ESI+ found 426.2202 (M+Na, C20H38NO3SiClNa requires 426.2207); Ȟmax/cm-1 (CHCl3): 
2930, 2857, 1682 (C=O), 1397, 1115, 1080, 1039, 1003. Spectroscopic data matched that 
previously reported.58 
 
 
N-Boc-(3R,5S)-3-(tert-butyl-dimethyl-silyloxy)-7-methyl-1-
azaspiro[4.4]non-6-ene (149)58 
 
EITHER: KHMDS (90.0 mL, 45.0 mmol, 0.50 M in toluene) was added to a stirred solution 
of the vinyl chloride 177 (9.10 g, 22.5 mmol) in dry Et2O (70 mL) under argon. The reaction 
mixture was stirred for 3 h before removal of the solvent in vacuo to give the crude product. 
Purification by column chromatography (9:1 petrol/Et2O) afforded the 5,5-spirocycle 149 
(7.55 g, 91%) as a yellow oil.  
OR: nBuLi (17.4 ml, 2.50 M in hexane, 43.3 mmol) was added dropwise over 1 h via syringe 
pump to a stirred, cooled (-78 °C) solution of trimethylsilyldiazomethane (25.0 mL, 50.0 
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mmol, 2.00 M in hexane) in dry THF (150 mL) under argon. The mixture was stirred for 1 h 
at -78 °C before a solution of the ketone 189 (12.4 g, 33.3 mmol) in dry THF (150 mL) was 
added slowly over 30 min via cannula. The mixture was stirred for another 1 h at -78 °C 
before being warmed slowly to 0 °C (over 40 min). The reaction was then quenched with 
saturated NH4Cl solution (150 mL). The two layers were separated and the aqueous layer was 
further extracted with Et2O (3 × 120 mL). The combined organic layers were dried over 
MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (95:5 petrol/Et2O) to afford the 5,5-spirocycle 149 (10.6 g, 86%) as a yellow 
oil>Į@D24 74.4 (c 0.7, CHCl3) [lit.,58 >Į@D28 69.2 (c 1.3, CHCl3)]. įH (400 MHz, d6-DMSO, 70 
°C) 5.08 (1H, d, J 1.4, C6H), 4.32-4.27 (1H, m, C3H), 3.47 (1H, dd, J 11.6 and 4.7, C2HAHB), 
3.25 (1H, app dt, J 11.6 and 1.9, C2HAHB), 2.33-2.10 (4H, m, CH2 and CH2), 1.96 (1H, dd, J 
13.0 and 4.5, CH2), 1.83 (1H, ddd, J 13.0, 2.8 and 1.8, CH2), 1.68 (3H, s, C10H3), 1.73 (3H, s, 
C9H3), 1.35 (9H, s, CO2C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.07 (6H, s, 2 × Si-CH3); m/z 
ESI+ found 390.2418 (M+Na, C20H37NO36L1DUHTXLUHVȞmax/cm-1 (CHCl3): 2929, 
2856, 1672 (C=O), 1391, 1366, 1129, 1075. Spectroscopic data matched that previously 
reported.58 
 
 
N-Boc-(3R,5S,6S,7R)-3-(tert-butyl-dimethyl-silyloxy)-6,7-dihydroxy-7-
methyl-1-azaspiro[4.4]nonane (196)58 
 
N-Methyl-morpholine-N-oxide monohydrate (11.6 g, 86.2 mmol) followed by potassium 
osmate dihydrate (106 mg, 287 ȝmol) was added to a stirred solution of spirocycle 149 (10.6 
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g, 28.7 mmol) in acetone (170 mL) and water (17 mL). The mixture was stirred for 4 days at 
rt before the addition of sodium thiosulfate (500 mg). The mixture was then allowed to stir 
for another 15 h. Water (150 mL) was added and the aqueous layer extracted with CH2Cl2 (3 
× 150 mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo. 
The crude was purified by column chromatography (6:4 petrol/EtOAc) to afford the diol 
product 196 (9.87g, 86%) DVDZKLWHIRDP>Į@D27     -32.7 (c 0.5, CHCl3) [lit.,58 >Į@D24 -25.3 (c 
0.2, CHCl3@įH (400 MHz, d6-DMSO, 70 °C): 4.53 (1H, br s, OH), 4.33 (1H, app p, J 5.1, 
C3H), 4.14 (1H, br s, OH), 3.60 (1H, s, C6H), 3.39 (1H, dd, J 11.1 and 5.4, C2HAHB), 3.15 
(1H, dd J 11.1 and 4.1, C2HAHB), 2.65-2.55 (1H, m, C4HAHB), 2.23-2.07 (1H, m, C4HAHB), 
1.94-1.70 (2H, m, C8/9H2), 1.62-1.49 (2H, m, C8/9H2), 1.41 (9H, s, CO2C(CH3)3), 1.15 (3H, s, 
C10H3), 0.87 (9H, s, Si-C(CH3)3), 0.05 (6H, s, 2 × Si-CH3); m/z ESI+ found 424.2484 (M+Na, 
C20H39NO5SiNa requires 424.2490 Ȟmax/cm-1 (CHCl3): 3550, 2929, 1679 (C=O), 1454, 
1392, 1088. Spectroscopic data matched that previously reported.58 
 
 
N-Boc-(3R,5S)-3-(tert-butyl-dimethyl-silyloxy)-6-hydroxy-8-oxo-1-
azaspiro[4.5]decane (198)58 
 
Sodium periodate (10.4 g, 48.7 mmol) was added to a stirred solution of the diol 196 (9.79 g, 
24.3 mmol) in THF (94 mL) and water (47 mL). The mixture was stirred for 1 h before the 
addition of water (200 mL). The aqueous layer was extracted with Et2O (3 × 100 mL) and the 
combined organic layers dried over MgSO4 and concentrated in vacuo to afford the crude 
keto-aldehyde 197 which was used without further purification. Potassium hydroxide (682 
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mg, 12.1 mmol) was added to a stirred, cooled (0 °C) solution of the crude keto-aldehyde 
(9.71g, 24.3 mmol) in dry ethanol (100 mL). The mixture was stirred for 2 h at rt before 
saturated NH4Cl solution (180 mL) was added and the aqueous layer extracted with Et2O (3 × 
150 mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo. 
The crude was purified by column chromatography (7:3 petrol/EtOAc) to afford the keto-
alcohol 198 (8.20 g, 84% over 2 steps) as a white foam. >Į@D27 -23.2 (c 0.4, CHCl3) [lit.,58 
>Į@D24 -4.6 (c 0.4, CHCl3)]; Data was collected for a mixture of diastereoisomers in a 2:1 
ratio: įH (400 MHz, d6-DMSO): Data for the major isomer: 5.15 (1H, d, J 4.8, OH), 4.54-4.46 
(1H, m, C3/6H), 4.44-4.38 (1H, m, C3/6H), 3.48-3.40 (1H, m, C2HAHB), 3.37-3.28 (1H, m, 
C2HAHB), 2.56-2.20 (5H, m, C7H2, C9H2 and C4/10H2), 2.15-2.07 (1H, m, C4/10H2), 2.01-1.87 
(2H, m, C4/10H2), 1.38 (9H, s, CO2C(CH3)3), 0.86 (9H, s, Si-C(CH3)3), 0.07 (6H, s, 2 × Si-
CH3); Data for the minor isomer, where different from the major isomer: 5.22 (1H, d, J 4.8, 
OH), 4.36-4.27 (1H, m, C3/6H); m/z ESI+ found 422.2321 (M+Na, C20H37NO5SiNa requires 
422.2339Ȟmax/cm-1 (CHCl3): 3610, 2954, 2930, 2857, 1716, 1681 (C=O), 1391, 1367, 1140, 
1078, 1041. Spectroscopic data matched that previously reported.58 
 
 
N-Boc-(3R,5S)-3-(tert-butyl-dimethyl-silyloxy)-8-oxo-1-azaspiro[4.5]dec-6-
ene (148)58 
 
Methanesulfonyl chloride (2.38 mL, 30.8 mmol) and triethylamine (7.92 mL. 61.6 mmol) 
were sequentially added to a stirred solution of the alcohol 198 (8.20 g, 20.5 mmol) in dry 
CH2Cl2 (150 mL) at 0 °C under argon. The mixture was stirred for 2 days during which time 
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the ice bath expired. Saturated NH4Cl solution (150 mL) was added and the aqueous layer 
extracted with CH2Cl2 (3 × 120 mL). The combined organic layers were dried over MgSO4 
and concentrated in vacuo. The crude was purified by column chromatography (3:1 
petrol/EtOAc) to afford the 5,6-spirocycle 148 (7.25 g, 92%) as a yellow oil. >Į@D23 62.3 (c 
1.3, CHCl3) [lit.,58 >Į@D25 63.3 (c 1.7, CHCl3)]. įH (400 MHz, d6-DMSO, 70 °C): 6.80 (1H, d, 
J 10.2, C6H), 5.76 (1H, d, J 10.2, C7H), 4.46-4.40 (1H, m, C3H), 3.66 (1H, dd, J 11.7 and 4.7, 
C2HAHB), 3.32 (1H, app d, J 11.7, C2HAHB), 2.69-2.21 (5H, m, C4H2, C9H2 and C10HAHB), 
2.05-1.95 (1H, m, C10HAHB), 1.38 (9H, s, CO2C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.09 (6H, 
s, 2 × Si-CH3); m/z ESI+ found 404.2209 (M+Na, C20H35NO4SiNa requires 404.2228); 
Ȟmax/cm-1 (CHCl3): 2930, 2884, 2857, 1792, 1681 (C=O), 1460, 1382, 1368, 1138, 1113, 
1075, 1042. Spectroscopic data matched that previously reported.58 
 
 
(2R,6aS,10aS)-2-(tert-butyl-dimethyl-silyloxy)-octahydro-6-oxa-3a-aza-
cyclopenta[d]naphthalene-8-one (202) 
 
Trifluoroacetic acid (1.29 mL, 16.8 mmol) was added to a stirred solution of the Boc-
protected amine 148 (214 mg, 561 ȝmol) in dry CH2Cl2 (5 mL) under argon. The mixture 
was stirred for 1 h at rt before being diluted with CH2Cl2 (5 mL) and water (5 mL). The 
mixture was cooled to 0 °C and NaOH (2 M) was added (until the aqueous phase was pH 10). 
The aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the combined organic layers 
dried over MgSO4 and concentrated in vacuo to a volume of about 5 mL. The solution was 
cooled to -30 °C under argon and the flask equipped with a cold finger. Oxirane gas (in 
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excess) was condensed in the flask and the mixture stirred for 3 h at -30 °C, then for 1 day at 
room temperature. The mixture was concentrated in vacuo and the crude product purified by 
column chromatography (95:5 CH2Cl2/MeOH) to afford the pure tricycle 202 (160 mg, 87% 
over 2 steps) as a yellow oil. [Į]D25 -31.6 (c 0.36, CHCl3); įH (400 MHz, CDCl3) 4.48 (1H, 
app tdd, J 7.0, 4.0 and 2.8, C3H); 3.83 (1H, app dd, J 11.6 and 3.6, C11HAHB); 3.60 (1H, td, J 
11.6 and 3.2, C11HAHB), 3.52 (1H, m, C10H); 3.37 (1H, dd, J 9.6 and 7.0, C2HAHB), 2.98 (1H, 
td, J 11.6 and 3.6, C12HAHB), 2.63 (1H, dd, J 9.6 and 4.0, C2HAHB), 2.55-2.49 (2H, m, 
C9HAHB and C12HAHB), 2.45-2.35 (4H, m, C6HAHB, C7H2 and C9HAHB), 1.97-1.84 (3H, m, 
C4H2, C6HAHB), 0.88 (9H, s, Si-C(CH3)3), 0.06 (3H, s, Si-CH3), 0.05 (3H, s, Si-CH3); įC (100 
MHz, CDCl3) 209.2 (C=O), 81.2 (CH), 69.5 (CH), 66.1 (CH2), 60.0 (CH2), 59.5 (C), 45.2 
(CH2), 43.8 (CH2), 43.2 (CH2), 38.0 (CH2), 25.9 (3 × CH3), 21.2 (CH2), 18.1 (C), -4.7 (2 × 
CH3); m/z ESI+ found 326.2141 (M+H, C17H32NO3Si requires 326.2146); Ȟmax/cm-1 (CHCl3): 
2930, 2857, 1720, 1119, 1084, 1044. 
 
 
N-Ethyl-acetate-(3R,5S)-3-(tert-butyl-dimethyl-silyloxy)-8-oxo-1-
azaspiro[4.5]dec-6-ene (203) 
 
Trifluoroacetic acid (3.44 mL, 44.7 mmol) was added to a stirred solution of the Boc-
protected amine 148 (568 mg, 1.49 mmol) in dry CH2Cl2 (15 mL) under argon. The mixture 
was stirred for 1 h at rt before being diluted with CH2Cl2 (5 mL) and water (5 mL). The 
mixture was cooled to 0 °C and NaOH (2 M) was added (until the aqueous phase was pH 10). 
The aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the combined organic layers 
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were dried over MgSO4 and concentrated in vacuo. To a solution of the free amine in dry 
acetonitrile (15 mL), potassium carbonate (823 mg, 5.96 mmol), sodium iodide (446 mg, 2.98 
mmol) and ethylbromoacetatH ȝ/ PPROZHUHDGGHG VHTXHQWLDOO\). The mixture 
was stirred for 20 h at rt before water (20 mL) was added and the aqueous layer extracted 
with EtOAc (3 × 20 mL). The combined organic layers were washed sequentially with 
saturated Na2S2O3 solution (20 mL) and brine (15 mL), dried over MgSO4 and concentrated 
in vacuo. The crude product was purified by column chromatography (4:1 petrol/EtOAc) to 
afford the ethyl ester 203 (477 mg, 87% over 2 steps) as a yellow oil. [Į]D25 1.2 (c 0.5, 
CHCl3); įH (400 MHz, CDCl3) 6.69 (1H, dd, J 10.4 and 2.0, C6H), 5.96 (1H, dd, J 10.4 and 
0.8, C7H), 4.51-4.45 (1H, m, C3H), 4.15 (2H, q, J 7.2, CO2CH2CH3), 3.62 (1H, dd, J 10.0 and 
6.8, C2HAHB), 3.37 (1H, d, J 16.4, C11HAHB), 3.24 (1H, d, J 16.4, C11HAHB), 2.66 (1H, dd, J 
10.0 and 4.0, C2HAHB), 2.56-2.39 (2H, m, C9H2), 2.32-2.26 (1H, m, C10HAHB), 2.08-1.96 
(3H, m, C4H2 and C10HAHB), 1.26 (3H, t, J 7.2, CO2CH2CH3), 0.86 (9H, s, Si-C(CH3)3), 0.04 
(3H, s, Si-CH3), 0.03 (3H, s, Si-CH3 įC (100 MHz, CDCl3) 199.3 (C=O), 171.3 (C=O), 
156.6 (CH), 130.6 (CH), 70.2 (CH), 63.9 (C), 61.0 (CH2), 60.9 (CH2), 50.9 (CH2), 44.4 
(CH2), 35.5 (CH2), 27.4 (CH2), 25.9 (3 × CH3), 18.0 (C), 14.3 (CH3), -4.7 (2 × CH3); m/z 
ESI+ found 368.2255 (M+H, C19H34NO4Si requires 368.2252) and 390.2063 (M+Na, 
C19H33NO46L1DUHTXLUHVȞmax/cm-1 (CHCl3): 2954, 2930, 2857, 1743, 1679, 1381, 
1106, 1061. Found C, 61.9; H, 9.1; N, 3.7. C19H33NO4Si requires C, 62.1; H, 9.1; N, 3.8%. 
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(3R,5S)-3-(tert-butyl-dimethyl-silyloxy)-1-(2-hydroxy-ethyl)-1-
azaspiro[4.5]dec-6-en-8-ol (204) 
 
Lithium aluminium hydride (3.93 mL, 1.00 M in THF, 3.93 mmol) was added dropwise to a 
cooled (0 °C), stirred solution of ethyl ester 203 (962 mg, 2.62 mmol) in dry THF (35 mL). 
The mixture was stirred for 24 h, during which time the ice bath expired. The mixture was 
then cooled to 0 °C, and saturated Na2SO4 solution (25 mL) was slowly added. The aqueous 
layer was extracted with EtOAc (3 × 25 mL) and the combined organic layers dried over 
MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (8:1 CHCl3/MeOH) to afford the diol 204 (799 mg, 93%) as a colourless oil. 
>Į@D26 -0.7 (c 0.4, CHCl3); Data was collected for a mixture of diastereoisomers in a 5:1 ratio: 
įH (400 MHz, CDCl3): Data for the major isomer: 5.76 (1H, dd, J 10.0 and 1.2, C7H), 5.38 
(1H, d, J 10.0, C6H), 4.41-4.34 (1H, m, C3H), 4.25-4.18 (1H, m, C8H), 3.58-3.48 (2H, m, 
C12H2), 3.24 (1H, app t, J 8.4, C2HAHB), 2.67-2.55 (3H, m, C2HAHB and C11H2), 2.16-2.09 
(1H, m, C9HAHB), 2.02-1.89 (2H, m, C4HAHB and C10HAHB), 1.86-1.75 (1H, m, C4HAHB), 
1.67-1.58 (1H, m, C10HAHB), 1.54-1.43 (1H, m, C9HAHB), 0.87 (9H, s, Si-C(CH3)3), 0.04 
(3H, s, Si-CH3), 0.03 (3H, s, Si-CH3); Data for the minor isomer, where different from the 
major isomer: 5.89 (1H, dd, J 10.0 and 4.4, C7H), 5.53 (1H, d, J 10.0, C6H), 4.14-4.09 (1H, 
m, C8H), 3.30 (1H, app t, J 8.0, C2HAHB), 2.77-2.68 (1H, m, C2HAHB); įC (100 MHz, CDCl3) 
134.6 (CH), 133.9 (CH), 70.0 (CH), 67.4 (CH), 63.9 (C), 59.5 (CH2), 58.8 (CH2), 50.1 (CH2), 
48.1 (CH2), 31.4 (CH2), 27.6 (CH2), 25.9 (3 × CH3), 18.1 (C), -4.7 (2 × CH3); m/z ESI+ found 
328.2298 (M+H, C17H34NO3Si requires 328.2302 Ȟmax/cm-1 (CHCl3): 3604, 3434, 2930, 
2885, 2857, 1462, 1392, 1362, 1108, 1078, 1053, 906. 
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(2R,6aS,10aS)-2-(tert-butyl-dimethyl-silyloxy)-6-hydroxy-octahydro-6-oxa-
3a-aza-cyclopenta[d]naphthalene-8-one (206) 
 
Freshly distilled dLPHWK\OVXOIR[LGHȝ/PPROZDVDGGHGGURSZLVHWRDFRoled (-60 
°C), stirred solution of oxalyl chloride (172 mg, 1.36 mmol) in dry CH2Cl2 (2.5 mL). The 
mixture was stirred for 1 h at this temperature before the slow addition of diol 204 (102 mg, 
311 ȝmol) dissolved in dry CH2Cl2 (1.5 mL). The mixture was stirred for 90 min at -60 °C 
before the slow additioQRIWULHWK\ODPLQHȝ/ mmol). The mixture was then stirred 
for another 60 min at -60 °C before being allowed to warm up to rt. Saturated NH4Cl solution 
(5 mL) was added and the aqueous layer extracted with CH2Cl2 (3 × 5 mL). The combined 
organic layers were washed with brine (5 mL), dried over MgSO4 and concentrated in vacuo 
to afford the crude aldehyde 200 DVDFRORXUOHVVRLOįH (500 MHz, CDCl3) 9.63 (1H, dd, J  
2.2 and 1.0 C12H), 6.62 (1H, dd, J 10.5 and 2.0, C6H), 5.98 (1H, dd, J 10.5 and 1.0, C7H), 
4.51-4.46 (1H, m, C3H), 3.47 (1H, dd, J 9.8 and 7.0, C2HAHB), 3.36 (1H, dd, J 17.5 and 1.0, 
C11HAHB), 3.24 (1H, dd, J 17.5 and 2.2, C11HAHB), 2.65 (1H, dd, J 9.8 and 3.5, C2HAHB), 
2.53 (1H, dddd, J 17.0, 4.5, 3.5 and 1.0, C9HAHB), 2.46 (1H, ddd, J 17.0, 13.5 and 5.0 
C9HAHB), 2.32-2.27 (1H, m, C10HAHB), 2.05-2.02 (2H, m, C4HAHB, C10HAHB), 1.98 (1H, dd, 
J 13.0 and 5.0, C4HAHB), 0.86 (9H, s, Si-C(CH3)3), 0.04 (3H, s, Si-CH3), 0.03 (3H, s, Si-
CH3); m/z ESI+ found 346.1812 (M+Na, C17H29NO3SiNa requires 346.1809); Ȟmax/cm-1 
(CHCl3): 2952, 2929, 2857, 1730 (C=O), 1681 (C=O), 1383, 1107, 1074. The aldehyde 200 
was used in its crude form for further reactions as, after attempted purification, a complex 
mixture of products were formed, including the side product 206. In addition, this side-
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product 206 was also formed during attempted reactions involving the aldehyde 200. Data 
was collected for a mixture of diastereoisomers in a 2:1 ratio: įH (400 MHz, CDCl3): Data for 
the major isomer: 5.12 (1H, br s, C11H), 4.55-4.46 (1H, m, C3H), 4.17 (1H, app s, C10H), 3.41 
(1H, dd, J 9.2 and 7.2, C2HAHB), 3.01 (1H, dd, J 12.4 and 2.4, C12HAHB), 2.77-2.60 (2H, m, 
C2HAHB and C12HAHB), 2.56-2.33 (5H, m, C6H2, C7H2 and C9HAHB), 1.98-1.85 (3H, m, C4H2 
and C9HAHB), 0.87 (9H, s, Si-C(CH3)3), 0.06 (3H, s, Si-CH3), 0.04 (3H, s, Si-CH3); Data for 
the minor isomer, where different from the major isomer: 4.87 (1H, dd, J 8.8 and 2.6, C11H), 
3.70 (1H, br s, C10H), 3.32 (1H, dd, J 9.2 and 7.2, C2HAHB), 2.86 (1H, dd, J 12.4 and 2.6, 
C12HAHB); įC (100 MHz, CDCl3): Data for the major isomer: 209.5 (C=O), 90.5 (CH), 73.8 
(CH), 69.4 (CH), 60.7 (CH2), 58.6 (C), 48.2 (CH2), 44.5 (CH2), 43.0 (CH2), 37.9 (CH2), 25.9 
(3 × CH3), 20.3 (CH2), 18.1 (C), -4.7 (2 × CH3); Data for the minor isomer, where different 
from the major isomer: 93.5 (CH), 79.2 (CH), 69.9 (CH), 59.9 (CH2), 59.3 (C), 49.8 (CH2), 
44.7 (CH2), 42.4 (CH2), 21.3 (CH2); m/z ESI+ found 342.2078 (M+H, C17H32NO4Si requires 
342.2095); Ȟmax/cm-1 (CHCl3): 3595, 2930, 2856, 1718 (C=O), 1118, 1090, 1054, 950, 908. 
 
 
N-Acetyl-chloride-(3R,5S)-3-(tert-butyl-dimethyl-silyloxy)-8-oxo-1-
azaspiro[4.5]dec-6-ene (210) 
 
Trifluoroacetic acid (1.71 mL, 22.1 mmol) was added to a stirred solution of the Boc-
protected amine 148 (282 mg, 738 ȝmol) in dry CH2Cl2 (5 mL) under argon. The mixture 
was stirred for 1 h at rt before being diluted with CH2Cl2 (5 mL) and water (5 mL). The 
mixture was cooled to 0 °C and NaOH (2 M) was added (until the aqueous phase was pH 10). 
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The aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the combined organic layers 
dried over MgSO4 and concentrated in vacuo to a volume of about 10 mL. Then the mixture 
was cooled to 0 °C under argon before the addition of triethylamine (118 ȝl, ȝPRO$ 
solution of chloroacetylchloride (115 mg, 1.02 mmol) in CH2Cl2 (2 mL) was added dropwise 
and the resultant mixture VWLUUHG IRU KDW Û& and then 3 h at rt. The mixture was again 
FRROHGWRÛ&DQGZDWHUP/ZDVDGGHG7KHDTXHRXVOD\HUZDVH[WUDFWHGZLWK&+2Cl2 
(3 × 10 mL) and the combined organic layers washed with brine (20 mL), dried over MgSO4 
and concentrated in vacuo. The crude product was purified by column chromatography (1:1 
petrol/EtOAc) to afford the keto-chloride 210 (204 mg, 77% over 2 steps) as a yellow oil 
which crystallised under high vacuum. [Į]D25 58.3 (c 0.7, CHCl3); mp : 62-63 °C; įH (270 
MHz, d6-DMSO, 70 °C) 6.81 (1H, d, J 10.3, C6H), 5.75 (1H, d, J 10.3, C7H), 4.53 (1H, m, 
C3H), 4.27 (1H, d, J 13.2, C12HAHB), 4.17 (1H, d, J 13.2, C12HAHB), 3.89 (1H, dd, J 11.0 and 
4.7, C2HAHB), 3.54 (1H, app d, J 11.0, C2HAHB), 2.78 (1H, td, J 13.2 and 5.1, C9HAHB), 
2.58-2.29 (3H, m, C9HAHB and C10H2), 2.24 (1H, app d, J 13.6, C4HAHB), 1.98 (1H, dd, J 
13.6 and 4.7, C4HAHB), 0.89 (9H, s, Si-C(CH3)3), 0.11 (6H, s, Si-(CH3)2) įC (100 MHz, 
CDCl3) 198.1 (C=O), 164.8 (C=O), 155.6 (CH), 127.2 (CH), 70.5 (CH), 64.6 (C), 57.0 
(CH2), 43.0, (CH2), 42.0 (CH2) 35.2 (CH2), 29.4 (CH2), 25.7 (3 × CH3), 18.0 (C), -4.7 (CH3), 
-4.8 (CH3); m/z ESI+ found 380.1404 (M+Na, C17H28NO3SiClNa requires 380.1419); 
Ȟmax/cm-1 (CHCl3): 2954, 2931, 2858, 1678, 1660, 1383, 1115, 1080, 1039, 1004. Found C, 
56.9; H, 7.9; N, 3.3. C17H28NO3SiCl requires C, 57.0; H, 7.9; N, 3.9%. 
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N-Acetyl-iodide-(3R,5S)-3-(tert-butyl-dimethyl-silyloxy)-8-oxo-1-
azaspiro[4.5]dec-6-ene (211) 
 
Sodium iodide (80.4 mg, 536 ȝmol) was added to a stirred solution of the keto-chloride 210 
PJȝmol) in acetone (2 mL). The mixture was stirred for 4 h before removal of the 
solvent in vacuo. The residue was dissolved in water (10 mL) and EtOAc (10 mL). The two 
layers were separated and the aqueous layer was further extracted with EtOAc (2 × 10 mL). 
The combined organic layers were washed sequentially with saturated Na2S2O3 solution (10 
mL) and brine (10 mL), dried over MgSO4 and concentrated in vacuo. The crude product was 
purified by column chromatography (8:2 petrol/EtOAc) to give the pure iodo-ketone 211 
(77.8 PJDVDQRUDQJHVROLG>Į@D27 55.0 (c 0.2, CHCl3); mp : 71-73 °&įH (400 MHz, 
CDCl3) 6.73 (1H, d, J 10.2, C6H), 5.92 (1H, d, J 10.2, C7H), 4.52 (1H, app s, C3H), 3.82 (1H, 
dd, J 10.8 and 4.4, C2HAHB), 3.65 (1H, d, J 9.6, C12HAHB), 3.60 (1H, d, J 9.6, C12HAHB), 
3.53 (1H, app d, J 10.8, C2HAHB), 2.99-2.90 (1H, m, C9HAHB), 2.60-2.51 (1H, m, C10HAHB), 
2.50-2.36 (2H, m, C9HAHB and C10 HAHB), 2.26 (1H, app d, J 13.8, C4HAHB), 1.92 (1H, dd, 
J, 13.8 and 4.4, C4 HAHB), 0.90 (9H, s, Si-C(CH3)3), 0.11 (6H, s, Si-(CH3)2įC (100 MHz, 
CDCl3) 198.2 (C=O), 166.5 (C=O), 155.6 (CH), 127.1 (CH), 70.5 (CH), 64.4 (C), 57.9 
(CH2), 42.1 (CH2), 35.1 (CH2), 29.1 (CH2), 25.8 (3 × CH3), 18.0 (C), -0.6 (CH2), -4.7 (CH3), 
-4.8 (CH3); m/z ESI+ found 450.0939 (M+H, C17H29NO3SiI requires 450.0956) and 472.0764 
(M+Na, C17H28NO3SiINa requires 472.077 Ȟmax/cm-1 (CHCl3): 2931, 2858, 1678, 1650, 
1399, 1383, 1115, 1080, 1031, 1003. Found C, 45.5; H, 6.2; N, 2.9. C17H28NO3SiI requires C, 
45.4; H, 6.3; N, 3.1%. 
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(2R,6aS,10aS)-2-(tert-butyl-dimethyl-silyloxy)-hexahydro-6-oxa-3a-aza-
cyclopenta[d]naphthalene-4,8-dione (212) 
 
A solution of potassium carbonate (45.5 mg, 329 ȝmol) in water (0.5 mL) was added to a 
stirred solution of the iodo-ketone 211 PJȝmol) in acetone (1.5 mL). The mixture 
was stirred for 10 days before removal of the solvent in vacuo. The residue was dissolved in 
water (10 mL) and EtOAc (10 mL). The two layers were separated and the aqueous layer was 
further extracted with EtOAc (2 × 10 mL). The combined organic layers were washed 
sequentially with water (10 mL) and brine (10 mL), dried over MgSO4 and concentrated in 
vacuo. The crude product was purified by column chromatography (3:2 CH2Cl2/Et2O) to 
afford the pure amide 212 (40.0 mg, 68%) as colourless columns, which were analysed by X-
ray crystallography (see Appendix). >Į@D23 60.0 (c 0.3, CHCl3); mp : 149-151 °&įH (400 
MHz, CDCl3) 4.56 (1H, app t, J 6.0, C3H), 4.32 (1H, d, J 16.8, C12HAHB), 4.12 (1H, d, J 
16.8, C12HAHB), 4.12 (1H, dd, J 14.0 and 6.0, C2HAHB), 3.66 (1H, dd, J, 4.0 and 2.8, C6H), 
3.42 (1H, app d, J 14.0, C2HAHB), 2.70-2.60 (2H, m, C7HAHB, C9HAHB), 2.55 (1H, dd, J 15.6 
and 4.0, C7HAHB), 2.44-2.22 (4H, m, C4HAHB, C9HAHB and C10H2), 1.89-1.81 (1H, app ddd, 
J 13.2, 6.0 and 1.2, C4HAHB), 0.88 (9H, s, Si-C(CH3)3), 0.09 (6H, s, Si-(CH3)2) įC (100 
MHz, CDCl3) 206.5 (C=O), 165.6 (C=O), 79.9 (CH), 69.3 (CH), 67.2 (CH2), 62.4 (C), 54.9 
(CH2), 44.2 (CH2), 41.8 (CH2), 37.5 (CH2), 30.4 (CH2), 25.7 (3 × CH3), 17.9 (C), -4.8 (CH3), 
-4.9 (CH3); m/z ESI+ found 340.1924 (M+H, C17H30NO4Si requires 340.1939) and 362.1754 
(M+Na, C17H29NO46L1D UHTXLUHV  Ȟmax/cm-1 (CHCl3): 2954, 2930, 2858, 1726, 
1649, 1454, 1133, 1102, 1087. 
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N-Boc-(3R,5S)-3-hydroxy-8-oxo-1-azaspiro[4.5]dec-6-ene (215)58 
 
TBAF (29.4 mL, 1.00 M in THF, 29.4 mmol) was added to a cooled (0 °C), stirred solution 
of enone 148 (5.61 g, 14.7 mmol) in dry THF (60 mL). The mixture was stirred for 2 days at 
rt before removal of the solvent in vacuo. The crude product was purified directly by column 
chromatography (1:1 petrol/EtOAc then EtOAc 100%) to afford the deprotected alcohol 215 
(3.63 g, 92%) as DZKLWHVROLG>Į@D27 96.5 (c 0.4, CHCl3) [lit.,58 >Į@D29 64.9 (c 0.1, CHCl3)]. 
įH (400 MHz, d6-DMSO): 6.80 (1H, dd, J 10.4 and 2.0, C6H), 5.75 (1H, d, J 10.4, C7H), 5.09 
(1H, d, J 2.4, OH), 4.29-4.23 (1H, m, C3H), 3.54 (1H, app td, J 10.8 and 4.8, C2HAHB), 3.36-
3.30 (1H, m, C2HAHB), 2.70-2.20 (5H, m, C4H2, C9H2 and C10HAHB), 1.93-1.82 (1H, m, 
C10HAHB), 1.39 and 1.33 (9H, s, CO2C(CH3)3); m/z ESI+ found 290.1371 (M+Na, 
C14H21NO4Na requires 290.1363Ȟmax/cm-1 (CHCl3): 3612, 2978, 1682 (C=O), 1382, 1368, 
1137, 1110. Spectroscopic data matched that previously reported.58 
 
 
N-Boc-(3R,5S)-3-(methanesulfonyloxy)-8-oxo-1-azaspiro[4.5]dec-6-ene 
(216)58 
 
Methanesulfonyl chloride (1.57 mL, 20.3 mmol) and triethylamine (5.66 mL. 40.6 mmol) 
were added to a stirred solution of the alcohol 215 (3.62 g, 13.5 mmol) in dry CH2Cl2 (130 
mL) at rt under argon. The mixture was stirred overnight at rt before removal of the solvent in 
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vacuo. The crude product was purified directly by column chromatography (2:8 
petrol/EtOAc) to afford the mesylated alcohol 216 (4.56 g, 98%) as a white VROLG>Į]D24 64.2 
(c 0.5, CHCl3) [lit.,58 >Į@D29 25.0 (c 0.1, CHCl3@įH (400 MHz, d6-DMSO) 6.84 (1H, dd, J 
10.4 and 2.4, C6H), 5.81 (1H, d, J 10.4, C6H), 5.27 (1H, app t, J 4.8, C3H), 3.85-3.76 (1H, m, 
C2HAHB), 3.68-3.62 (1H, m, C2HAHB), 3.27 (3H, s, SO2CH3), 2.70-2.55 (3H, m, C9H2 and 
C4HAHB), 2.40-2.32 (1H, m, C4HAHB), 2.27-2.07 (2H, m, C10H2), 1.40 and 1.34 (9H, s, 
CO2C(CH3)3); m/z ESI+ found 368.1133 (M+Na, C15H23NO6SNa requires 368.1138); 
Ȟmax/cm-1 (CHCl3): 2978, 1682 (C=O), 1381, 1368, 1347, 1139, 962, 900. Spectroscopic data 
matched that previously reported.58 
 
 
N-Boc-(3R,5S)-3-azido-8-oxo-1-azaspiro[4.5]dec-6-ene (178)58 
 
Sodium azide (2.14 g, 32.9 mmol) was added to a stirred solution of the mesylated alcohol 
216 (4.55 g, 13.2 mmol) in dry DMF (90 mL) under argon. The mixture was stirred at 80 °C 
for 2 days. Water (150 mL) was added and the aqueous layer extracted with EtOAc (3 × 100 
mL). The combined organic layers were washed with water (150 mL), dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by column chromatography (7:3 
petrol/EtOAc) to afford the azido compound 178 (3.50 g, 91%) as a colourless oil>Į]D22 30.4 
(c 0.7, CHCl3) [lit.,58 >Į@D31 28.2 (c 1.4, CHCl3@įH (400 MHz, d6-DMSO) 6.91 (1H, d, J 
10.0, C6H), 5.77 (1H, d, J 10.0, C7H), 4.39 (1H, app p, J 6.0, C3H), 3.70-3.60 (1H, m, 
C2HAHB), 3.34 (1H, dd, J 11.6 and 6.0 C2HAHB), 2.71-2.52 (3H, m, C9H2 and C4HAHB), 2.38-
2.30 (1H, m, C4HAHB), 2.06-1.83 (2H, m, C10H2), 1.39 and 1.33 (9H, s, CO2C(CH3)3); m/z 
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ESI+ found 315.1425 (M+Na, C14H20N4O3Na requires 315.1428 Ȟmax/cm-1 (CHCl3): 2938, 
2105, 1682 (C=O), 1380, 1368, 1154, 1136. Spectroscopic data matched that previously 
reported.58 
 
 
N-Boc-(3R,5S,9R)-3-azido-8-oxo-9-(ethyl-acetate)-1-azaspiro[4.5]dec-6-ene 
(217) 
N-Boc-(3R,5S,9S)-3-azido-8-oxo-9-(ethyl-acetate)-1-azaspiro[4.5]dec-6-ene 
(218) 
 
Freshly prepared LDA (1.98 mL, 0.611 M in THF, 1.21 mmol) was slowly added to a cooled 
(-78 °C), stirred solution of the enone 178 (272 mg, 93 ȝmol) in dry THF (9 mL). The 
mixture was stirred for 1 h at -78 °C before the aGGLWLRQRIHWK\OEURPRDFHWDWHȝ/
mmol) dissolved in dry DMPU (1.12 mL, 9.30 mmol). The mixture was then stirred for 
another 3 h at -78 °C before being allowed to warm slowly to rt overnight. Saturated 
NaHCO3 solution (10 mL) was added and the aqueous layer extracted with Et2O (3 × 10 mL). 
The combined organic layers were dried over MgSO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (8:2 petrol/EtOAc then 6:4 petrol/EtOAc) to 
afford the ethyl ester 217:218 (203 mg, 57%) as a yellow oil, in addition to the recovery of 
some starting material 178 (72.5 mg, 27%). >Į@D27 93.9 (c 0.8, CHCl3); Data was collected for 
a mixture of diastereoisomers in a 1:1.4 ratio: įH (270 MHz, d6-DMSO, 90 °C): Data for the 
major isomer 218: 6.73 (1H, dd, J 10.0 and 1.4, C6H), 5.95 (1H, d, J 10.0, C7H), 4.40-4.28 
(1H, m, C3H), 4.14-4.00 (2H, m, CO2CH2CH3), 3.66 (1H, dd, J 5.9 and 2.6 C2HAHB), 3.56-
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3.38 (1H, m, C2HAHB), 2.98-2.86 (1H, m, C9H), 2.72-2.54 (2H, m, C11H2), 2.47-2.36 (1H, m, 
C10HAHB), 2.35-2.23 (1H, m, C4HAHB), 2.19-2.06 (1H, m, C4HAHB), 2.03-1.90 (1H, m, 
C10HAHB), 1.38 (9H, s, CO2C(CH3)3), 1.20 (3H, t, J 7.0, CO2CH2CH3); Data for the minor 
isomer 217, where different from the major isomer: 6.88 (1H, dd, J 10.0 and 2.2, C6H), 5.80 
(1H, d, J 10.0, C7H), 3.71 (1H, dd, J 5.9 and 2.9, C2HAHB), 1.21 (3H, t, J 7.0, CO2CH2CH3); 
įC (68 MHz, d6-DMSO, 90 °C): Data for the major isomer 218: 198.1 (C=O), 170.9 (C=O), 
155.6 (CH), 149.9 (C=O), 127.4 (CH), 79.4 (C), 61.4 (C), 59.3 (CH2), 56.9 (CH), 51.6 (CH2), 
46.9 (CH2), 40.6 (CH), 39.7 (CH2), 34.2 (CH2), 27.5 (3 × CH3), 13.5 (CH3); Data for the 
minor isomer 217, where different from the major isomer: 196.9 (C=O), 170.7 (C=O), 152.5 
(CH), 152.0 (C=O), 125.2 (CH), 79.3 (C), 56.8 (CH), 50.9 (CH2), 47.4 (CH2), 38.7 (CH2), 
33.6 (CH2); m/z ESI+ found 401.1797 (M+Na, C18H26N4O5Na UHTXLUHVȞmax/cm-1 
(CHCl3): 2980, 2934, 2105 (N3), 1727, 1682, 1368, 1154, 1137, 1097. 
 
 
N-Boc-(3R,5S,9R)-3-azido-8-oxo-9-(acetic-acid)-1-azaspiro[4.5]dec-6-ene 
(219) 
 
NaOH (2 M, 4 mL) was added to a stirred solution of ethyl ester 217:218 (110 PJȝPRO
in THF (1.5 mL) and the resultant mixture stirred vigorously for 2 days at rt. The mixture was 
then diluted with Et2O (10 mL) and cooled to 0 °C before the slow addition of concentrated 
HCl with vigorous agitation (until the pH of the solution was slightly acidic). The aqueous 
layer was then extracted with Et2O (3 × 20 mL) and the combined organic layers dried over 
MgSO4 and concentrated in vacuo. The crude product was purified by column 
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chromatography (95:4:1 CH2Cl2/MeOH/AcOH) to afford the acid 219 (91.1 mg, 90%) as a 
white solid>Į@D25 75.3 (c 0.8, CHCl3); mp: 62-64 °C; įH (270 MHz, d6-DMSO, 90 °C) 6.87 
(1H, dd, J 10.2 and 2.3, C6H), 5.80 (1H, d, J 10.2, C7H), 4.35 (1H, app pent, J 5.9, C3H), 3.68 
(1H, dd, J 11.3 and 5.9 C2HAHB), 3.43 (1H, ddd, J 11.3, 5.9 and 1.0, C2HAHB), 2.93-2.80 
(1H, m, C11HAHB), 2.73-2.54 (3H, m, C4HAHB, C9HAHB and C10HAHB), 2.31 (1H, dd, J 16.5 
and 5.9, C11HAHB), 2.10 (1H, dd, J 13.3 and 5.9, C4HAHB), 1.99 (1H, ddd, J 12.1, 4.4 and 2.3, 
C10HAHB), 1.38 (9H, s, CO2C(CH3)3); įC (68 MHz, d6-DMSO, 90 °C) 197.1 (C=O), 172.0 
(C=O), 155.5 (CH), 152.0 (C=O), 125.3 (CH), 79.2 (C), 61.4 (C), 56.8 (CH), 50.9 (CH2), 
41.4 (CH2), 40.5 (CH), 38.1 (CH2), 33.6 (CH2), 27.6 (3 × CH3); m/z ESI+ found 373.1479 
(M+Na, C16H22N4O51DUHTXLUHVȞmax/cm-1 (CHCl3): 3176, 2977, 2931, 2105 (N3), 
1710, 1682, 1392, 1368, 1138. 
 
 
Tricycle (221) 
 
7ULIOXRURDFHWLFDFLG ȝ/PPROZDVDGGHG WRD VWLUUHGVROXWLRQRIDFLG 219 (61.6 
PJȝmol) in CH2Cl2 at rt under argon. The mixture was stirred for 90 min before the 
solvent was removed in vacuo. Triethylamine (73ȝ/ ȝPRODQG'33$ ȝ/ 264 
ȝPROZHUHDGGHGWRDFRROHG (0 °C), stirred solution of the crude free amine in dry DMF (5 
mL). The mixture was then stirred at rt overnight before removal of the solvent in vacuo. The 
crude product was purified by column chromatography (9:1 CH2Cl2/MeOH) to afford the 
tricycle 221 (40.0 mg, 99%) as colourless rods, which were analysed by X-ray 
crystallography (see Appendix)>Į@D25 396.3 (c 0.6, CHCl3); mp : 108-110 °&įH (400 MHz, 
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CDCl3) 7.34 (1H, d, J 9.6 C6H), 5.94 (1H, d, J 9.6, C7H), 4.47-4.40 (1H, m, C3H), 3.99 (1H, 
dd, J 13.6 and 6.8, C2HAHB), 3.61 (1H, d, J 13.6, C2HAHB), 3.03-2.96 (1H, m, C9H), 2.77 
(1H, dd, J  19.0 and 8.4, C11HAHB), 2.61 (1H, d, J 12.4, C10HAHB), 2.46 (1H, d, J 19.0, 
C11HAHB), 2.35 (1H, d, J 14.0, C4HAHB), 2.12 (1H, dd, J 14.0 and 6.4, C4HAHB), 1.84 (1H, d, 
12.6, C10HAHB); įC (100 MHz, CDCl3) 199.9 (C=O), 167.1 (C=O), 152.4 (CH), 127.5 (CH), 
58.7 (C), 58.1 (CH), 51.4 (CH2), 43.5 (CH2), 41.4 (CH), 37.6 (CH2), 33.7 (CH2); m/z ESI+ 
found 255.0846 (M+Na, C11H12N4O21D UHTXLUHV  Ȟmax/cm-1 (CHCl3): 2117 (N3), 
1683 (C=O), 1640 (C=O). Found C, 56.9; H, 5.4; N, 24.1. C11H12N4O2 requires C, 56.9; H, 
5.2; N, 22.1% (loss of azido group possible at high temperature). 
 
 
(3R,5S)-1-(2-bromo-allyl)-3-(tert-butyl-dimethyl-silyloxy)-1-
azaspiro[4.5]dec-6-en-8-one (187)58 
 
Trifluoroacetic acid (12.3 mL, 160 mmol) was added to a stirred solution of the Boc-
protected amine 148 (2.04 g, 5.34 mmol) in dry CH2Cl2 (50 mL) under argon. The mixture 
was stirred for 1 h at rt before being diluted with CH2Cl2 (10 mL) and water (10 mL). The 
mixture was then cooled to 0 °C and NaOH (2 M) was added (until the aqueous layer was pH 
10). The aqueous layer was extracted with CH2Cl2 (3 × 40 mL) and the combined organic 
layers dried over MgSO4 and concentrated in vacuo to dryness. Potassium carbonate (3.69 g, 
26.7 mmol), sodium iodide (397 mg, 2.67 mmol) and 2,3-dibromopropene (1.30 mL, 13.3 
mmol) were added to a stirred solution of the crude free amine in dry acetonitrile (50 mL). 
The mixture was stirred for 2 days at rt, before another addition of 2,3-dibromopropene (521 
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ȝL, 5.34 mmol) and sodium iodide (159 mg, 1.07 mmol). The mixture was stirred for another 
2 days. Water (40 mL) was added and the aqueous layer extracted with EtOAc (3 × 40 mL). 
The combined organic layers were washed sequentially with saturated Na2S2O3 solution (30 
mL) and brine (30 mL), dried over MgSO4 and concentrated in vacuo. The crude product was 
purified by column chromatography (10:1 petrol/EtOAc) to afford the vinyl bromide 187 
(1.58 g, 74% over 2 steps) as a yellow oil. >Į]D26 23.9 (c 0.5, CHCl3) [lit.,58 >Į@D25 25.5 (c 0.8, 
CHCl3)]įH (400 MHz, CDCl3) 6.69 (1H, dd, J 8.4 and 1.6, C6H), 5.97 (1H, d, J 8.4, C7H), 
5.90 (1H, d, J 0.8, C13HAHB), 5.52 (1H, app s, C13HAHB), 4.46-4.41 (1H, m, C3H), 3.38-3.33 
(1H, m, C2HAHB) 3.35 (1H, d, J 12.4, C11HAHB), 3.27 (1H, d, J 12.4, C11HAHB), 2.61 (1H, 
dd, J 8.0 and 2.8, C2HAHB), 2.55-2.50 (1H, m, C9HAHB), 2.49-2.41 (1H, m, C9HAHB), 2.32-
2.27 (1H, m, C4HAHB), 2.05-1.98 (3H, m, C4HAHB and C10H2), 0.87 (9H, s, Si-C(CH3)3), 0.05 
(3H, s, Si-CH3), 0.04 (3H, s, Si-CH3); m/z ESI+ found 400.1300 (M+H, C18H31NO279BrSi 
requires 400.1302 Ȟmax/cm-1 (CHCl3): 2954, 2930, 2857, 1678 (C=O), 1382, 1106, 1062, 
900. Spectroscopic data matched that previously reported.58 
 
 
(1S,3R)-3-(tert-butyl±dimethyl-silyloxy)-7-methylene-5-aza-tricyclo[6.3.1.0]-
dodec-10-en-9-one (188)58 
Tricyclic structure (224) 
       
Pd2(dba)3 (365 mg, 35ȝPRO;DQWSKRVPJ ȝmol), potassium-tert-butoxide (991 
mg, 8.83 mmol), and phenol (997 mg, 10.6 mmol) were added to a dry flask, which was then 
flushed with argon. Dry THF (25 mL) was added and the mixture stirred at reflux for 10 min. 
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A solution of vinyl bromide 187 (1.41 g, 3.53 mmol) in dry THF (20 mL) was then added 
slowly and the mixture stirred for 4 h at reflux. The mixture was allowed to cool to rt and was 
poured into NaOH (1 M, 150 mL). The aqueous phase was extracted with CH2Cl2 (3 × 60 
mL) and the combined organic layers dried over MgSO4 and concentrated in vacuo. The 
crude product was dry-loaded onto silica and purified by column chromatography (4:1 
petrol/EtOAc then 1:1 petrol/EtOAc) to afford the desired tricycle 188 (589 mg, 52%) as a 
yellow oil and the undesired tricycle (221 mg, 19%) 224 as a yellow oil. Data for tricycle 
188: >Į]D24 16.0 (c 0.7, CHCl3) [lit.,58 >Į@D24 41.1 (c 0.2, CHCl3@įH (400 MHz, CDCl3) 6.49 
(1H, dd, J 10.0 and 2.2, C6H), 6.18 (1H, dd, J 10.0 and 0.8, C7H), 5.01 (1H, br s, C13HAHB), 
4.90 (1H, br s, C13HAHB), 4.61-4.54 (1H, m, C3H), 3.37 (1H, d, J 14.4,  C11HAHB), 3.24-3.18 
(2H, m  C11HAHB and C9H), 2.90 (2H, d, J 5.2, C2H2), 2.28 (1H, dd, J 12.8 and 7.6, C4HAHB), 
2.26 (1H, dd, J 12.4 and 3.2, C10HAHB), 2.11 (1H, J 12.4, 3.2 and 2.2 C10HAHB), 1.76 (1H, 
dd, J 12.8 and 4.8, C4HAHB), 0.89 (9H, s, Si-C(CH3)3), 0.06 (6H, s, 2 × Si-CH3); m/z ESI+ 
found 320.2027 (M+H, C18H30NO2Si requires 320.2027 Ȟmax/cm-1 (CHCl3): 2930, 2857, 
1680 (C=O), 1124, 1105, 1087, 1056, 902. Spectroscopic data matched that previously 
reported.58  
Data for tricycle 224: [Į]D24 4.78 (c 1.002, CHCl3įH (400 MHz, CDCl3) 7.13 (1H, dd, J 9.6 
and 1.6, C6H), 5.83-5.92 (2H, m, C7H and C12H), 5.28 (1H, ddd, J 16.8, 1.6 and 0.8, 
C13HAHB), 5.22 (1H, dd, J 10.0 and 1.6, C13HAHB), 4.50 (1H, app pent, J 5.3, C3H), 3.58 (1H, 
d, J 9.6, C11H), 3.01 (1H, dd, J 10.4 and 5.3, C2HAHB), 2.96 (1H, app d, J 4.4, C9H), 2.89 
(1H, dd, J 10.4 and 5.3, C2HAHB), 2.26 (1H, ddd, J 11.2, 4.4 and 1.6, C10HAHB), 2.20-2.14 
(2H, m, C4HAHB and C10HAHB), 2.00 (1H, dd, J 13.2 and 5.3, C4HAHB), 0.89 (9H, s, Si-
C(CH3)3), 0.07 (3H, s, Si-CH3), 0.06 (3H, s, Si-CH3)įC (100 MHz, CDCl3) : 201.8 (C=O), 
160.5 (CH), 137.1 (CH), 127.7 (CH), 118.9 (CH2), 74.6 (CH), 70.2 (C), 63.5 (CH), 60.4 
(CH), 55.5 (CH), 43.2 (CH2), 42.1 (CH2), 25.9 (3 × CH3), 18.2 (C) -4.8 (2 × CH3); m/z ESI+ 
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found 320.2042 (M+H, C18H30NO2Si requires 320.2040); Ȟmax/cm-1 (CHCl3) : 2954, 2929, 
2885, 2857, 1674 (C=O), 1375, 1115, 1061, 1043, 901. 
 
 
(1S,3R)-3-(tert-butyl±dimethyl-silyloxy)-7-methylene-5-aza-tricyclo[6.3.1.0]-
dodecan-9-one (225)58 
 
A 2-neck flask equipped with a cold finger condenser was flame-dried, flushed with Argon 
for 20 minutes and then flushed with dry ammonia. The flask was cooled to -78 °C and dry 
ice/acetone was added to the cold trap of the condenser. After ammonia (~ 100 mL) was 
condensed in the flask, a small piece of lithium solid (washed with petrol) was added and the 
solution turned deep blue in a few seconds. After 10 minutes of stirring, a solution of enone 
188 (750 mg, 2.35 mmol) in dry THF (25 mL) was added slowly. The mixture was stirred for 
2 h at -78 °C, and the excess of lithium was quenched with anhydrous NH4Cl until the 
solution became transparent again. Then Et2O (30 mL) was added and the mixture left 
stirring overnight in order to allow the ammonia to evaporate. Water (50 ml) was added and 
the two layers were separated before the aqueous layer was further extracted with Et2O (3 × 
40 mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo. 
The crude product was purified by column chromatography (1:1 petrol/EtOAc) to afford the 
pure ketone 225 (543 mg, 72%) as a yellow oil. >Į@D24 70.3 (c 0.7, CHCl3) [lit.,58 >Į@D24 45.0 
(c 0.1, CHCl3@ įH (400 MHz, CDCl3) 4.99 (1H, app s, C13HAHB), 4.93 (1H, app s, 
C13HAHB), 4.42 (1H, app pent, J 5.6, C3H), 3.60 (1H, d, J 14.0, C11HAHB), 3.54 (1H, d, J 
14.0, C11HAHB), 3.28 (1H, dd, J 10.2 and 5.6, C2HAHB), 3.26-3.28 (1H, m, C9H), 2.89 (1H, 
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ddd, J 12.4, 7.6 and 3.2, C7HAHB), 2.71 (1H, ddd, J 10.2, 5.6 and 0.8, C2HAHB), 2.41 (1H, 
app dt, J 13.6 and 3.2, C10HAHB), 2.20 (1H, app ddt, J 12.4, 6.0 and 2.0, C7HAHB), 1.94-1.86 
(2H, m, C4HAHB and C6HAHB), 1.86-1.79 (1H, m, C10HAHB), 1.76-1.67 (2H, m, C4HAHB and 
C6HAHB), 0.88 (9H, s, Si-C(CH3)3), 0.06 (6H, s, 2 × Si-CH3); m/z ESI+ found 322.2199 
(M+H, C18H32NO2Si UHTXLUHVȞmax/cm-1 (CHCl3): 2929, 2857, 1708 (C=O), 1124, 
1106, 1089, 1048, 905, 864. Spectroscopic data matched that previously reported.58 
 
 
(1S,3R)-3-(tert-butyl±dimethyl-silyloxy)-7-methylene-5-aza-tricyclo[6.3.1.0]-
dodecan-9-ol (226) 
(1S,3R)-3-(tert-butyl±dimethyl-silyloxy)-7-epoxy-5-aza-tricyclo[6.3.1.0]-
dodecan-9-ol (227) 
 
Sodium borohydride (33.1 mg, 875 ȝmol) was added to a stirred and cooled (0 °C) solution 
of ketone 225 (PJȝPRO in dry methanol (12 mL) under argon. The mixture was 
stirred for 90 min at 0 °C before the careful addition of water (5 mL). The aqueous layer was 
extracted with Et2O (3 × 10 mL) and the combined organic layers dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by column chromatography (1:4 
MeOH/CHCl3) to afford the pure alcohol 226 (231 mg, 86%) as a yellow oil. In addition, 
varying amounts of the undesired side-product 227 were also obtained. Data for the alcohol 
226>Į@D25 11.4 (c 0.3, CHCl3įH (400 MHz, CDCl3) 5.05 (1H, app s, C13HAHB), 4.92 (1H, 
app s, C13HAHB), 4.37 (1H, app pent, J 6.0, C3H), 3.64 (1H, app dt, J 10.8 and 5.2, C8H), 
3.58 (1H, d, J 15.0, C11HAHB), 3.46 (1H, d, J 15.0, C11HAHB), 3.24 (1H, dd, J 9.6 and 6.0, 
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C2HAHB), 2.75 (1H, br s, C9H), 2.61 (1H, dd, J 9.6 and 6.0, C2HAHB), 2.14 (1H, app dt, J 
13.2 and 3.2, C10HAHB), 1.85 (1H, dd, J 12.8 and 6.0, C4HAHB), 1.80-1.73 (1H, m, C7HAHB), 
1.64-148 (4H, m, C4HAHB, C7HAHB, C10HAHB and C6HAHB), 1.40-1.30 (1H, m, C6HAHB), 
0.87 (9H, s, Si-C(CH3)3), 0.04 (6H, s, 2 × Si-CH3); įC (100 MHz, CDCl3) 144.3 (C), 111.8 
(CH2), 71.4 (CH), 70.5 (CH), 63.2 (CH2), 58.2 (C), 56.0 (CH2), 48.4 (CH2), 42.5 (CH), 37.6 
(CH2), 34.8 (CH2), 29.7 (CH2), 26.0 (3 × CH3), 18.2 (C), -4.7 (2 × CH3); m/z ESI+ found 
324.2367 (M+H, C18H34NO26L UHTXLUHV  Ȟmax/cm-1 (CHCl3) : 3608, 2929, 2857, 
1390, 1094, 1049, 906. 
Data for the side product 227 >Į@D27 20.6 (c 0.3, CHCl3įH (500 MHz, CDCl3) 4.36 (1H, 
app pent, J 5.0, C3H), 3.50 (1H, br s, C8H), 3.30 (1H, d, J 13.0, C13HAHB), 3.21 (1H, dd, J 
10.5 and 5.0, C2HAHB), 275 (1H, d, J 4.5, C11HAHB), 2.68 (1H, d, J 4.5, C11HAHB) 2.52 (1H, 
ddd, J 10.5, 5.0 and 1.0, C2HAHB), 2.49 (1H, d, J 13.0, C13HAHB), 2.33 (1H, br s, C9H), 2.12 
(1H, app dt, J 13.5 and 3.5, C10HAHB), 2.09-1.98 (1H, m, C7HAHB), 1.91-1.85 (1H, m, 
C4HAHB), 1.79 (1H, app dd, J 12.5 and 6.0, C7HAHB), 1.64-1.58 (2H, m, C4HAHB and 
C6HAHB), 1.45 (1H, dd, J 13.5 and 2.5, C10HAHB), 1.32 (1H, app td, J 13.0 and 4.5, C6HAHB), 
0.86 (9H, s, Si-C(CH3)3), 0.04 (3H, s, Si-CH3), 0.03 (3H, s, Si-CH3); įC (100 MHz, CDCl3) 
74.2 (CH), 71.6 (CH), 63.3 (CH2), 61.2 (C), 57.9 (C), 56.6 (CH2), 53.8 (CH2), 48.2 (CH2), 
39.1 (CH2), 38.1 (CH), 35.1 (CH2), 30.5 (CH2), 26.0 (3 × CH3), 18.2 (C), -4.7 (2 × CH3); m/z 
ESI+ found 340.2312 (M+H, C18H34NO36L UHTXLUHV  Ȟmax/cm-1 (CHCl3) : 2930, 
2857, 1648, 1462, 1362, 1050, 907. 
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(1S,3R)-3-(tert-butyl±dimethyl-silyloxy)-7-methylene-5-aza-tricyclo[6.3.1.0]-
dodecan-9-ol acetate (228) 
 
Pyridine (0.5 mL) was added to a stirred solution of the alcohol 226 (53.9 mg, 167 ȝmol) in 
Ac2O (0.5 mL) under argon. The mixture was stirred for 15 h at rt before the solvents were 
removed in vacuo. The residue was dissolved in EtOAc (10 mL), and the organic layer 
washed sequentially with saturated NaHCO3 solution (10 mL) and HCl (2 M). The organic 
layer was dried over MgSO4 and concentrated in vacuo. The crude product was purified by 
column chromatography using (1:9 MeOH/CHCl3) to afford the pure acetate-protected 
alcohol 228 (52.9 mg, 86%) as a yellow oil>Į@D28 26.1 (c 0.7, CHCl3įH (400 MHz, CDCl3) 
5.14 (1H, app s, C13HAHB), 4.97 (1H, app s, C13HAHB), 4.81 (1H, ddd, J 9.6, 5.2 and 4.4 
C8H), 4.45-4.40 (1H, m, C3H), 3.86 (1H, d, J 14.4, C11HAHB), 3.59 (1H, dd, J 11.2 and 5.2, 
C2HAHB), 3.52 (1H, d, J 14.4, C11HAHB), 2.93 (1H, br s, C9H), 2.76 (1H, ddd, J 11.2, 4.0 and 
1.0, C2HAHB), 2.38 (1H, app dt, J 13.6 and 3.6, C10HAHB), 2.02 (3H, s, CO2CH3), 2.02-1.98 
(3H, m, C4HAHB, C6H2 and C7HAHB), 1.85-1.79 (1H, m, C7HAHB), 1.70 (1H, ddd, J 13.2, 3.6 
and 1.0, C4HAHB), 1.60-1.58 (1H, m, C10HAHB), 0.85 (9H, s, Si-C(CH3)3), 0.03 (6H, s, Si-
(CH3)2); įC (100 MHz, CDCl3) 170.6 (C=O), 139.2 (C), 116.0 (CH2), 73.6 (CH), 70.3 (CH), 
62.7 (CH2), 61.2 (C), 54.9 (CH2), 47.9 (CH2), 38.4 (CH), 35.1 (CH2), 34.2 (CH2), 25.8 (3 × 
CH3), 25.1 (CH2), 21.4 (CH3), 18.0 (C), -4.8 (2 × CH3); m/z ESI+ found 366.2465 (M+H, 
C20H36NO36LUHTXLUHVȞmax/cm-1 (CHCl3) : 2930, 2857, 1728 (C=O), 1368, 1099, 
1046, 903. 
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(1S,3R)-3-(tert-butyl±dimethyl-silyloxy)-7-oxo-5-aza-tricyclo[6.3.1.0]-
dodecan-9-ol acetate (233) 
 
Following a modified procedure reported by Mariano,77 60% aq. perchloric acid ( ȝ/  
was added to a stirred solution of alkene 228 (33.0 mg, 9 ȝmol) in a mixture of 
CH2Cl2/MeOH (2.5 mL/7.5 mL) in a flask equipped with an inlet and outlet for gases. Firstly, 
O2 was bubbled through the mixture to check the permeability of the system. Then O3 was 
bubbled through the mixture for 20 s after which point TLC analysis showed complete 
consumption of starting material. The mixture was stirred for 30 min at -78 °C before the 
slow addition of dimethylsulfide (0.4 mL), followed, 5 min later by saturated NaHCO3 
solution (0.4 mL). The mixture was allowed to warm to rt, poured into cold water (10 mL) 
and extracted with CHCl3 (3 × 10 mL). The combined organic layers were dried over MgSO4 
and concentrated in vacuo to give a colourless oil. Purification of the crude product 233 (29.5 
mg, 90%) was unsuccessful as degradation occurred during column chromatography. The 
crude product was therefore used in the next step without further purification. 
 
 
N-Boc-(S,E)-2-methoxy-5-(3-oxobut-1-enyl)-pyrrolidine (251) 
 
A solution of DIBAL-H (2.84 mL of a 1.00 M solution in hexane, 2.84 mmol) was added 
dropwise (via syringe pump) to a cooled (-78 °C), stirred solution of the methyl ester 249 
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(369 mg, 1.42 mmol) in dry CH2Cl2 (15 mL) under argon. The mixture was stirred for 2 h at -
78 °C before the dropwise addition of dry methanol (1 mL). The reaction was warmed to rt 
and potassium sodium tartrate solution (2 M, 15 mL) was added. The mixture was stirred for 
1 h before the addition of water (15 mL) and CH2Cl2 (10 mL). The aqueous layer was 
extracted with CH2Cl2 (3 × 25 mL) and the combined organic layers dried over MgSO4. The 
solvent was removed in vacuo to afford the crude aldehyde 250 (371 mg) as a colourless oil. 
1-Triphenylphoshoranylidene-2-propanone 160 (590 mg, 1.85 mmol) was added to a stirred 
solution of the crude aldehyde 250 in CH2Cl2 (5 mL) under argon. The mixture was stirred 
for 5 days at rt. The solvent was removed in vacuo and the resulting solid redissolved in the 
minimum amount of CH2Cl2. Addition of petrol resulted in the formation of a solid, which 
was then triturated. The solid was filtered and washed several times with petrol before the 
filtrate was collected and the solvent removed in vacuo. The crude product was purified by 
column chromatography (8:2 petrol/EtOAc) to afford enone 251 (244 mg, 64 %) as a yellow 
oil. [Į]D21 - 49.7 (c 0.7, CHCl3); Data was collected for a mixture of diastereoisomers in a 1:1 
ratio: įH (270 MHz, d6-DMSO, 90 °C): Data for the first isomer: 6.69 (1H, dd, J 16.0 and 6.3, 
C6H), 6.07 (1H, dd, J 16.0 and 1.0, C7H), 5.16 (1H, dd, J 3.2 and 2.1, C2H), 4.43-4.31 (1H, 
m, C5H), 3.27 (3H, s, OCH3), 2.31-2.12 (1H, m, C3HAHB) 2.20 (3 H, s, C9H3), 1.88-1.65 (2H, 
m, C3HAHB and C4HAHB), 1.48-1.34 (1H, m, C4HAHB), 1.41-1.40 (9H, CO2C(CH3)3; Data for 
the second isomer, where different from the first isomer: 6.68 (1H, dd, J 16.0 and 6.3, C6H), 
5.94 (1H, dd, J 16.0 and 1.0, C7H), 5.06 (1H, app d, J 3.6, C2H), 2.19 (3H, s, C9H3); įC (100 
MHz, CDCl3): Data was collected for a mixture of diastereoisomers and rotamers: 
198.7/198.6/198.1 (C=O), 154.2/153.6 (C=O), 147.2/146.8 (CH), 130.4/129.6/129.4 (CH), 
89.8/89.6/89.2 (CH), 80.8/80.7/80.6 (C), 58.0/57.4 (CH), 56.6/56.3/55.7 (CH3), 
30.0/29.3/29.1/28.1/27.5/27.4/27.1 (2 × CH2 + CH3), 28.4 (3 × CH3). m/z ESI+ found 
292.1514 (M+Na, C14H23NO4Na requires 292.1519Ȟmax/cm-1 (CHCl3) : 2979, 2934, 1695, 
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1368, 1120, 1078, 976. 
 
 
N-Boc-(E)-1-methoxy-7-oxo-oct-4-enyl (254) 
 
A 2-neck flask equipped with a cold finger condenser was flame-dried, flushed with argon for 
20 minutes and then flushed with dry ammonia. The flask was cooled to -78 °C and dry 
ice/acetone was added to the cold trap of the condenser. After ammonia (10-15 mL) was 
condensed in the flask, a small piece of lithium solid (washed with petrol) was added and the 
solution turned deep blue in a few seconds. After 10 minutes of stirring, a solution of enone 
251 (60.0 mg, 223 ȝmol) in dry THF (8 mL) was added slowly. The mixture was stirred for 2 
hours at -78 °C, and the excess of lithium was quenched with dry NH4Cl until the solution 
became transparent again. Then Et2O (20 mL) was added and the mixture left stirring 
overnight in order to allow the ammonia to evaporate. Water (30 ml) was added and the 
aqueous phase extracted with Et2O (3 × 25 mL). The combined organic layers were dried 
over MgSO4 and the mixture concentrated in vacuo. The crude product was purified by 
column chromatography (8:2 petrol/EtOAc) to afford the carbamate 254 (41.0 mg, 68%) as a 
colourless oil. >Į]D25 7.5 (c 0.4, CHCl3); data was collected for a mixture of diastereoisomers: 
įH (400 MHz, CDCl3): 5.59-5.50 (2H, m, C5H and C6H), 4.87-4.74 (2H, m, C2H and NH), 
3.30 (3H, s, OCH3), 3.20-3.10 (2H, m, C7H2), 2.14-2.09 (2H, m, C4H2), 2.12 (3H, s, C9H3), 
1.75-1.65 (1H, m, C3HAHB), 1.63-1.53 (1H, m, C3HAHB), 1.43 (9H, s, CO2C(CH3)3įC (100 
MHz, CDCl3) 207.5/206.9 (C=O), 155.5 (C=O), 133.7/132.2 (CH), 122.9/122.0 (CH), 82.4 
(CH), 79.9 (C), 55.4 (CH3), 47.6 (CH2), 35.2 (CH2), 29.5 (CH2), 28.4 (3 × CH3), 28.2 (CH3). 
m/z ESI+ found 292.1666 (M+Na, C14H25NO4Na requires 292.1676 Ȟmax/cm-1 (CHCl3) : 
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3436, 2933, 1714, 1494, 1368, 1158, 1049. Found C, 61.9; H, 9.3; N, 4.8. C14H25NO4 
requires C, 62.0; H, 9.3; N, 5.2%. 
 
 
N-Boc-(S)-2-methoxy-5-(3-oxo-butyl)-pyrrolidine (260) 
 
Pyridine (1.00 mL) was added to a stirred solution of enone 251 (1.38 g, 5.13 mmol) in 
EtOAc (40 mL) and the mixture degased with argon for 20 min. Then palladium (100 mg, 
10% on C) was added and the mixture stirred for one day under an atmosphere of hydrogen 
(balloon). The catalyst was removed by filtration through a short pad of celite®, which was 
washed several times with EtOAc. The solvent was then removed in vacuo to afford pure 
ketone 260 (1.38 g, 99%) as a yellow oil. >Į]D30 - 43.9 (c 0.7, CHCl3); Data was collected for 
a mixture of diastereoisomers and rotamers: įH (400 MHz, CDCl3) 5.30-5.00 (1H, m, C2H), 
3.80 (1H, br s, C5H), 3.31 (3H, s, OCH3), 2.43 (2H, t, J 7.6, C7H2), 2.14 (3H, s, C9H3), 2.15-
1.98 (2H, m, C3H2), 1.90-1.67 (4H, m, C4H2 and C6H2), 1.47 (9H, s, CO2C(CH3)3įC (100 
MHz, CDCl3) : 208.7 (C=O), 155.3 (C=O), 89.7 (CH), 80.2 (C), 57.4 (CH), 55.2 (CH3), 
41.2/40.4/39.7 (CH2), 32.4/31.6/30.8/29.9/29.5 (3 × CH2 + CH3), 28.6 (3 × CH3); m/z ESI+ 
found 294.1662 (M+Na, C14H25NO4Na requires 294.1676); Ȟmax/cm-1 (CHCl3) : 2934, 1690, 
1391, 1367, 1119, 1078. Found C, 61.9; H, 9.4; N, 4.9. C14H25NO4 requires C, 62.0; H, 9.3; 
N, 5.2%. 
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 (R)-2-methoxy-7-methyl-1-azaspiro[4.4]non-6-ene (261) 
 
n%X/Lȝl, 2.20LQKH[DQHȝPROZDVDGGHGWRDFRROHG-78 °C), stirred solution 
of trimethylsilyldiazomethane (235 ȝL, 2.00 M in Et2O, 470 ȝmol) in dry THF (15 mL) 
under argon. The mixture was stirred for 45 minutes at -78 °C before a solution of ketone 260 
(85.0 mg, 313 ȝmol) in dry THF (5 mL) was added slowly. The mixture was stirred for 
another 90 minutes at -78 °C before slowly being warmed to 0 °C. After 30 minutes of 
stirring at 0 °C, the reaction was quenched with saturated NH4Cl solution (10 mL). The 
aqueous phase was extracted with Et2O (3 × 15 mL), the combined organic layers dried over 
MgSO4 and the mixture concentrated in vacuo. Purification of the crude product was 
attempted using column chromatography (95:5 petrol/EtOAc) to afford the spirocycle 261 
(66.4 mg, 79%) as a yellow oil. However, it has never been possible to purify this product to 
a satisfactory standard, and due to its instability it was used immediately. 
 
 
N-Boc-(S)-2-formyl-5-hydroxy-2-(3-oxo-butyl)-pyrrolidine (262) 
 
N-Methyl-morpholine-N-oxide monohydrate (58.7 PJ  ȝmol) followed by potassium 
osmate dihydrate (2.70 mg, 7.24 ȝmol) was added to a stirred solution of spirocycle 261 
(38.7 PJȝPROLQDFHWRQHP/DQGZDWHU mL). The mixture was stirred for 4 
days at rt before the addition of sodium thiosulfate (20 mg). The mixture was then allowed to 
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stir for another 2 h. Water (10 mL) was added and the aqueous layer extracted with CH2Cl2 (3 
× 10 mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo to 
afford the crude diol which was used without further purification. Sodium periodate (52.4 
mg, 245 mmol) was added to a stirred solution of diol (36.9 mg, 123 ȝmol) in a mixture of 
THF/water (2:1, 1.2 mL). The mixture was stirred for 1 hour before water (5 mL) was added 
and the aqueous layer extracted with Et2O (3 × 5 mL). The combined organic layers were 
dried over MgSO4 and the mixture concentrated in vacuo. The crude product was purified by 
column chromatography (5:4 petrol/EtOAc) to afford 262 (25.2 mg, 69%) as a colourless oil 
and 263 (5.90 mg, 16%) as a white foam. Data for the major product 262: [Į]D24 36.4 (c 0.9, 
CHCl3); data was collected for a mixture of rotamers and diastereoisomers: įH (400 MHz, 
CDCl3) : 9.47-9.28 (1H, m, C10H), 5.72-5.41 (1H, m, C2H), 4.00-3.20 (1H, m, C7HAHB), 
2.67-2.43 (2H, m, C7HAHB and C3HAHB), 2.17-2.14 (3H, m, C9H3), 2.14-2.08 (1H, m, 
C3HAHB) 2.05-1.65 (4H, m, C4H2 and C6H2), 1.49-1.41 (9H, m, CO2C(CH3)3); įC (100 MHz, 
CDCl3) 208.7/207.7 (C=O), 199.1/198.8/198.7 (CHO), 154.0/153.3 (C=O), 84.0/83.6 (CH), 
82.3/82.1/81.7 (C), 71.8/71.4 (C), 39.2/38.8/38.4/38.0 (CH2), 31.8/31.2/30.8 (CH2), 
30.5/30.3/29.9 (CH2), 28.5 (CH3), 28.2 (3 × CH3), 26.5/26.0/25.8 (CH2); m/z ESI+ found 
308.1450 (M+Na, C14H23NO5Na requires 308.1450); Ȟmax/cm-1 (CHCl3) : 3586, 2977, 2934, 
2814, 1737, 1689, 1456, 1369, 1141, 1046, 980. 
Data for the minor product 263: see below. 
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N-Boc-(S)-2-formyl-5-methoxy-2-(3-oxo-butyl)-pyrrolidine (263) 
 
Pb(OAc)4 (335 mg, 75ȝPROwas added to a stirred solution of diol  PJȝmol, 
obtained as described previously) in dry CH2Cl2 (0.5 mL). The mixture was stirred for 10 min 
before water (12 mL) was added and the aqueous layer extracted with EtOAc (3 × 15 mL). 
The combined organic layers were dried over MgSO4 and the mixture concentrated in vacuo. 
The crude product was used in the next step without further purification. For analytical 
purposes, some of the crude product was purified by column chromatography (6:4 
petrol/EtOAc) to afford the pure compound 263 as a white foaming solid. [Į]D24 34.4 (c 0.6, 
CHCl3); Data was collected for a mixWXUH RI URWDPHUV DQG GLDVWHURLVRPHUV įH (400 MHz, 
CDCl3) 9.53-9.31 (1H, m, C10H), 5.42-4.96 (1H, m, C2H), 3.43-3.33 (3H, m, OCH3), 2.68-
2.55 (1H, m, C7HAHB), 2.53-2.40 (1H, m, C7HAHB), 2.18-2.14 (3H, m, C9H3), 2.18-2.10 (2H, 
m, C3H2), 1.95-1.72 (4H, m, C4H2 and C6H2), 1.47-1.41 (9H, m, CO2C(CH3)3įC (100 MHz, 
CDCl3) 207.9 (C=O), 200.2/199.7 (CHO), 154.1 (C=O), 90.6 (CH), 81.9/81.4 (C), 71.6 (C), 
56.2/55.8 (CH3), 39.2/38.8/38.1/37.6 (CH2), 31.8/31.2/30.8 (CH2), 30.6/30.2/30.0 (CH2), 28.4 
(CH3), 28.2 (3 × CH3), 26.6/26.2/26.0 (CH2); m/z ESI+ found 322.1611 (M+Na, 
C15H25NO5Na requires 322.1625); Ȟmax/cm-1 (CHCl3) : 2979, 2935, 1735, 1698, 1456, 1368, 
1141, 1081. 
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N-Boc-(R)-2-hydroxy-8-oxo-1-azaspiro[4.5]dec-6-ene-1 (264) 
 
Potassium hydroxide (17.6 mg, 31ȝmol) was added to a stirred, cooled (0 °C) solution of 
crude aldehyde 263 (188 mg, ȝmol) in dry ethanol (8 mL). The mixture was stirred for 2 
h at rt before the mixture was concentrated in vacuo. The residue was dissolved in saturated 
NH4Cl solution (25 mL) and Et2O (25 mL) and the aqueous layer extracted with Et2O (2 × 25 
mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo to give 
the crude keto-alcohol. Methanesulfonyl chloride (74 ȝL, 9.59 mmol) and triethylamine 
(2.67 mL. 19.2 mmol) were sequentially added to a stirred solution of the crude keto alcohol 
(1.43 g, 4.79 mmol) in dry CH2Cl2 (70 mL) at 0 °C under argon. The mixture was stirred for 
2 days during which time the ice bath expired. Saturated NH4Cl solution (100 mL) was added 
and the aqueous layer extracted with CH2Cl2 (3 × 100 mL). The combined organic layers 
were dried over MgSO4 and concentrated in vacuo. Attempted purification of the crude 
product by column chromatography led to significant loss of material and therefore it was 
used directly in the next reaction. For analytical purposes, some of the crude product was 
purified by column chromatography (1:1 petrol/EtOAc) to afford the pure 5,6-spirocycle 264 
as a yellow oil. >Į@D24 -115.3 (c 0.6, CHCl3); Data was collected for a mixture of rotamers and 
diastereoisomers: įH (400 MHz, CDCl3) 6.85-6.68 (1H, m, C6H), 5.95-5.80 (1H, m, C7H), 
5.60-5.40 (1H, m, C2H), 2.70-2.32 (3H, m, C9H2, C10HAHB), 2.21-2.05 (2H, C3H2), 2.04-1.81 
(3H, m, C4H2, C10HAHB), 1.47-1.38 (9H, CO2C(CH3)3); įC (100 MHz, CDCl3) 198.3/198.0 
(C=O), 157.9/157.6/157.3 (CH), 154.1/152.5 (C=O), 127.7/126.8/126.4 (CH), 83.4/82.9/82.3 
(CH), 81.7/81.4 (C), 63.1/62.7/62.3 (C), 35.7/35.4 (CH2), 33.2/32.1 (CH2), 31.0/30.9/30.7 
(CH2), 30.2/30.1/29.4 (CH2), 28.6/28.4 (3 × CH3); m/z ESI+ found 290.1352 (M+Na, 
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C14H21NO4Na requires 290.1363Ȟmax/cm-1 (CHCl3) : 3582, 2978, 1730 (C=O), 1674 (C=O), 
1368, 1137, 1042, 972, 900. 
 
 
N-Boc-(S,E)-2-oxo-5-(3-oxo-but-1-enyl)-pyrrolidine (266) 
 
Enone 251 (52.3 mg, 194 ȝmol) was dissolved in CH2Cl2 (10 mL) in a separating funnel, and 
washed with HCl (2 M, 2 × 10 mL). The combined aqueous layers were then extracted with 
CH2Cl2 (2 × 10 mL) and the combined organic layers dried over MgSO4 before being 
concentrated in vacuo to afford enone 265 (41.8 mg, 84%) as a colourless oil. 
EITHER: Crushed 4 Å molecular sieves (30 mg) were added to a stirred solution of 265 
(19.9 mg, 78.0 ȝmol) in dry CH2Cl2 (1 mL) under argon. The mixture was stirred for 10 
minutes before the addition of pyridinium chlorochromate (PCC) (33.6 mg, 156 ȝmol). The 
mixture was stirred for 20 h before celite® was added and the crude product dry loaded onto 
silica gel. The crude product was then purified by flash chromatography (2:8 petrol/EtOAc) 
to afford the amide 266 (11.6 mg, 59%) as a colourless solid. 
OR: Pyridine (60 ȝ/74ȝmol) was dissolved in CH2Cl2 (0.6 mL) under argon and CrO3 
(40 mg, 400 ȝmol) was added. The mixture was stirred for 10 minutes and then a solution of 
265  PJ  ȝmol) in CH2Cl2 (1 mL) was added dropwise, followed by acetic 
anhydride (39 ȝL, 400 ȝmol). The reaction mixture was stirred for an additional 1 h before 
being purified by column chromatography (2:8 petrol/EtOAc) to afford the amide 266 (6.0 
mg, 26%) as a colourless solid. [Į]D23 -131.7 (c 0.6, CHCl3); įH (400 MHz, CDCl3) 6.72 (1H, 
dd, J 16.0 and 6.4, C6H), 6.15 (1H, d, J 16.0, C7H), 4.78 (1H, app td, J 6.4 and 2.6, C5H), 
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2.55 (1H, app dt, J 17.2 and 9.2, C3HAHB), 2.48 (1H, ddd, J 17.2, 9.2 and 6.2, C3HAHB), 
2.37-2.27 (1H, m, C4HAHB), 2.26 (3H, s, C9H3), 1.91-1.82 (1H, m, C4HAHB), 1.48 (9H, s, 
CO2C(CH3)); įC (100 MHz, CDCl3) 197.5 (C=O), 173.5 (N-C=O), 149.6 (C=O), 144.3 (CH), 
130.0 (CH), 83.7 (C), 58.2 (CH), 31.1 (CH2), 28.1 (3 × CH3), 23.9 (CH2); m/z ESI+ found 
276.1202 (M+Na, C13H19NO4Na requires 276.1206); Ȟmax/cm-1 (CHCl3) : 2981, 2930, 1783 
(C=O), 1747, 1716, 1679, 1632, 1370,1310, 1149, 977. 
 
 
N-Boc-(S)-2,8-dioxo-1-azaspiro[4.5]dec-6-ene (267) 
 
The crude derivative of enone 264 (1.35 g, 4.79 mmol) was dissolved in CH2Cl2 (50 mL) in a 
separating funnel, and washed with HCl (2 M, 2 × 60 mL). The combined aqueous layers 
were then extracted with CH2Cl2 (2 × 40 mL) and the combined organic layers dried over 
MgSO4 before being concentrated in vacuo to afford enone 264 as a colourless oil. Crushed 4 
Å molecular sieves (2.00 g) were added to a stirred solution of enone 264 (1.28 g, 4.79 
mmol) in dry CH2Cl2 (50 mL) under argon. The mixture was stirred for 10 minutes before the 
addition of pyridinium chlorochromate (PCC) (2.06 g, 9.58 mmol). The mixture was stirred 
for 20 h before celite® was added and the crude product dry loaded onto silica gel. The crude 
product was purified by column chromatography (3:7 petrol/EtOAc) to afford the pure amide 
267 (554 mg, 43% over 3 steps) as colourless blocks, which were analysed by X-ray 
crystallography (see Appendix). [Į]D24 -83.5 (c 0.4, CHCl3); įH (400 MHz, CDCl3) 6.80 (1H, 
d, J 10.0, C6H), 5.94 (1H, d, J 10.0, C7H), 2.77 (1H, app dt, J 13.2 and 6.0, C9HAHB), 2.66-
2.51 (4H, m,
 
C3H2, and C10H2), 2.30 (1H, ddd, J 12.8, 8.4 and 2.0, C4HAHB), 2.09 (1H, br d, J 
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13.2, C9HAHB), 1.98-1.88 (1H, m, C4HAHB), 1.49 (9H, s, CO2C(CH3)3 įC (100 MHz, 
CDCl3) 196.9 (C=O), 173.3 (N-C=O), 154.3 (C=O), 149.5 (C=O), 127.0 (CH), 84.4 (C), 63.4 
(CH), 34.8 (CH2), 30.7 (CH2), 30.3 (CH2), 28.1 (3 × CH3), 27.2 (CH2); m/z ESI+ found 
288.1206 (M+Na, C14H19NO4Na requires 288.1206); Ȟmax/cm-1 (CHCl3) : 2981, 2936, 1781 
(C=O), 1747, 1714, 1682, 1371, 1340, 1304, 1151, 1140, 1080. 
 
 
N-Boc-(3S,5S)-3-azido-8-(trimethyl-silyloxy)-1-azaspiro[4.5]deca-6,8-diene 
(278) 
 
Freshly prepared LDA (8.25 mL, 0.528 M in THF, 4.36 mmol) was slowly added to a cooled 
(-78 °C), stirred solution of enone 178 (1.06 g, 3.63 mmol) and freshly distilled 
chlorotrimethylsilane (1.39 mL, 10.9 mmol) in dry THF (30 mL) under argon. The mixture 
was then stirred for 4 h at -78 °C. Saturated NaHCO3 solution (25 mL) was added and the 
mixture was allowed to warm to rt. The organic layer was separated and the aqueous layer 
extracted with Et2O (3 × 40 mL). The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by column chromatography (8:2 
petrol/EtOAc then 6:4 petrol/EtOAc) to afford the TMS enol ether 278 (938 mg, 72%) as a 
yellow oil in addition to recovered starting material 178 (258 mg, 24%)>Į@D26 -90.6 (c 0.4, 
CHCl3įH (270 MHz, d6-DMSO, 90 °C) 5.74 (1H, d, J 10.0, C6H), 5.50 (1H, dd, J 10.0 and 
2.3, C7H), 4.86-4.81 (1H, m, C9H), 4.28 (1H, app pent, J 6.0, C3H), 3.61 (1H, dd, J 11.4 and 
6.0, C2HAHB), 3.32 (1H, dd, J 11.4 and 6.0, C2HAHB), 3.09-2.96 (1H, m, C10HAHB), 2.56 
(1H, dd, J 13.1 and 6.0, C4HAHB), 2.10 (1H, dd, J 16.8 and 6.2, C10HAHB), 1.82 (1H, dd, J  
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13.1 and 6.0, C4HAHB), 1.40 (s, 9H, CO2C(CH3)3, 0.18 (s, 9H, Si-(CH3)3); įC (68 MHz, d6-
DMSO, 90 °C) 152.2 (C=O), 146.4 (C), 136.6 (CH), 122.4 (CH), 100.7 (CH), 78.6 (C), 61.4 
(C), 55.8 (CH), 50.9 (CH2), 43.0 (CH2), 32.4 (CH2), 27.7 (3 × CH3), -0.4 (3 × CH3); m/z ESI+ 
found 387.1823 (M+Na, C17H28N4O36L1D UHTXLUHV  Ȟmax/cm-1 (CHCl3) : 2931, 
2103 (N3), 1682 (C=O), 1394, 1367, 1157, 893. 
The TMS enol ether was used as soon as possible in the next step (no more than 2 days after 
preparation). 
 
 
N-Boc-(3S,5R,9R)-3-azido-9-hydroxy-8-oxo-1-azaspiro[4.5]dec-6-ene (179) 
 
Freshly titrated DMDO (64.2 mL, 41.0 mM in acetone, 2.63 mmol) was slowly added to a 
cooled (-78 °C), stirred solution of the silyl enol ether 278 (914 mg, 2.51 mmol) in dry 
acetone (20 mL) under argon. The mixture was then stirred for 20 min at -78 °C. Water (10 
mL) was added and the mixture allowed to warm to rt before the solvent was removed in 
vacuo. Water (30 mL) was added and the aqueous layer extracted with Et2O (3 × 25 mL). The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (7:3 petrol/EtOAc) to afford the Į-hydroxy 
ketone 179 (750 mg, 97%) as white needles, which were analysed by X-ray crystallography 
(see Appendix). >Į@D25 129.2 (c 0.7, CHCl3) [lit.,58 >Į@D29 166.7 (c 0.03, CHCl3)]; mp: 64-65 
°C; įH (270 MHz, d6-DMSO, 90 °C) 6.81 (1H, dd, J 10.3 and 1.3, C6H), 5.86 (1H, d, J 10.3, 
C7H), 5.39 (1H, br s, OH), 4.34 (1H, app tt, J 5.8 and 5.0 C3H), 4.19 (1H, app t J 4.6, C9H), 
3.67 (1H, dd J 11.4 and 5.8, C2HAHB), 3.42 (1H, ddd, J 11.4, 5.0 and 0.8, C2HAHB), 2.70 (1H, 
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dd, J  9.9 and 4.6, C10HAHB), 2.65 (1H, dd, J 9.9 and 4.6, C10HAHB), 2.11 (1H, dd, J  12.8 and 
5.8, C4HAHB) 2.04 (1H, ddd, J  12.8, 5.0 and 1.3, C4HAHB), 1.37 (9H, s, CO2C(CH3)3įC (68 
MHz, d6-DMSO, 90 °C) 196.7 (C=O), 153.9 (C=O), 152.1 (CH), 125.0 (CH), 79.2 (C), 68.9 
(CH), 60.0 (C), 56.9 (CH), 51.0 (CH2), 45.3 (CH2), 40.0 (CH2), 27.6 (3 × CH3); m/z ESI+ 
found 331.1372 (M+Na, C14H20N4O4Na requires 331.1377Ȟmax/cm-1 (CHCl3) : 3512, 2931, 
2105 (N3), 1688 (C=O), 1368, 1155, 1135, 1097. Found C, 54.7; H, 6.6; N, 17.8. C14H20N4O4 
requires C, 54.5; H, 6.5; N, 18.2% (loss of azido group possible at high temperature). 
Spectroscopic data matched that previously reported.58 
 
 
N-Boc-(3S,5R,9R)-3-azido-9-(tert-butyl-dimethyl-silyloxy)-8-oxo-1-
azaspiro[4.5]dec-6-ene (279) 
N-Boc-(3S,5R)-3-azido-8,9-bis(tert-butyl-dimethyl-silyloxy)-1-
azaspiro[4.5]deca-6,8-diene (280) 
 
2,6-/XWLGLQHȝ/ȝPRODQGtert-butyldimethylsilyl trifluoromethanesulfonate (35.4 
ȝ/ȝPROZHUHDGGHGWRDcooled (0 °C), stirred solution of alcohol 179 (23.8 mg, 77.2 
ȝPROLQGU\&+2Cl2 (2 mL) under argon. The mixture was stirred for 5 min at 0 °C and then 
1 h at rt. Saturated NaHCO3 solution (10 mL) was added, the organic layer separated and the 
aqueous layer extracted with CH2Cl2 (3 × 15 mL). The combined organic layers were dried 
over MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (19:1 petrol/EtOAc) to afford the TBS-protected alcohol 279 (28.2 mg, 
86%) as a colourless sticky oil. In addition, varying amounts of the undesired side-product 
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280 was also isolated. Data for alcohol 279: >Į@D27 78.0 (c 0.8, CHCl3); įH (270 MHz, d6-
DMSO, 90 °C) 6.85 (1H, dd, J 10.3 and 1.5, C6H), 5.87 (1H, dd, J 10.3 and 0.9, C7H), 4.42-
4.32 (2H, m, C3H and C9H), 3.68 (1H, dd J 11.5 and 5.9, C2HAHB), 3.42 (1H, ddd, J 11.5, 4.8 
and 1.1, C2HAHB), 2.75-2.64 (2H, m, C10H2), 2.17-2.05 (2H, m, C4H2), 1.38 (9H, s, 
CO2C(CH3)3, 0.89 (9H, Si-C(CH3)3, 0.11 (3H, Si-CH3), 0.06 (3H, Si-CH3įC (68 MHz, d6-
DMSO, 90 °C) 195.0 (C=O), 154.1 (CH), 152.1 (C=O), 124.8 (CH), 79.3 (C), 70.8 (CH), 
60.0 (C), 57.0 (CH), 50.9 (CH2), 45.2 (CH2), 40.5 (CH2), 27.6 (3 × CH3), 25.2 (3 × CH3), 
17.4 (C), -5.4 (CH3), -5.6 (CH3); m/z ESI+ found 445.2242 (M+Na, C20H34N4O4SiNa requires 
445.2242Ȟmax/cm-1 (CHCl3) : 2929, 2855, 2104 (N3), 1688 (C=O), 1380, 1368, 1100, 974, 
903.  
Data for the side-product 280: >Į@D23 -63.7 (c 1.0, CHCl3); mp: 80-82 Û&; įH (270 MHz, d6-
DMSO, 90 °C) 5.54 (1H, d, J 9.9, C7H), 5.40 (1H, d, J 9.9, C6H), 4.31 (1H, app pent, J 5.8, 
C3H), 3.61 (1H, dd, J 11.4 and 5.8, C2HAHB), 3.36-3.24 (2H, m, C2HAHB and C10HAHB), 
2.56-2.42 (1H, m, C4HAHB), 2.00 (1H, d, J 16.2, C10HAHB), 1.91 (1H, dd, J 12.3 and 5.8, 
C4HAHB), 1.40 (9H, s, CO2C(CH3)3), 0.94 (18H, 2 × Si-C(CH3)3), 0.18 (6H, Si-(CH3)2), 0.11 
(6H, Si-(CH3)2); įC (68 MHz, d6-DMSO, 90 °C) 152.2 (C=O), 132.0 (C), 129.1 (C), 128.7 
(CH), 122.7 (CH), 78.7 (C), 62.9 (C), 55.7 (CH), 51.0 (CH2), 44.4 (CH2), 27.7 (3 × CH3), 
27.5 (CH2), 25.3 (3 × CH3), 25.2 (3 × CH3), 17.4 (C), 17.3 (C), -4.1 (CH3), -4.4 (CH3), -4.5 
(CH3), -4.6 (CH3); m/z ESI+ found 559.3102 (M+Na, C26H48N4O4Si2Na requires 559.3112); 
Ȟmax/cm-1 (CHCl3) : 2930, 2857, 2104 (N3), 1682 (C=O), 1383, 1367, 1150, 890. 
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N-Boc-(3S,5R,9R)-3-azido-9-(tert-butyl-dimethyl-silyloxy)-8-acetoxy-1-
azaspiro[4.5]dec-6-ene (283) 
 
L-Selectride (1.03 mL, 1.00 M in THF, 1.03 mmol) was slowly added to a cooled (-78 °C), 
stirred solution of enone 279 (415 mg, 982 ȝmol) in dry THF (10 mL) under argon. The 
mixture was then stirred for 1 h at -78 °C. Saturated NaHCO3 solution (20 mL) was added, 
the organic layer separated and the aqueous layer extracted with Et2O (3 × 20 mL). The 
combined organic layers were dried over MgSO4 and concentrated in vacuo to afford the 
crude alcohol 282 (387 mg, 93%) as a colourless sticky oil. Acetic anhydride (2.5 mL) was 
added to a stirred solution of crude alcohol 282 (370 mg, 872 ȝmol) in pyridine (2.5 mL) 
under argon. The mixture was then stirred overnight at rt under argon before being 
concentrated in vacuo. The residue was dissolved in EtOAc and the organic layer washed 
with saturated NaHCO3 solution (15 mL). The organic layer was dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by column chromatography (8:2 
petrol/EtOAc) to afford the acetate-protected alcohol 283 (378 mg, 93%) as a colourless oil. 
>Į@D27 80.8 (c 0.8, CHCl3); Data was collected for a mixture of diastereoisomers in a 4:1 ratio: 
įH (270 MHz, d6-DMSO, 90 °C): Data for the major isomer: 5.66 (1H, app dt, J 10.8 and 1.9, 
C7H), 5.55-5.43 (1H, m, C6H), 5.28-5.22 (1H, m, C8H), 4.44-4.36 (1H, m, C9H), 4.34-4.22 
(1H, m, C3H), 3.62 (1H, dd, J 11.6 and 6.0, C2HAHB), 3.32 (1H, ddd, J 11.6, 5.1 and 1.1, 
C2HAHB), 2.57-2.48 (1H, m, C10HAHB), 2.42 (1H, dd, J 14.0 and 2.8, C4HAHB), 2.03 (3H, s, 
COCH3), 2.03-1.94 (1H, m, C10HAHB), 1.88 (1H, ddd, J 14.0, 5.9 and 1.1, C4HAHB), 1.40 
(9H, s, CO2C(CH3)3), 0.90 (9H, Si-C(CH3)3), 0.09 (3H, Si-CH3), 0.07 (3H, Si-CH3); Data for 
the minor isomer, where different from the major isomer: 5.81 (1H, d, J 10.2, C7H), 4.97-4.91 
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(1H, m, C8H), 3.38 (1H, ddd, J 11.7, 4.4 and 1.1, C2HAHB), 2.01 (3H, s, COCH3), 1.75 (1H, 
dd, J 13.8 and 7.2, C4HAHB); įC (68 MHz, d6-DMSO, 90 °C): Data for the major isomer: 
169.2 (C=O), 152.1 (C=O), 134.4 (CH), 123.4 (CH), 78.7 (C), 69.6 (CH), 67.5 (CH), 60.1 
(C), 56.6 (CH), 50.7 (CH2), 45.2 (CH2), 38.5 (CH2), 27.6 (3 × CH3), 25.3 (3 × CH3), 20.3 
(CH3), 17.3 (C), -5.1 (CH3), -5.5 (CH3); Data for the minor isomer, where different from the 
major isomer: 169.1 (C=O), 68.2 (CH), 56.5 (CH), 46.3 (CH2), 27.7 (3 × CH3), 25.2 (3 × 
CH3), 20.2 (CH3), -5.4 (CH3); m/z ESI+ found 489.2494 (M+Na, C22H38N4O5SiNa requires 
489.2504Ȟmax/cm-1 (CHCl3) : 2930, 2856, 2103 (N3), 1682 (C=O), 1368, 1112, 964. 
 
 
N-Ethyl-acetate-(3S,5R,8R,9R)-3-azido-9-(tert-butyl-dimethyl-silyloxy)-8-
acetoxy-1-azaspiro[4.5]dec-6-ene (284) 
N-Ethyl-acetate-(3S,5R,8S,9R)-3-azido-9-(tert-butyl-dimethyl-silyloxy)-8-
acetoxy-1-azaspiro[4.5]dec-6-ene (285) 
 
Trifluoroacetic acid (1.83 mL, 23.8 mmol) was added to a stirred solution of Boc-protected 
amine 283 (370 mg, 792 ȝmol) in dry CH2Cl2 (10 mL) under argon. The mixture was then 
stirred at rt, during which time the reaction was followed carefully by TLC. When TLC 
analysis indicated complete consumption of the starting material (40 min), the mixture was 
concentrated in vacuo to dryness. Potassium carbonate (328 mg, 2.38 mmol), sodium iodide 
 PJ  PPRO DQG HWK\OEURPRDFHWDWH  ȝ/  PPRO ZHUH DGGHG WR D VWLUUHG
solution of the free amine in dry acetonitrile (8 mL). The mixture was stirred for 5 days at rt. 
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Water (15 mL) was added, the organic layer separated and the aqueous layer extracted with 
EtOAc (3 × 20 mL). The combined organic layers were washed sequentially with saturated 
Na2S2O3 solution (15 mL) and brine (15 mL), dried over MgSO4 and concentrated in vacuo. 
The crude product was purified by column chromatography (9:1 petrol/EtOAc) to afford the 
ethyl ester 284 (265 mg, 74% over 2 steps) as a yellow oil along with its diastereoisomer, 285 
(52.2 mg, 15%). Data for the major isomer 284: >Į@D24 105.7 (c 0.7, CHCl3įH (400 MHz, 
CDCl3): 5.74 (1H, dd, J 10.4 and 2.3, C6H), 5.61 (1H, ddd, J 10.4, 2.3 and 1.2, C7H), 5.23 
(1H, app dt, J 3.2 and 2.3, C8H), 4.24-2.19 (1H, m, C9H), 4.15 (1H, q, J 7.2, CO2CH2), 4.14-
4.06 (1H, m, C3H), 3.41 (1H, dd, J 10.0 and 7.2, C2HAHB), 3.27 (1H, d, J 16.8, C11HAHB), 
3.18 (1H, d, J 16.8, C11HAHB), 2.82 (1H, dd, J 10.0 and 4.8, C2HAHB), 2.39 (1H, dd, J 14.0 
and 8.4, C4HAHB), 2.07 (3H, s, COCH3), 2.01 (1H, dd J 14.0 and 4.8, C4HAHB), 1.82-1.79 
(2H, m, C10H2), 1.25 (3H, t, J 7.2, CO2CH2CH3), 0.89 (9H, Si-C(CH3)3), 0.05 (3H, Si-CH3), 
0.04 (3H, Si-CH3); įC (100 MHz, CDCl3) 171.3 (C=O), 170.8 (C=O), 133.3 (CH), 126.7 
(CH), 70.4 (CH), 67.8 (CH), 63.2 (C), 60.9 (CH2), 58.6 (CH), 56.7 (CH2), 50.8 (CH2), 46.1 
(CH2), 37.6 (CH2), 25.9 (3 × CH3), 21.4 (CH3), 18.3 (C), 14.3 (CH3), -4.3 (CH3), -4.9 (CH3); 
m/z ESI+ found 453.2540 (M+H, C21H37N4O5Si requires 453.2528 Ȟmax/cm-1 (CHCl3) : 
2930, 2856, 2103 (N3), 1732 (C=O), 1372, 1088, 978.  
Data for the minor isomer 285. >Į@D24 -22.6 (c 1.0, CHCl3įH (400 MHz, CDCl3) 5.79 (1H, 
d, J 10.4, C6H), 5.70 (1H, dd, J 10.4 and 3.2, C7H), 4.97 (1H, app t, J 4.0, C8H), 4.20-4.05 
(3H, m, CO2CH2 and C3H), 3.97-3.93 (1H, m, C9H), 3.36 (1H, dd, J 10.0 and 7.2, C2HAHB), 
3.32 (1H, d, J 16.8, C11HAHB), 3.25 (1H, d, J 16.8, C11HAHB), 2.90 (1H, dd, J 10.0 and 4.4, 
C2HAHB), 2.39 (1H, dd, J 13.6 and 8.0, C4HAHB), 2.05 (3H, s, COCH3), 1.96 (1H, dd J 13.6 
and 4.8, C4HAHB), 1.92 (1H, dd, J 14.0 and 3.2, C10HAHB), 1.61 (1H, dd, J 14.0 and 7.2, 
C10HAHB), 1.26 (3H, t, J 7.0, CO2CH2CH3), 0.86 (9H, Si-C(CH3)3), 0.07 (3H, Si-CH3), 0.06 
(3H, Si-CH3); įC (100 MHz, CDCl3) 171.3 (C=O), 170.4 (C=O), 135.1 (CH), 125.9 (CH), 
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71.4 (CH), 68.4 (CH), 63.0 (C), 60.9 (CH2), 58.5 (CH), 56.9 (CH2), 51.1 (CH2), 46.3 (CH2), 
36.7 (CH2), 25.8 (3 × CH3), 21.3 (CH3), 18.1 (C), 14.3 (CH3), -4.7 (CH3), -4.8 (CH3); m/z 
ESI+ found 453.2541 (M+H, C21H37N4O5Si requires 453.2528) and found 475.2357 (M+Na, 
C21H36N4O5SiNa requires 475.2347 Ȟmax/cm-1 (CHCl3) : 2930, 2856, 2104 (N3), 1732 
(C=O), 1371, 1116, 966. 
 
 
N-Boc-(3S,5R,8R,9R)-3-azido-8,9-dihydroxy-1-azaspiro[4.5]dec-6-ene (290) 
 
L-Selectride ( ȝ/  0 LQ 7+)  ȝPRO ZDV VORZO\ DGGHG WR D FRROHG (-78 °C), 
stirred solution of enone 179 ( PJȝmol) in dry THF (1.5 mL) under argon. The 
mixture was then stirred for 2 h at -78 °C. Saturated NaHCO3 solution (10 mL) was added, 
the organic layer separated and the aqueous layer extracted with Et2O (3 × 10 mL). The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (3:7 petrol/EtOAc) to afford the diol 290 
(47.0 mg, 80%) as a colourless sticky oil. >Į@D24 73.7 (c 0.7, CHCl3įH (400 MHz, CDCl3) 
6.00-5.93 (1H, m, C7H), 5.68 (1H, d, J 10.0, C6H), 4.21-4.15 (1H, m, C9H), 4.08 (1H, app 
pent, J 6.4, C3H), 3.91-3.74 (2H, m, C8H and OH), 3.69 (1H, dd, J 11.6 and 6.4, C2HAHB), 
3.37-3.27 (1H, m, C2HAHB), 2.65 (1H, app d, J 14.0, C10HAHB), 2.40 (1H, dd, J 12.8 and 6.4, 
C4HAHB), 2.17 (1H, br s, OH), 2.02-1.92 (1H, m, C4HAHB), 1.75 (1H, dd, J 14.0 and 3.6, 
C10HAHB), 1.42 (s, 9H, CO2C(CH3)3); įC (100 MHz, CDCl3) 153.1 (C=O), 134.6 (CH), 127.1 
(CH), 80.6 (C), 70.5 (CH), 67.4 (CH), 59.9 (C), 57.4 (CH), 51.6 (CH2), 46.8 (CH2), 36.2 
(CH2), 28.6 (3 × CH3); m/z ESI+ found 333.1526 (M+Na, C14H22N4O4Na requires 333.1533); 
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Ȟmax/cm-1 (CHCl3) : 3612 (OH), 3403 (OH), 2978, 2932, 2104 (N3), 1681 (C=O), 1385, 1368, 
1092. 
 
 
N-Ethyl-acetate-(3S,5R,8R,9R)-3-azido-8,9-dihydroxy-1-azaspiro[4.5]dec-6-
ene (291) 
 
Trifluoroacetic acid (2.41 mL, 31.2 mmol) was added to a stirred solution of Boc-protected 
amine 290 (323 mg, 1.04 mmol) in dry CH2Cl2 (20 mL) under argon. The mixture was then 
stirred for at rt, during which time the reaction was followed carefully by TLC. When TLC 
analysis indicated complete consumption of the starting material (1 h), the mixture was 
concentrated in vacuo to dryness. Potassium carbonate (432 mg, 3.12 mmol), sodium iodide 
(233 mg, 1.56 mmol) and ethylEURPRDFHWDWH  ȝ/  mmol) were added to a stirred 
solution of the free amine in dry acetonitrile (10 mL). The mixture was stirred for 3 days at rt. 
Saturated Na2S2O3 solution (20 mL) was added, the organic layer separated and the aqueous 
layer extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with 
brine (20 mL), dried over MgSO4 and concentrated in vacuo. The crude product was purified 
by column chromatography (EtOAc) to afford the ethyl ester 291 (266 mg, 86% over 2 steps) 
as a colourless oil. >Į@D23 15.5 (c 0.7, CHCl3); įH (400 MHz, CDCl3) 5.77 (1H, dd, J 10.4 and 
2.0, C7H), 5.55 (1H, d, J 10.4, C6H), 4.20-4.05 (3H, m, CO2CH2 and C3H), 3.93 (1H, app dt, 
J 7.6 and 2.0, C9H), 3.72-2.63 (1H, m, C8H), 3.37 (2H, s, C11H2), 3.28 (1H, dd, J 10.4 and 
7.2, C2HAHB), 2.98 (1H, dd, J  10.4 and 4.4, C2HAHB), 2.16-2.07 (2H, m, C4HAHB and 
C10HAHB), 1.95 (1H, dd, J 13.4 and 5.6, C4HAHB), 1.49 (1H, dd, J 13.4 and 11.6, C10HAHB), 
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1.25 (3H, t, J 7.2, CO2CH2CH3); įC (100 MHz, CDCl3) 171.9 (C=O), 131.8 (CH), 131.7 
(CH), 72.6 (CH), 70.8 (CH), 64.3 (C), 61.1 (CH2), 58.4 (CH), 57.0 (CH2), 51.8 (CH2), 47.3 
(CH2), 38.1 (CH2), 14.3 (CH3); m/z ESI+ found 319.1373 (M+Na, C13H20N4O4Na requires 
Ȟmax/cm-1 (CHCl3) : 3610, 2938, 2104 (N3), 1741 (C=O), 1378, 1323, 1056. 
 
 
N-Ethyl-acetate-(3S,5R,8R,9R)-3-azido-8,9-bis(tert-butyl-dimethyl-silyloxy)-
1-azaspiro[4.5]dec-6-ene (292) 
 
2,6-/XWLGLQHȝ/Pmol) and tert-butyldimethylsilyl trifluoromethanesulfonate (616 
ȝ/Pmol) were added to a cooled (-78 °C), stirred solution of diol 291 (265 mg, 895 
ȝmol) in dry CH2Cl2 (10 mL) under argon. The mixture was then stirred for 2 h at -78 °C. 
Saturated NaHCO3 solution (15 mL) was added, the organic layer separated and the aqueous 
layer extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were dried over 
MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (92:8 petrol/EtOAc) to afford the bis-TBS-protected alcohol 292 (439 mg, 
93%) as a colourless oil. >Į@D24 -14.3 (c 0.8, CHCl3įH (400 MHz, CDCl3) 5.73 (1H, dd, J 
10.0 and 3.9, C7H), 5.66 (1H, d, J 10.0, C6H), 4.15 (2H, q, J 7.2, CO2CH2), 4.12-4.06 (1H, m, 
C3H), 3.86-3.82 (1H, m, C9H), 3.79 (1H, app t, J 3.9, C8H), 3.38 (1H, dd, J 10.0 and 7.2, 
C2HAHB), 3.33 (1H, d, J 16.8, C11HAHB), 3.21 (1H, d, J 16.8, C11HAHB), 2.85 (1H, dd, J 10.0 
and 4.8, C2HAHB), 2.33 (1H, dd, J 13.8 and 8.4, C4HAHB), 2.00 (1H, dd, J 14.0 and 2.8, 
C10HAHB), 1.94 (1H, dd, J 13.8 and 4.8, C4HAHB), 1.52 (1H, dd, J 14.0 and 5.2, C10HAHB), 
1.25 (3H, t, J 7.2, CO2CH2CH3), 0.88 (18H, s, 2 × Si-C(CH3)3), 0.07 (6H, s, (Si-CH3)2), 0.06 
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(6H, s, Si-CH3)2); įC (100 MHz, CDCl3) 171.7 (C=O), 132.5 (CH), 129.5 (CH), 71.6 (CH), 
68.5 (CH), 62.9 (C), 60.7 (CH2), 58.7 (CH), 56.8 (CH2), 50.9 (CH2), 46.1 (CH2), 34.9 (CH2), 
26.0 (3 × CH3), 25.9 (3 × CH3), 18.2 (C), 18.1 (C), 14.3 (CH3), -4.3 (CH3), -4.5 (2 × CH3), -
4.6 (CH3); m/z ESI+ found 525.3276 (M+H, C25H49N4O4Si2 requires 525.3287) and 547.3097 
(M+Na, C25H48N4O4Si2Na requires 547.3106Ȟmax/cm-1 (CHCl3) : 2950, 2930, 2886, 2857, 
2103 (N3), 1741 (C=O), 1361, 1108, 1070, 866, 838. 
 
 
N-Ethyl-acetate-(3S,5R,8R,9R)-3-amino-8,9-bis(tert-butyl-dimethyl-
silyloxy)-1-azaspiro[4.5]dec-6-ene (293) 
 
Triphenylphosphine (321 mg, 1.22 mmol) and water (1 mL) were added to a stirred solution 
of azide 292 PJȝPROLQ7+)P/7KHPL[WXUHZDVKHDWHGWR&DQGNHSW
at reflux for 4 hours. The solvent was then removed in vacuo. The crude compound was 
purified by column chromatography (1:19 MeOH/CH2Cl2 then 2:3 MeOH/CH2Cl2) to afford 
the free amine 293 (380 mg, 93%) as a pale yellow oil. >Į@D23    -35.8 (c 0.7, CHCl3įH (400 
MHz, CDCl3) 5.70-5.65 (1H, m, C7H), 5.60 (1H, d, J 10.4, C6H), 4.14 (2H, q, J 7.0, 
CO2CH2), 3.82-3.76 (2H, m, C8H and C9H), 3.57 (1H, app p, J 7.0, C3H), 3.30 (1H, d, J 16.8, 
C11HAHB), 3.21 (1H, d, J 16.8, C11HAHB), 3.13 (1H, dd, J 9.2 and 7.0, C2HAHB), 2.70 (1H, 
dd, J 9.2 and 7.0, C2HAHB), 2.31 (1H, dd, J 13.0 and 7.0, C4HAHB), 1.99-1.93 (1H, m, 
C10HAHB), 1.70 (2H, br s, NH2), 1.55 (1H, dd, J 13.0 and 7.0, C4HAHB), 1.52-1.45 (1H, m, 
C10HAHB), 1.24 (3H, t, J 7.0, CO2CH2CH3), 0.88 (9H, s, Si-C(CH3)3), 0.87 (9H, s, Si-
C(CH3)3), 0.07-0.04 (12H, app m, 4 × Si-CH3); įC (100 MHz, CDCl3) 172.1 (C=O), 134.1 
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(CH), 129.6 (CH), 71.7 (CH), 69.4 (CH), 63.6 (C), 60.9 (CH2), 60.6 (CH2), 51.2 (CH2), 50.7 
(CH2), 49.6 (CH), 34.7 (CH2), 26.1 (3 × CH3), 26.0 (3 × CH3), 18.2 (C), 18.1 (C), 14.3 (CH3), 
-4.3 (CH3), -4.4 (2 × CH3), -4.5 (CH3); m/z ESI+ found 499.3375 (M+H, C25H51N2O4Si2 
requires 499.3382)Ȟmax/cm-1 (CHCl3) : 2954, 2929, 2894, 2857, 1739 (C=O), 1069, 867. 
 
 
(1'R,4'R,5S,5'R)-4',5'-bis(tert-butyl-dimethyl-silyloxy)-1,4-
diazaspiro[bicyclo[3.2.1]octane-7,1'-cyclohex[2]en]-3-one (294) 
 
K2CO3 PJȝPROZDVDGGHGWRDVWLUUHGVROXWLRQRIDPLQH293 PJȝPRO
in MeOH (10 mL). The mixture was stirred overnight at rt before the solvent was removed in 
vacuo 7ULHWK\ODPLQH  ȝ/  PPRO IROORZHG E\ '33$  ȝ/  PPRO ZHUH
added to a stirred solution of the crude amino-acid in dry DMF (17 mL). The mixture was 
then stirred at rt for 3 h. Water (20 mL) was added, the organic layer separated and the 
aqueous layer extracted with EtOAc (3 × 20 mL). The combined organic layers were washed 
with water (3 × 30 mL), dried over MgSO4 and concentrated in vacuo. The crude product was 
purified by column chromatography (EtOAc) to afford the tricycle 294 (137 mg, 40% over 2 
steps) as a white solid>Į@D27 -16.5 (c 0.6, CHCl3); mp: 207-208 °C (decompįH (400 MHz, 
CDCl3) 6.35 (1H, br d, J 3.2, NH), 5.65 (1H, dd, J 10.0 and 1.8, C7H), 5.50 (1H, br d, J 10.0, 
C6H), 4.01 (1H, dt, J 7.6 and 1.8, C8H), 3.91 (1H, ddd, J 10.8, 7.6 and 2.6, C9H), 3.87-3.82 
(1H, m, C3H), 3.60 (1H, d, J 18.6, C11HAHB), 3.51 (1H, d, J 18.6, C11HAHB), 3.18 (1H, dd, J 
12.0 and 2.4, C2HAHB), 2.94 (1H, app d, J 12.0, C2HAHB), 2.10 (1H, dd, J 13.2 and 2.6, 
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C10HAHB), 1.83 (1H, app d, J 12.0, C4HAHB), 1.70 (1H, dd, J 13.2 and 4.0, C10HAHB), 1.42 
(1H app t, J  12.0, C4HAHB), 0.91 (9H, s, Si-C(CH3)3), 0.90 (9H, s, Si-C(CH3)3), 0.10 (3 × Si-
CH3), 0.09 (Si-CH3); įC (100 MHz, CDCl3) 170.8 (C=O), 134.3 (CH), 130.8 (CH), 74.3 
(CH), 72.7 (CH), 65.7 (C), 56.6 (CH2), 56.5 (CH2), 54.5 (CH), 51.1 (CH2), 45.2 (CH2), 26.2 
(6 × CH3), 18.4 (C), 18.2 (C), -3.8 (CH3), -3.9 (CH3), -4.5 (2 × CH3); m/z ESI+ found 
453.2955 (M+H, C23H45N2O3Si2 requires 453.2963) and found 475.2776 (M+Na, 
C23H44N2O3Si21D UHTXLUHV  Ȟmax/cm-1 (CHCl3) : 3408, 2955, 2929, 2894, 2857, 
1664 (C=O), 1098, 1046, 1002, 871. Found C, 60.7; H, 9.8; N, 6.2. C23H44N2O3Si2 requires 
C, 61.0; H, 9.8; N, 6.2%. 
 
 
(1'R,4'R,5S,5'R)-4',5'-bis(tert-butyl-dimethyl-silyloxy)-4-methyl-1,4-
diazaspiro[bicyclo[3.2.1]octane-7,1'-cyclohex[2]en]-3-one (295) 
 
1D+  PJ  ȝPRO  LQ RLO ZDV DGGHG WR D VWLUUHG FRROHG  & VROXWLRQ RI
tricycle 294 PJȝPROLQGU\7+)P/XQGHUDUJRQ7KHPL[WXUHZDVVWLUUHGIRU
 PLQDW & EHIRUH WKHDGGLWLRQRI LRGRPHWKDQH ȝ/ȝPRO7KH PL[WXUHZDV
stirred for a further 2 h at 0 °C before saturated Na2S2O3 solution (10 mL) was added. The 
organic layer was separated and the aqueous layer extracted with EtOAc (3 × 10 mL). The 
combined organic layers were washed with brine (20 mL), dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by column chromatography (1.5:8.5 
petrol/EtOAc) to afford the N-methyl tricycle 295 (112 mg, 80%) as white needles, which 
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were analysed by X-ray crystallography (see Appendix). >Į@D30 -14.0 (c 0.6, CHCl3); mp: 
125-126 °CįH (400 MHz, CDCl3) 5.62 (1H, dd, J 10.0 and 2.0, C7H), 5.37 (1H, app dt, J 
10.0 and 1.6, C6H), 4.00 (1H, app dt, J 7.6 and 2.0, C8H), 3.90 (1H, ddd, J 11.0, 7.6, and  3.0, 
C9H), 3.67-3.63 (1H, m, C3H), 3.53 (1H, d, J 18.4, C11HAHB), 3.47 (1H, d, J 18.4, C11HAHB), 
3.23 (1H, dd, J 12.0 and 2.8, C2HAHB), 2.95-2.90 (1H, m, C2HAHB), 2.90 (3H, s, C14H3), 2.05 
(1H, dd, J 13.4 and 2.4, C4HAHB), 1.84 (1H, app dt, J 13.0 and 3.0, C10HAHB), 1.65 (1H, dd, 
J 13.4 and 4.4, C4HAHB), 1.42 (1H, dd, J 13.0 and 11.0, C10HAHB); įC (100 MHz, CDCl3) 
168.5 (C=O), 134.2 (CH), 130.9 (CH), 74.3 (CH), 72.7 (CH), 65.7 (C), 61.2 (CH), 56.7 
(CH2), 56.6 (CH2), 48.3 (CH2), 45.2 (CH2), 33.6 (CH3), 26.2 (6 × CH3), 18.4 (C), 18.2 (C), -
3.8 (CH3), -3.9 (CH3), -4.5 (CH3), -4.6 (CH3); m/z ESI+ found 467.3118 (M+H, 
C24H47N2O3Si2 requires 467.3120) and found 489.2939 (M+Na, C24H46N2O3Si2Na requires 
489.2939Ȟmax/cm-1 (CHCl3) : 2955, 2930, 2894, 2857, 1640 (C=O), 1399, 1096, 1043, 870. 
Found C, 61.8; H, 10.0; N, 6.0. C24H46N2O3Si2 requires C, 61.7; H, 9.9; N, 6.0%. 
 
 
(1'R,4'R,5S,5'R)-4',5'-bis(tert-butyl-dimethyl-silyloxy)-2-(hydroxy(4-(3-
methylbut-2-enyloxy)phenyl)methyl)-4-methyl-1,4-
diazaspiro[bicyclo[3.2.1]octane-7,1'-cyclohex[2]en]-3-one (298) 
 
Freshly prepared LDA (ȝ/ mM in THF, ȝmol) was slowly added to a cooled (-
78 °C), stirred solution of enone 295 (108 mg, ȝmol) in THF (3 mL) under argon. The 
mixture was stirred for 30 min before addition of aldehyde 118 (88.0 mg, 46.3 mmol) in dry 
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THF (0.5 mL). The mixture was then stirred for 4 h at -78 °C. Saturated NaHCO3 solution (15 
mL) was added and the mixture was allowed to warm to rt. The organic layer was separated 
and the aqueous layer extracted with EtOAc (3 × 15 mL). The combined organic layers were 
dried over MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (2:3 petrol/EtOAc then 3:2 petrol/EtOAc) to afford the aldol product 298 as 
a separable 3:1 mixture of diastereoisomers (110.3 mg, 73%) as a colourless oil. Data for the 
major isomer: >Į@D25    -0.8 (c 0.8, CHCl3įH (400 MHz, CDCl3) 7.24 (2H, d, J 8.8, C18H, 
C20H), 6.86 (2H, d, J 8.8, C17H, C20H), 5.63 (1H, dd, J 10.0 and 1.8, C7H), 5.48 (1H, app tt, J 
6.8 and 1.2, C23H), 5.33 (1H, br d, J 10.0, C6H), 4.89 (1H, d, J 6.4, C15H), 4.47 (2H, d, J 6.8, 
C22H2), 3.97 (1H, app dt, J 6.6 and 1.8, C8H), 3.84 (1H, d, J 6.4, C11H), 3.73 (1H, ddd, J 
11.2, 6.6 and 2.8, C9H), 3.60-3.57 (1H, m, C3H), 3.27 (1H, dd, J 12.4 and 1.8, C2HAHB), 2.89 
(3H, s, C14H3), 2.59 (1H, d, J 12.4, C2HAHB), 1.99 (1H, dd, J 13.6 and 2.4, C4HAHB), 1.83 
(1H, app dt, J 11.2 and 2.8, C10HAHB), 1.78 (3H, s, C25H3), 1.72 (3H, s, C26H3), 1.65 (1H, dd, 
J 13.6 and 4.4, C4HAHB), 1.44 (1H, app t, J 11.2, C10HAHB), 0.92 (9H, s, Si-C(CH3)3), 0.88 
(9H, s, Si-C(CH3)3), 0.09 (3H, s, Si-CH3), 0.08 (3H, s, Si-CH3), 0.05 (3H, s, Si-CH3), 0.04 
(3H, s, Si-CH3); įC (100 MHz, CDCl3) 168.7 (C=O), 158.4 (C), 138.0 (C), 135.1 (CH), 134.1 
(C), 130.2 (CH), 128.2 (CH), 119.9 (CH), 114.4 (CH), 74.6 (CH), 74.2 (CH), 72.7 (CH), 66.9 
(CH), 66.3 (C), 64.7 (CH2), 61.3 (CH), 52.0 (CH2), 47.6 (CH2), 45.0 (CH2), 33.7 (CH3), 26.1 
(6 × CH3), 25.9 (CH3), 18.3 (C), 18.2 (C), 18.1 (CH3), -3.9 (2 × CH3), -4.6 (CH3), -4.8 (CH3); 
m/z ESI+ found 657.4114 (M+H, C36H61N2O5Si2 requires 657.4114) and found 679.3931 
(M+Na, C36H60N2O5Si2Na requires 679.3933Ȟmax/cm-1 (CHCl3) : 3369 (OH), 2954, 2930, 
2894, 2857, 1645 (C=O), 1463, 1398, 1314, 1096, 1043, 1000, 871. 
Data for the minor LVRPHU>Į@D25 -13.1 (c 0.5, CHCl3įH (400 MHz, CDCl3) 7.21 (2H, d, J 
8.4, C18H, C20H), 6.85 (2H, d, J 8.4, C17H, C20H), 5.63 (1H, d, J 9.8, C7H), 5.51-5.44 (1H, m, 
C23H), 5.36 (1H, d, J 9.8, C6H), 5.26 (1H, br s, OH), 4.81 (1H, d, J 9.2, C15H), 4.53-4.39 (2H, 
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m, C22H2), 3.88 (1H, d, J 7.2, C8H), 3.78 (1H, d, J 9.2, C11H), 3.66 (1H, br s, C3H), 3.30-3.18 
(2H, m, C9H, C2HAHB), 2.97 (3H, s, C14H3), 2.62 (1H, d, J 12.4, C2HAHB), 2.01 (1H, d, J 
13.2, C4HAHB), 1.78 (3H, s, C25H3), 1.72 (3H, s, C26H3), 1.65-1.54 (2H, m, C4HAHB, 
C10HAHB), 1.33-1.29 (1H, m, C10HAHB), 0.95 (9H, s, Si-C(CH3)3), 0.78 (9H, s, Si-C(CH3)3), 
0.07 (3H, s, Si-CH3), 0.06 (3H, s, Si-CH3), -0.11 (3H, s, Si-CH3), -0.30 (3H, s, Si-CH3); įC 
(100 MHz, CDCl3) 171.3 (C=O), 158.4 (C), 137.8 (C), 135.1 (CH), 133.5 (C), 130.2 (CH), 
128.7 (CH), 120.0 (CH), 114.5 (CH), 75.6 (CH), 74.1 (CH), 72.0 (CH), 66.0 (CH), 64.5 (CH2 
and C), 61.6 (CH), 52.5 (CH2), 47.5 (CH2), 44.9 (CH2), 33.9 (CH3), 26.2 (CH3), 26.1 (3 × 
CH3), 25.9 (3 × CH3), 18.3 (C), 18.1 (CH3), 17.8 (C), -4.0 (CH3), -4.2 (CH3), -4.6 (CH3), -5.2 
(CH3); m/z ESI+ found 657.4101 (M+H, C36H61N2O5Si2 requires 657.4114) and found 
679.3922 (M+Na, C36H60N2O5Si2Na requires 679.3933  Ȟmax/cm-1 (CHCl3) : 3388 (OH), 
2955, 2930,  2856, 1622 (C=O), 1462, 1398, 1097, 1044, 1000, 873. 
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X-ray crystallographic data for tricycle 212 (sppyra) 
 
Table 1.  Crystal data and structure refinement for sppyra at 150(2)K.  
Empirical formula    C17H29NO4Si  
Formula weight     339.50  
Crystal description    colourless column  
Crystal size     0.42 × 0.17 × 0.15 mm  
Crystal system     Orthorhombic  
Space group     P 21 21 21  
Unit cell dimensions    a = 7.1508(5) Å  Į  
b = 11.5559(8) Å  ȕ  90 ° 
c = 22.7795(17) Å Ȗ  
Volume      1882.4(2) Å3  
Reflections for cell refinement   6871  
5DQJHLQș     2.51 ° to 27.18 °  
Z      4  
Density (calculated)    1.198 Mg/m3  
Absorption coefficient    0.143 mm-1  
F(000)      736  
Diffractometer type    Bruker SMART1000 CCD area detector  
Wavelength     0.71073 Å  
Scan type     Ȧ 
Reflections collected    16329  
șUDQJHIRUGDWDFROOHFWLRQ    1.98 ° to 27.50 ° 
Index ranges     -K-N-O 
Independent reflections    4289 [Rint = 0.0312]  
Observed reflections    3840 [I > ı,@ 
Absorption correction    Semi-empirical from equivalents  
Max. and Min. transmission   0.98000 and 0.87176 
Decay correction     0%  
Structure solution by    direct and difmap methods  
Hydrogen atom location    geom  
Hydrogen atom treatment    constr  
Data / restraints / parameters   4289/0/208 (least-squares on F2)  
Final R indices [I > ı,@    R1 = 0.0354, wR2 = 0.0869  
Final R indices (all data)    R1 = 0.0416, wR2 = 0.0914  
Goodness-of-fit on F2    1.024  
Absolute structure parameter   0.04(11)  
)LQDOPD[LPXPįı    0.001  
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Weighting scheme  
calc w =1/[ı2(Fo2) + (0.0556P)2 + 0.1395P] where P = (Fo2 + 2Fc2)/3  
Largest diff. peak and hole          0.220 and -0.261 e.Å-3 
 
 
Table 2.  Atomic coordinates ( × 104) and equivalent isotropic displacement parameters (Å2 × 103) for sppyra. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_________________________________________________________________________ 
   
     
 
x y z U(eq) 
 
_________________________________________________________________________ 
   
     
Si1 2175(1)  9553(1) 2114(1) 37(1) 
 
N1 -2587(2) 8929(1)  627(1)  29(1) 
 
O1  307(2) 9307(1) 1706(1) 35(1) 
 
C2 -1787(2) 8212(1) 1093(1) 34(1) 
 
O2 -1445(2) 13127(1) -293(1) 40(1) 
 
C3 222(2) 8666(1) 1173(1) 29(1) 
 
O3 -5109(2) 7782(1) 467(1) 46(1) 
 
O4 -3488(2) 10302(1) -328(1) 34(1) 
 
C4  569(2) 9425(1) 632(1) 28(1) 
 
C5 -1351(2) 9900(1) 461(1) 26(1) 
 
C6 -1555(2) 10095(1) -201(1) 29(1) 
 
C7  -498(2) 11160(1) -408(1) 34(1) 
 
C8            -1012(2) 12222(1) -58(1) 32(1) 
 
C9 -921(2) 12080(1) 598(1) 32(1) 
 
C10 -1959(2) 10988(1) 801(1)  28(1) 
 
C11 -4123(2) 8618(1) 332(1) 34(1) 
 
C12  -4599(2)  9316(2) -214(1) 40(1) 
 
C13 3755(3) 8273(2) 2105(1) 54(1) 
 
C14 3458(4) 10848(2) 1839(1) 71(1) 
 
C15 1193(3) 9819(1) 2868(1)  41(1)  
 
C16 -42(4)  8789(2) 3053(1) 55(1) 
 
C17 -43(4) 10902(2) 2869(1) 58(1) 
 
C18 2783(4) 9977(2) 3312(1) 65(1) 
 
_________________________________________________________________________ 
 
 
Table 3.   Bond lengths [Å], angles and torsions [°] for sppyra.  
 
___________________________________________________ 
Si1-O1 1.651(12) 
 
Si1-C13 1.862(2) 
 
Si1-C14 1.864(2) 
 
Si1-C15 1.881(18) 
 
N1-C11 1.337(2) 
 
N1-C2 1.463(19) 
 
N1-C5 1.477(18) 
 
O1-C3 1.424(18) 
 
C2-C3 1.540(2) 
 
O2-C8 1.215(19) 
 
C3-C4 1.533(2) 
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O3-C11 1.235(2) 
 
O4-C12 1.413(2) 
 
O4-C6 1.432(19) 
 
C4-C5 1.529(2) 
 
C5-C6 1.531(19) 
 
C5-C10 1.539(19) 
 
C6-C7 1.519(2) 
 
C7-C8 1.509(2) 
 
C8-C9 1.505(2) 
 
C9-C10 1.535(2) 
 
C11-C12  1.521(2) 
 
C15-C17 1.532(3) 
 
C15-C18 1.533(3) 
 
C15-C16 1.541(3) 
 
   
O1-Si1-C13 110.39(8) 
 
O1-Si1-C14 110.34(9) 
 
C13-Si1-C14 109.61(13) 
 
O1-Si1-C15 103.88(8) 
 
C13-Si1-C15 111.48(9) 
 
C14-Si1-C15 111.04(10) 
 
C11-N1-C2 122.25(13) 
 
C11-N1-C5 124.47(12) 
 
C2-N1-C5 112.51(12) 
 
C3-O1-Si1 127.13(10) 
 
N1-C2-C3 104.87(12) 
 
O1-C3-C4 112.46(12) 
 
O1-C3-C2 108.50(12) 
 
C4-C3-C2 104.55(12) 
 
C12-O4-C6 111.73(12) 
 
C5-C4-C3 105.37(12) 
 
N1-C5-C4 101.49(11) 
 
N1-C5-C6 107.94(12) 
 
C4-C5-C6 112.89(12) 
 
N1-C5-C10 108.79(11) 
 
C4-C5-C10 114.73(12) 
 
C6-C5-C10 110.38(11) 
 
O4-C6-C7 106.36(12) 
 
O4-C6-C5 108.37(12) 
 
C7-C6-C5 112.19(13) 
 
C8-C7-C6 111.97(12) 
 
O2-C8-C9  122.86(15) 
 
O2-C8-C7 121.99(15) 
 
C9-C8-C7 115.15(13) 
 
C8-C9-C10 111.59(13) 
 
C9-C10-C5 112.54(12) 
 
O3-C11-N1 123.67(15) 
 
O3-C11-C12 119.34(15) 
 
N1-C11-C12 116.92(14) 
 
O4-C12-C11 116.90(13) 
 
C17-C15-C18 109.25(16) 
 
C17-C15-C16 107.43(18) 
 
C18-C15-C16 109.68(17) 
 
C17-C15-Si1 110.53(12) 
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C18-C15-Si1 110.22(15) 
 
C16-C15-Si1 109.68(11) 
 
   
C13-Si1-O1-C3 -35.79(15) 
 
C14-Si1-O1-C3 85.52(16) 
 
C15-Si1-O1-C3 -155.40(12) 
 
C11-N1-C2-C3 162.61(14) 
 
C5-N1-C2-C3 -7.78(16) 
 
Si1-O1-C3-C4 -89.39(14) 
 
Si1-O1-C3-C2 155.45(11) 
 
N1-C2-C3-O1 106.47(13) 
 
N1-C2-C3-C4 -13.74(15) 
 
O1-C3-C4-C5 -87.95(15) 
 
C2-C3-C4-C5 29.57(15) 
 
C11-N1-C5-C4 -144.38(14) 
 
C2-N1-C5-C4 25.75(15) 
 
C11-N1-C5-C6 -25.50(18) 
 
C2-N1-C5-C6 144.63(12) 
 
C11-N1-C5-C10 94.28(16) 
 
C2-N1-C5-C10 -95.59(14) 
 
C3-C4-C5-N1 -33.23(14) 
 
C3-C4-C5-C6 -148.50(12) 
 
C3-C4-C5-C10 83.87(14) 
 
C12-O4-C6-C7 173.55(11) 
 
C12-O4-C6-C5 -65.64(16) 
 
N1-C5-C6-O4 56.74(15) 
 
C4-C5-C6-O4 168.08(12) 
 
C10-C5-C6-O4 -62.03(16) 
 
N1-C5-C6-C7 173.86(12) 
 
C4-C5-C6-C7 -74.79(16) 
 
C10-C5-C6-C7 55.09(16) 
 
O4-C6-C7-C8 65.46(16) 
 
C5-C6-C7-C8 -52.86(17) 
 
C6-C7-C8-O2 -130.32(15) 
 
C6-C7-C8-C9 50.46(19) 
 
O2-C8-C9-C10 131.44(16) 
 
C7-C8-C9-C10 -49.35(18) 
 
C8-C9-C10-C5 51.13(17) 
 
N1-C5-C10-C9 -172.58(12) 
 
C4-C5-C10-C9 74.57(15) 
 
C6-C5-C10-C9 -54.33(17) 
 
C2-N1-C11-O3 8.4(2) 
 
C5-N1-C11-O3 177.65(14) 
 
C2-N1-C11-C12 -168.70(14) 
 
C5-N1-C11-C12 0.5(2) 
 
C6-O4-C12-C11 39.70(19) 
 
O3-C11-C12-O4 176.49(15) 
 
N1-C11-C12-O4 -6.2(2) 
 
O1-Si1-C15-C17 -63.24(15) 
 
C13-Si1-C15-C17 177.89(14) 
 
C14-Si1-C15-C17 55.35(19) 
 
O1-Si1-C15-C18 175.89(13) 
 
C13-Si1-C15-C18 57.02(16) 
 
C14-Si1-C15-C18 -65.52(17) 
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O1-Si1-C15-C16 55.03(15) 
 
C13-Si1-C15-C16 -63.84(17) 
 
C14-Si1-C15-C16 173.62(15) 
 
___________________________________________________ 
 Symmetry transformations used to generate equivalent atoms: 
 
 
Table 4.   Anisotropic displacement parameters (Å2 × 103) for sppyra. The anisotropic displacement factor 
exponent takes the form: -ʌ2 [h2 a*2 U11 + ... + 2 h k a* b* U12]  
_________________________________________________________________________________ 
 
U11 U22 U33 U23 U13 U12 
_________________________________________________________________________________ 
Si1 43(1) 43(1) 26(1) 2(1) -4(1) -3(1) 
N1 31(1) 29(1) 26(1) 2(1) -1(1) -1(1) 
O1 40(1) 41(1) 24(1) -1(1) -1(1) 6(1) 
C2 36(1) 33(1) 33(1) 7(1) 0(1) 1(1) 
O2 39(1) 35(1) 45(1) 13(1) -1(1) -2(1) 
C3 34(1) 30(1) 25(1) 0(1) -1(1) 4(1) 
O3 45(1) 42(1) 51(1) -3(1) -6(1) -14(1) 
O4 33(1) 41(1) 28(1) 1(1) -6(1) 3(1) 
C4 30(1) 31(1) 23(1) -1(1) 1(1) 4(1) 
C5 28(1) 27(1) 22(1) -1(1) 1(1) 0(1) 
C6 32(1) 34(1) 21(1) -2(1) -1(1) 4(1) 
C7 38(1) 42(1) 22(1) 4(1) 3(1) 2(1) 
C8 26(1) 35(1) 36(1) 6(1) 0(1) -4(1) 
C9 37(1) 29(1) 31(1) -2(1) -1(1) 2(1) 
C10 31(1) 31(1) 22(1) -1(1) 1(1) 3(1) 
C11 38(1) 34(1) 31(1) -6(1) 0(1) -2(1) 
C12 36(1) 50(1) 35(1) -2(1) -9(1) -5(1) 
C13 40(1) 75(1) 46(1) -10(1) -5(1) 12(1) 
C14 81(2) 83(2) 48(1) 9(1) -3(1) -39(1) 
C15 64(1) 36(1) 24(1) 0(1) -6(1) 6(1) 
C16 84(2) 49(1) 31(1) 1(1) 13(1) 2(1) 
C17 89(2) 43(1) 41(1) -5(1) -4(1) 17(1) 
C18 87(2) 73(1) 34(1) -11(1) -20(1) 12(1) 
_________________________________________________________________________________ 
 
 
Table 5.   Hydrogen coordinates ( × 104) and isotropic displacement parameters (Å2 × 103) for sppyra.  
_______________________________________________________________________  
 
x y z U(eq) 
_______________________________________________________________________  
     
H2A -1779 7386 977 41 
H2B -2510 8295 1461 41 
H3A 1130 8008 1183 35 
H4A 1440 10064 727 33 
H4B 1107 8961 308 33 
H6A -1110 9396 -420 35 
H7A 862 11018 -372 40 
H7B -780 11298 -828 40 
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H9A -1482 12766 788 39 
H9B 404 12031 722 39 
H10A -3320 11104 747 33 
H10B -1723 10867 1224 33 
H12A -4513 8794 -558 49 
H12B -5917 9569 -182 49 
H13A 4238 8155 1707 80 
H13B 3059 7584 2229 80 
H13C 4801 8404 2375 80 
H14A 3955 10687 1446 106 
H14B 4492 11028 2106 106 
H14C 2602 11509 1820 106 
H16A -552 8931 3446 82 
H16B 712 8081 3058 82 
H16C -1071 8700 2772 82 
H17A -538 11030 3265 87 
H17B -1083 10795 2594 87 
H17C 701 11574 2749 87 
H18A 2255 10119 3703 97 
H18B 3558 10637 3196 97 
H18C 3552 9275 3322 97 
_______________________________________________________________________  
 
 
  
172 
 
X-ray crystallographic data for tricycle 221 (chn3no) 
 
Table 1.  Crystal data and structure refinement for chn3no at 150(2)K. 
Empirical formula                    C11H12N4O2 
Formula weight                       232.25  
Crystal description                  colourless rod  
Crystal size                          0.35 × 0.17 × 0.05 mm  
Crystal system                       Orthorhombic  
Space group                          P 21 21 21  
Unit cell dimensions                 a = 9.4647(10) Å    Į  
                                      b = 10.3435(11) Å    ȕ = 90 ° 
                                            c = 11.1653(12) Å    Ȗ   
Volume                                1093.1(2) Å3 
Reflections for cell refinement      3291  
Range in ș                        2.69 ° to 27.48 °  
Z                                     4  
Density (calculated)                 1.411 Mg/m3  
Absorption coefficient               0.102 mm-1  
F(000)                                488  
Diffractometer type                  Bruker SMART APEX CCD area detector  
Wavelength                           0.71073 Å  
Scan type                             Ȧ 
Reflections collected                6949  
ș range for data collection      2.68 ° to 27.50 °  
Index ranges                          -12 K2, -N-O  
Independent reflections              1459 [Rint = 0.0230]  
Observed reflections                 1427 >,!ı,@ 
Absorption correction                Semi-empirical from equivalents 
Max. and Min. transmission   0.995 and 0.873 
Decay correction                     0%  
Structure solution by                direct and difmap methods  
Hydrogen atom location               geom  
Hydrogen atom treatment              constr  
Data / restraints / parameters       1459/0/154 (least-squares on F2)  
Final R indices >,!ı,@        R1 = 0.0422, wR2 = 0.1021  
Final R indices (all data)           R1 = 0.0433, wR2 = 0.1027  
Goodness-of-fit on F2               1.167  
Final maximum į/ı             0.000  
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Weighting scheme  
calc w = >ı2(Fo2) + (0.0519P)2 + 0.2896P] where P = (Fo2+2Fc2)/3  
Largest diff. peak and hole          0.287 and -0.202 e.Å-3  
 
 
Table 2.  Atomic coordinates ( × 104) and equivalent isotropic displacement parameters (Å2 × 103) for chn3no. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_________________________________________________________________________ 
   
     
 
x y z U(eq) 
 
_________________________________________________________________________ 
   
     
N1 8224(1) 8037(1) 1675(1) 23(1) 
 
C2 8194(2) 7052(2) 733(1) 31(1) 
 
C3 7232(2) 5999(2) 1217(2) 28(1) 
 
C4 6326(2) 6682(2) 2163(2) 29(1) 
 
C5 7284(2) 7727(1) 2702(1) 22(1) 
 
C6 8202(2) 7242(2) 3729(1) 27(1) 
 
C7 8747(2) 8036(2) 4533(2) 32(1) 
 
C8 8517(2) 9448(2) 4484(1) 28(1) 
 
O2 9053(1) 10173(1) 5212(1) 35(1) 
 
C9 7610(2) 9943(2) 3461(1) 25(1) 
 
C10 6507(2) 8942(2) 3096(1) 24(1) 
 
C11 8853(2) 9190(2) 1498(1) 23(1) 
 
O1 9613(1) 9393(1) 624(1) 32(1) 
 
C12 8527(2) 10276(2) 2367(1) 25(1) 
 
N13 8157(1) 4965(1) 1738(1) 30(1) 
 
N14 7513(2) 4058(1) 2192(1) 30(1) 
 
N15 7031(2) 3182(2) 2642(2) 47(1) 
 
_________________________________________________________________________ 
 
 
Table 3.   Bond lengths [Å], angles and torsions [°] for chn3no.  
___________________________________________________ 
N1-C11 1.347(2) 
N1-C2 1.465(2) 
N1-C5 1.4861(19) 
C2-C3 1.519(2) 
C3-N13 1.500(2) 
C3-C4 1.532(2) 
C4-C5 1.534(2) 
C5-C10 1.521(2) 
C5-C6 1.523(2) 
C6-C7 1.322(2) 
C7-C8 1.477(2) 
C8-O2 1.217(2) 
C8-C9 1.517(2) 
C9-C10 1.526(2) 
C9-C12 1.537(2) 
C11-O1 1.2305(18) 
C11-C12 1.516(2) 
174 
 
N13-N14 1.2283(19) 
N14-N15 1.132(2) 
  
C11-N1-C2 121.24(13) 
C11-N1-C5 124.68(12) 
C2-N1-C5 113.09(12) 
N1-C2-C3 104.76(13) 
N13-C3-C2 107.43(13) 
N13-C3-C4 112.87(14) 
C2-C3-C4 104.51(13) 
C3-C4-C5 105.31(12) 
N1-C5-C10 109.51(12) 
N1-C5-C6 108.11(11) 
C10-C5-C6 109.26(12) 
N1-C5-C4 101.72(12) 
C10-C5-C4 114.19(12) 
C6-C5-C4 113.62(13) 
C7-C6-C5 121.96(15) 
C6-C7-C8 122.09(15) 
O2-C8-C7 121.51(15) 
O2-C8-C9 122.05(15) 
C7-C8-C9 116.43(14) 
C8-C9-C10 111.04(13) 
C8-C9-C12 110.75(13) 
C10-C9-C12 109.04(12) 
C5-C10-C9 107.89(12) 
O1-C11-N1 121.77(14) 
O1-C11-C12 119.98(14) 
N1-C11-C12 118.14(13) 
C11-C12-C9 117.20(13) 
N14-N13-C3 114.52(13) 
N15-N14-N13 174.00(17) 
  
C11-N1-C2-C3 -172.42(13) 
C5-N1-C2-C3 -3.28(17) 
N1-C2-C3-N13 -98.13(14) 
N1-C2-C3-C4 22.00(16) 
N13-C3-C4-C5 83.73(15) 
C2-C3-C4-C5 -32.70(16) 
C11-N1-C5-C10 30.93(19) 
C2-N1-C5-C10 -137.77(13) 
C11-N1-C5-C6 -88.02(16) 
C2-N1-C5-C6 103.29(14) 
C11-N1-C5-C4 152.09(14) 
C2-N1-C5-C4 -16.60(15) 
 C3-C4-C5-N1 29.68(15) 
C3-C4-C5-C10 147.52(13) 
C3-C4-C5-C6 -86.25(16) 
N1-C5-C6-C7 89.43(18) 
C10-C5-C6-C7 -29.7(2) 
C4-C5-C6-C7 -158.47(15) 
C5-C6-C7-C8 -0.7(3) 
C6-C7-C8-O2 -178.09(16) 
C6-C7-C8-C9 0.4(2) 
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O2-C8-C9-C10 -150.97(15) 
C7-C8-C9-C10 30.56(19) 
O2-C8-C9-C12 87.73(18) 
C7-C8-C9-C12 -90.74(17) 
N1-C5-C10-C9 -59.71(15) 
C6-C5-C10-C9 58.52(15) 
C4-C5-C10-C9 -172.99(13) 
C8-C9-C10-C5 -59.95(16) 
C12-C9-C10-C5 62.34(16) 
C2-N1-C11-O1 -11.6(2) 
C5-N1-C11-O1 -179.45(13) 
C2-N1-C11-C12 164.49(13) 
C5-N1-C11-C12 -3.3(2) 
O1-C11-C12-C9 -178.06(14) 
N1-C11-C12-C9 5.8(2) 
C8-C9-C12-C11 86.88(16) 
C10-C9-C12-C11 -35.58(18) 
C2-C3-N13-N14 178.30(14) 
C4-C3-N13-N14 63.63(18) 
___________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
 
 
Table 4.   Anisotropic displacement parameters (Å2 × 103) for chn3no. The anisotropic displacement factor 
exponent takes the form: -ʌ2 [h2 a*2 U11 + ... + 2 h k a* b* U12]  
_________________________________________________________________________________ 
 
U11 U22 U33 U23 U13 U12 
_________________________________________________________________________________ 
   
      
N1 27(1) 24(1) 18(1) 0(1) 3(1) 4(1) 
C2 47(1) 24(1) 22(1) 0(1) 1(1) 8(1) 
C3 32(1) 25(1) 28(1) -3(1) -9(1) 5(1) 
C4 26(1) 25(1) 36(1) -1(1) -2(1) 1(1) 
C5 22(1) 24(1) 22(1) 2(1) 2(1) 1(1) 
C6 33(1) 25(1) 23(1) 5(1) 3(1) 5(1) 
C7 40(1) 35(1) 21(1) 4(1) -5(1) 3(1) 
C8 30(1) 33(1) 20(1) -1(1) 6(1) -3(1) 
O2 41(1) 41(1) 24(1) -8(1) 4(1) -9(1) 
C9 27(1) 24(1) 23(1) -3(1) 3(1) 1(1) 
C10 21(1) 26(1) 26(1) 2(1) 4(1) 1(1) 
C11 21(1) 30(1) 19(1) 4(1) -1(1) 3(1) 
O1 32(1) 38(1) 24(1) 5(1) 8(1) 1(1) 
C12 28(1) 26(1) 22(1) 2(1) -1(1) -3(1) 
N13 29(1) 23(1) 39(1) 4(1) -2(1) -1(1) 
N14 30(1) 25(1) 33(1) 0(1) -1(1) 4(1) 
N15 44(1) 36(1) 61(1) 16(1) 9(1) 3(1) 
_________________________________________________________________________________ 
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Table 5.   Hydrogen coordinates ( × 104) and isotropic displacement parameters (Å2 × 103) for chn3no.   
_______________________________________________________________________  
 
x y z U(eq) 
_______________________________________________________________________  
   
    
H2A 9153 6710 580 37 
H2B 7811 7414 -21 37 
H3A 6625 5639 565 34 
H4A 6017 6064 2787 35 
H4B 5480 7075 1790 35 
H6A 8388 6342 3794 32 
H7A 9304 7688 5164 38 
H9A 7111 10744 3731 30 
H10A 5879 8745 3781 29 
H10B 5922 9279 2430 29 
H12A 8049 10975 1917 30 
H12B 9435 10629 2662 30 
_______________________________________________________________________  
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X-ray crystallographic data for spirocycle 267 (spirco) 
 
Table 1.  Crystal data and structure refinement for spirco at 150(2)K.  
Empirical formula    C14H19NO4  
Formula weight     265.30  
Crystal description                  colourless block  
Crystal size                          0.42 × 0.41 × 0.25 mm  
Crystal system                       Orthorhombic  
Space group                          P 21 21 21  
Unit cell dimensions    a = 10.4932(6) Å  Į  
                                            b = 10.7663(6) Å  ȕ  
                                            c = 24.8152(14) Å Ȗ  
Volume                                2803.4(3) Å3  
Reflections for cell refinement      6179  
5DQJHLQș    2.54 ° to 24.22 ° 
Z                                     8  
Density (calculated)                 1.257 Mg/m3  
Absorption coefficient               0.092 mm-1  
F(000)                                1136  
Diffractometer type                  Bruker SMART1000 CCD area detector  
Wavelength                            0.71073 Å 
Scan type                             Ȧ  
Reflections collected                24794  
șUDQJHIRUGDWDFROOHFWLRQ      2.06 ° to 27.51 ° 
Index ranges                          -K-N-O 
Independent reflections             3627 [Rint = 0.0549]  
Observed reflections                 >,!ı,@ 
Decay correction                     0%  
Structure solution by                direct and difmap methods  
Hydrogen atom location               geom  
Hydrogen atom treatment              constr  
Data / restraints / parameters       3627/0/349 (least-squares on F2)  
)LQDO5LQGLFHV>,!ı,@   R1 = 0.0328, wR2 = 0.0674  
Final R indices (all data)           R1 = 0.0471, wR2 = 0.0715  
Goodness-of-fit on F2               0.932  
)LQDOPD[LPXPįı    0.000  
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Weighting scheme  
FDOFZ >ı2(Fo2) + (0.0391P)2] where P = (Fo2 + 2Fc2)/3  
Largest diff. peak and hole          0.147 and -0.152 e.Å-3 
 
 
Table 2.  Atomic coordinates ( × 104) and equivalent isotropic displacement parameters (Å2 × 103) for spirco.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
_________________________________________________________________________ 
 
x y z U(eq) 
_________________________________________________________________________ 
     
N1 3986(1) 8411(1) 8001(1) 29(1) 
C2 3797(2) 8721(2) 7459(1) 33(1) 
O1 3009(1) 9441(1) 7289(1) 42(1) 
C3 4750(2) 7998(2) 7133(1) 38(1) 
C4 5080(2) 6900(2) 7491(1) 34(1) 
C5 4933(2) 7391(2) 8076(1) 26(1) 
C6 4420(2) 6370(2) 8425(1) 29(1) 
C7 5133(2) 5698(2) 8760(1) 31(1) 
C8 6500(2) 5930(2) 8831(1) 32(1) 
O2 7121(1) 5362(1) 9168(1) 45(1) 
C9 7098(2) 6886(2) 8468(1) 31(1) 
C10 6172(2) 7914(2) 8308(1) 29(1) 
C11 3362(2) 9017(2) 8427(1) 34(1) 
O3 2634(2) 9864(1) 8371(1) 48(1) 
O4 3734(1) 8504(1) 8888(1) 35(1) 
C12 3206(2) 8898(2) 9419(1) 34(1) 
C13 3895(3) 8053(2) 9805(1) 55(1) 
C14 3525(3) 10237(2) 9526(1) 58(1) 
C15 1789(2) 8647(3) 9425(1) 61(1) 
N1' -541(1) 2450(1) 7979(1) 28(1) 
C2' -798(2) 2641(2) 7430(1) 32(1) 
O1' -1541(1) 2043(1) 7161(1) 39(1) 
C3' 9(2) 3713(2) 7243(1) 38(1) 
C4' 1034(2) 3832(2) 7674(1) 35(1) 
C5' 385(2) 3377(2) 8198(1) 26(1) 
C6' 1375(2) 2789(2) 8550(1) 31(1) 
C7' 1910(2) 3376(2) 8964(1) 36(1) 
C8' 1527(2) 4622(2) 9134(1) 35(1) 
O2' 2020(2) 5123(1) 9523(1) 62(1) 
C9' 546(2) 5277(2) 8803(1) 30(1) 
C10' -338(2) 4410(2) 8492(1) 28(1) 
C11' -1316(2) 1698(2) 8306(1) 31(1) 
O3' -2239(1) 1141(1) 8152(1) 41(1) 
O4' -849(1) 1722(1) 8806(1) 32(1) 
C12' -1568(2) 1192(2) 9272(1) 31(1) 
C13' -694(2) 1499(2) 9738(1) 40(1) 
C14' -2843(2) 1850(2) 9321(1) 44(1) 
C15' -1707(2) -204(2) 9201(1) 38(1) 
_________________________________________________________________________ 
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Table 3.   Bond lengths [Å], angles and torsions [°] for spirco. 
___________________________________________________ 
N1-C2 1.402(2) 
N1-C11 1.404(2) 
N1-C5 1.492(2) 
C2-O1 1.210(2) 
C2-C3 1.503(3) 
C3-C4 1.518(3) 
C4-C5 1.552(3) 
C5-C6 1.501(2) 
C5-C10 1.530(2) 
C6-C7 1.332(3) 
C7-C8 1.466(3) 
C8-O2 1.224(2) 
C8-C9 1.505(3) 
C9-C10 1.525(2) 
C11-O3 1.198(2) 
C11-O4 1.329(2) 
O4-C12 1.491(2) 
C12-C14  1.503(3) 
C12-C13 1.507(3) 
C12-C15  1.511(3) 
N1'-C2' 1.403(2) 
N1'-C11' 1.405(2) 
N1'-C5' 1.496(2) 
C2'-O1' 1.211(2) 
C2'-C3' 1.505(3) 
C3'-C4' 1.523(3) 
C4'-C5' 1.548(2) 
C5'-C6' 1.498(2) 
C5'-C10' 1.529(2) 
C6'-C7' 1.330(3) 
C7'-C8' 1.462(3) 
C8'-O2' 1.221(2) 
C8'-C9' 1.494(3) 
C9'-C10' 1.526(3) 
C11'-O3' 1.201(2) 
C11'-O4' 1.335(2) 
O4'-C12' 1.493(2) 
C12'-C13' 1.513(3) 
C12'-C14' 1.519(3) 
C12'-C15' 1.520(3) 
  
  
C2-N1-C5 112.83(15) 
C11-N1-C5 124.05(14) 
O1-C2-N1 125.75(19) 
O1-C2-C3 126.85(18) 
N1-C2-C3 107.41(16) 
C2-C3-C4 103.90(16) 
C3-C4-C5 105.01(15) 
N1-C5-C6 111.80(14) 
N1-C5-C10 110.00(14) 
C6-C5-C10 110.90(15) 
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N1-C5-C4 101.60(14) 
C6-C5-C4 109.08(15) 
C10-C5-C4 113.15(16) 
C7-C6-C5 123.86(17) 
C6-C7-C8 122.13(18) 
O2-C8-C7 121.13(19) 
O2-C8-C9 121.95(18) 
C7-C8-C9 116.93(17) 
C8-C9-C10 112.75(15) 
C9-C10-C5 111.90(15) 
O3-C11-O4 127.21(19) 
O3-C11-N1 124.31(18) 
O4-C11-N1 108.47(15) 
C11-O4-C12 122.17(14) 
O4-C12-C14 110.26(17) 
O4-C12-C13 102.24(15) 
C14-C12-C13 111.07(19) 
O4-C12-C15 108.95(17) 
C14-C12-C15 112.9(2) 
C13-C12-C15 110.9(2) 
C2'-N1'-C11' 122.21(16) 
C2'-N1'-C5' 112.41(15) 
C11'-N1'-C5' 123.33(14) 
O1'-C2'-N1' 125.51(18) 
O1'-C2'-C3' 126.85(18) 
N1'-C2'-C3' 107.64(17) 
C2'-C3'-C4' 104.21(16) 
C3'-C4'-C5' 104.65(15) 
N1'-C5'-C6' 112.35(15) 
N1'-C5'-C10' 109.71(14) 
C6'-C5'-C10' 112.00(15) 
N1'-C5'-C4' 100.98(14) 
C6'-C5'-C4' 108.50(14) 
C10'-C5'-C4' 112.83(15) 
C7'-C6'-C5' 122.78(17) 
C6'-C7'-C8' 122.87(18) 
O2'-C8'-C7'  121.13(19) 
O2'-C8'-C9' 121.14(18) 
C7'-C8'-C9'  117.69(17) 
C8'-C9'-C10' 114.06(15) 
C9'-C10'-C5' 112.65(15) 
O3'-C11'-O4' 126.91(18) 
O3'-C11'-N1' 124.79(17) 
O4'-C11'-N1' 108.30(15) 
C11'-O4'-C12' 121.85(14) 
O4'-C12'-C13'  101.71(14) 
O4'-C12'-C14' 109.23(15) 
C13'-C12'-C14' 111.73(17) 
O4'-C12'-C15' 109.68(16) 
C13'-C12'-C15' 111.27(17) 
C14'-C12'-C15' 112.65(17) 
  
C11-N1-C2-O1 -7.5(3) 
C5-N1-C2-O1 173.61(17) 
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C11-N1-C2-C3 172.44(17) 
C5-N1-C2-C3 -6.5(2) 
O1-C2-C3-C4 -156.89(19) 
N1-C2-C3-C4 23.2(2) 
C2-C3-C4-C5 -30.6(2) 
C2-N1-C5-C6 -128.73(16) 
C11-N1-C5-C6 52.4(2) 
C2-N1-C5-C10 107.59(17) 
C11-N1-C5-C10 -71.3(2) 
C2-N1-C5-C4 -12.53(19) 
C11-N1-C5-C4 168.56(17) 
C3-C4-C5-N1 26.2(2) 
C3-C4-C5-C6 144.41(17) 
C3-C4-C5-C10 -91.64(19) 
N1-C5-C6-C7 -146.60(18) 
C10-C5-C6-C7 -23.4(2) 
C4-C5-C6-C7 101.8(2) 
C5-C6-C7-C8 2.1(3) 
C6-C7-C8-O2 174.82(18) 
C6-C7-C8-C9 -5.7(3) 
O2-C8-C9-C10 -149.67(17) 
C7-C8-C9-C10 30.9(2) 
C8-C9-C10-C5 -52.1(2) 
N1-C5-C10-C9 171.57(14) 
C6-C5-C10-C9 47.4(2) 
C4-C5-C10-C9 -75.58(19) 
C2-N1-C11-O3 -1.5(3) 
C5-N1-C11-O3 177.33(17) 
C2-N1-C11-O4 179.45(16) 
C5-N1-C11-O4 -1.8(2) 
O3-C11-O4-C12 3.6(3) 
N1-C11-O4-C12 -177.36(16) 
C11-O4-C12-C14 -62.6(2) 
C11-O4-C12-C13 179.26(18) 
C11-O4-C12-C15 61.8(2) 
C11'-N1'-C2'-O1' -13.5(3) 
C5'-N1'-C2'-O1' -177.66(17) 
C11'-N1'-C2'-C3' 166.46(16) 
C5'-N1'-C2'-C3' 2.27(19) 
O1'-C2'-C3'-C4'  -162.39(19) 
N1'-C2'-C3'-C4' 17.7(2) 
C2'-C3'-C4'-C5'  -30.07(19) 
C2'-N1'-C5'-C6'  -136.07(16) 
C11'-N1'-C5'-C6' 59.9(2) 
C2'-N1'-C5'-C10' 98.66(17) 
C11'-N1'-C5'-C10' -65.3(2) 
C2'-N1'-C5'-C4' -20.65(18) 
C11'-N1'-C5'-C4' 175.37(16) 
C3'-C4'-C5'-N1' 30.40(18) 
C3'-C4'-C5'-C6' 148.65(16) 
C3'-C4'-C5'-C10' -86.63(19) 
N1'-C5'-C6'-C7' -149.01(17) 
C10'-C5'-C6'-C7' -25.0(2) 
C5'-C6'-C7'-C8' 100.2(2) 
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C5'-C6'-C7'-C8' 3.7(3) 
C6'-C7'-C8'-O2' 178.4(2) 
C6'-C7'-C8'-C9' -3.6(3) 
O2'-C8'-C9'-C10' -156.6(2) 
C7'-C8'-C9'-C10' 25.4(2) 
C8'-C9'-C10'-C5' -46.4(2) 
N1'-C5'-C10'-C9' 170.77(14) 
C6'-C5'-C10'-C9' 45.3(2) 
C4'-C5'-C10'-C9' -77.49(19) 
C2'-N1'-C11'-O3' 1.3(3) 
C5'-N1'-C11'-O3' 163.75(18) 
C2'-N1'-C11'-O4' -178.48(16) 
C5'-N1'-C11'-O4' -16.0(2) 
O3'-C11'-O4'-C12' -10.1(3) 
N1'-C11'-O4'-C12' 169.70(14) 
C11'-O4'-C12'-C13' -177.26(16) 
C11'-O4'-C12'-C14' -59.0(2) 
C11'-O4'-C12'-C15' 64.9(2) 
___________________________________________________ 
 Symmetry transformations used to generate equivalent atoms:  
 
 
Table 4.   Anisotropic displacement parameters (Å2 × 103) for spirco. The anisotropic displacement factor 
exponent takes the form: -ʌ2 [h2 a*2 U11 + ... + 2 h k a* b* U12] 
_________________________________________________________________________________ 
 
U11 U22 U33 U23 U13 U12 
_________________________________________________________________________________ 
       
N1 31(1) 23(1) 32(1) 3(1) -3(1) 3(1) 
C2 34(1) 28(1) 38(1) 9(1) -7(1) -7(1) 
O1 38(1) 39(1) 50(1) 18(1) -9(1) -2(1) 
C3 46(1) 39(1) 30(1) 3(1) -4(1) -1(1) 
C4 44(1) 29(1) 30(1) -1(1) -5(1) 2(1) 
C5 28(1) 23(1) 29(1) 1(1) -2(1) 2(1) 
C6 28(1) 25(1) 35(1) 0(1) -1(1) -1(1) 
C7 36(1) 27(1) 32(1) 1(1) 2(1) 2(1) 
C8 37(1) 29(1) 29(1) -6(1) -4(1) 9(1) 
O2 49(1) 49(1) 37(1) 0(1) -12(1) 16(1) 
C9 26(1) 31(1) 35(1) -9(1) -3(1) 3(1) 
C10 28(1) 25(1) 33(1) -3(1) 1(1) -1(1) 
C11 33(1) 25(1) 43(1) 2(1) -6(1) 1(1) 
O3 54(1) 39(1) 51(1) -2(1) -8(1) 22(1) 
O4 37(1) 36(1) 33(1) 2(1) 4(1) 12(1) 
C12 35(1) 33(1) 34(1) -6(1) 5(1) 4(1) 
C13 72(2) 60(2) 33(1) 2(1) 9(1) 20(1) 
C14 81(2) 39(1) 53(1) -10(1) 0(1) -11(1) 
C15 41(1) 83(2) 60(2) -17(1) 13(1) -9(1) 
N1' 29(1) 29(1) 25(1) -3(1) 1(1) -1(1) 
C2' 33(1) 32(1) 29(1) -5(1) 1(1) 8(1) 
O1' 46(1) 39(1) 33(1) -12(1) -6(1) 5(1) 
C3' 44(1) 43(1) 26(1) 0(1) 6(1) 2(1) 
C4' 34(1) 38(1) 31(1) 2(1) 8(1) -1(1) 
C5' 25(1) 26(1) 27(1) -1(1) 1(1) -1(1) 
C6' 28(1) 26(1) 39(1) 4(1) 3(1) 0(1) 
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C7' 32(1) 33(1) 43(1) 8(1) -10(1) 2(1) 
C8' 41(1) 30(1) 35(1) 4(1) -7(1) -6(1) 
O2' 87(1) 42(1) 58(1) -5(1) -42(1) -1(1) 
C9' 36(1) 26(1) 30(1) 1(1) -2(1) 1(1) 
C10' 28(1) 27(1) 28(1) -1(1) -1(1) 2(1) 
C11' 31(1) 29(1) 32(1) -5(1) 1(1) 0(1) 
O3' 39(1) 47(1) 38(1) -4(1) -3(1) -13(1) 
O4' 32(1) 37(1) 26(1) 2(1) 1(1) -9(1) 
C12' 34(1) 30(1) 30(1) 3(1) 6(1) -5(1) 
C13' 47(1) 41(1) 31(1) -2(1) 2(1) -9(1) 
C14' 40(1) 47(1) 46(1) 5(1) 10(1) 3(1) 
C15' 39(1) 33(1) 41(1) 2(1) 2(1) -5(1) 
_________________________________________________________________________________ 
 
 
Table 5.   Hydrogen coordinates ( × 104) and isotropic displacement parameters (Å2 × 103) for spirca.  
_______________________________________________________________________  
 
x y z U(eq) 
_______________________________________________________________________  
   
    
H3A 5516 8506 7056 46 
H3B 4374 7717 6788 46 
H4A 5963 6618 7424 41 
H4B 4490 6199 7424 41 
H6A 3534 6192 8407 35 
H7A 4743 5048 8960 38 
H9A 7416 6471 8139 37 
H9B 7838 7261 8655 37 
H10A 6582 8456 8036 34 
H10B 5974 8428 8628 34 
H13A 4814 8206 9782 83 
H13B 3718 7186 9712 83 
H13C 3602 8217 10173 83 
H14A 4446 10361 9488 87 
H14B 3263 10457 9892 87 
H14C 3075 10765 9266 87 
H15A 1635 7768 9347 92 
H15B 1370 9160 9152 92 
H15C 1444 8851 9782 92 
H3'A -502 4483 7218 45 
H3'B 393 3536 6887 45 
H4'A 1316 4705 7711 41 
H4'B 1781 3309 7586 41 
H6'A 1633 1961 8474 37 
H7'A 2569 2968 9158 43 
H9'A 983 5832 8544 36 
H9'B 23 5805 9044 36 
H10C -826 4901 8225 33 
H10D -954 4031 8745 33 
H13D -639 2403 9780 59 
H13E 157 1162 9667 59 
H13F -1033 1131 10070 59 
H14D -2711 2750 9305 66 
H14E -3241 1630 9666 66 
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H14F -3400 1593 9025 66 
H15D -863 -578 9155 56 
H15E -2228 -375 8882 56 
H15F -2121 -557 9520 56 
_______________________________________________________________________  
 
 
 
 
 
Full X-ray crystallographic data for Į-hydroxy ketone 179 and tricycle 295 were not available at the time of 
submission. 
 
 
 
